<?xml version="1.0" encoding="UTF-8"?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" xml:lang="en"><front xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="01693cc4-ea56-4dde-be05-ce79ad1d2489" data-edited="true" data-edited-version="2"><journal-meta id="496ee269-469e-4a82-bf4c-7133f45eff5e"><journal-id journal-id-type="hwp" id="c0fa57a7-fb83-4a80-973a-4e059120b590">bmjcr</journal-id><journal-id journal-id-type="publisher-id" id="ed18d667-448e-4b9a-b354-ac824af901f0">bcr</journal-id><journal-title-group id="ed8714da-ed65-40d1-afa7-d54ba5cefdcc"><journal-title id="5d42c764-3b0e-490f-a62b-61c3c5a74baf">BMJ Case Reports</journal-title><abbrev-journal-title id="6e5b1466-f745-459e-b0f8-ca0444a34099">BMJ Case Rep</abbrev-journal-title></journal-title-group><issn pub-type="ppub" id="451f89f4-29c7-42e6-8e3c-4fc4bc0ef916"/><issn pub-type="epub" id="1dd5edcb-076f-4da5-86c3-37881f40ed7d">1757-790X</issn><publisher id="8730edd4-d350-44cc-9142-e996a8027c94"><publisher-name id="9fc499d2-dea8-426b-bf2f-93ca6a96805a">BMJ Publishing Group</publisher-name><publisher-loc id="e1e7919b-2dee-4940-bcc0-d8efccba9c19">BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta id="36951124-48d2-45b6-901e-986ffa5b5c82"><article-id pub-id-type="publisher-id" id="4e9f016f-d386-450b-9a19-e0de647bb20f">10.1136/bcr-2020-238413</article-id><article-id pub-id-type="doi" id="220b268c-a71d-4fbd-9a48-5e23f3ef2348">bcr-2020-238413</article-id><article-id pub-id-type="paw-acronomy" id="262c8118-f6c8-49de-b8e4-d75167516bfa">bmjcr</article-id><article-id pub-id-type="nlm-ta" id="2a1443c2-ffd6-4369-b6c8-fd2f6bee4d34">BMJ Case Rep</article-id><article-categories id="e2dc8e4e-903f-4064-b373-30d68869b768"><subj-group subj-group-type="display-channel" id="1be08adb-7acb-4272-ae53-8a4532bb2366"><subject id="28ce88a5-22b0-481b-9440-8ec87f2edf8a">Case report</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" id="d8d97689-8cc0-4c4b-8db6-bf75c251af7b"><subject id="11aac105-a41e-4618-886c-322c4042e1aa">1330</subject><subject id="5392f990-ef7f-40c4-991f-186811e638f6">181</subject><subject id="c3378b1c-b550-4414-a1c2-c459dd5d3dde">495</subject><subject id="ab860adc-36c1-48c8-8308-86126f5cd77b">505</subject><subject id="b4fe2394-dbc1-457a-84ba-87cba952b2dc">2474</subject></subj-group></article-categories><title-group id="26b3af8f-3f99-451f-83b0-2d86b014159c"><article-title id="2954cb0c-b417-4781-95b2-8e858daa4bbc"><named-content rid="1607691718043" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="preeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="2d81e5d8-2f0d-4a6d-96df-28658ac65521"> </named-content><named-content rid="1607691718041" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="preeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="f87681cb-2ebf-4f3d-a99d-4c72da18924e"> </named-content>Complete recovery from COVID-19 in kidney-pancreas transplant recipient &#x2013; potential benefit from everolimus?</article-title></title-group><contrib-group data-group="author" id="babff121-5b96-411a-b776-df254e534a10"><contrib contrib-type="author" id="author-79405181" data-id="author-79405181"><name id="7f29de4c-6274-44c4-9426-ac92880b7f7b"><surname id="7cb85a91-2131-4fba-8344-cf7367db15e2">Heron</surname><given-names id="80dbc6df-d4c0-4d35-9e29-27538965010f">Vanessa C</given-names><prefix id="b010826a-64e8-445a-9752-8db0ff2691eb">Dr</prefix></name><xref ref-type="aff" rid="aff1" id="13776278-df2f-4a7f-bff7-e7518bbedc07">1</xref><email id="fe44199e-6767-4d8c-bb57-a5de51e716e0">vanessa.heron@austin.org.au</email><contrib-id contrib-id-type="orcid" data-retain="true" id="b8c96119-1d5d-479e-a74e-64597603e3dd">http://orcid.org/0000-0002-7659-6264</contrib-id></contrib><contrib contrib-type="author" id="author-79405956" data-id="author-79405956"><name id="cc07c6ee-ffdd-4121-b0dc-bce0b7507838"><surname id="d3decfa4-71fa-4c50-9a49-03d1f8aec3a7">Bach</surname><given-names id="a5aa807c-9c84-4caf-a112-d6ff622960cf">Cindy-Anne T</given-names><prefix id="84f2ddd3-a725-4323-9bbf-c9095418e01a">Dr</prefix></name><xref ref-type="aff" rid="aff2" id="6a8e23e1-2118-4178-9244-73d6002724df">2</xref><email id="c580560e-49f1-4956-ade7-d6fc7b6abf62">Cindy.Bach@austin.org.au</email></contrib><contrib contrib-type="author" id="author-44403352" data-id="author-44403352" data-edited-node="true"><name id="77c71050-df72-4cc4-9f76-db42a5613989"><surname id="21961db4-1766-4a7e-a85c-c3089a2cc529">B</surname><given-names id="9384086e-d9cf-405d-bccc-6042a9bf74df">Nitish</given-names><prefix id="9e521e57-bc30-4171-92eb-4cc541bc120d">Mr</prefix></name><contrib-id contrib-id-type="twitter" id="6eeaadc3-1514-4fc9-90fe-66b0c99c4505">@Karthik</contrib-id></contrib><corresp node-parent-node="author-notes" node-parent-insertafter-xpath="//front//contrib-group[last()]" node-parent-insert-xpath="//front//article-meta" fn-type="corresp" data-id="cor1" id="1a2a9471-7d00-4bf9-be55-0abe52d98fb5"><name data-class="jrnlAuthor" id="607d39df-ec0e-447b-9067-f1342bc9d18a"><prefix id="ddcf22d0-dfb7-4ece-a655-6206bbb76ea7">Mr</prefix> <given-names id="e29d8c22-6f5b-4ecf-9070-9d4ca16d2153">Nitish</given-names> <surname id="84399866-c77e-4278-99cf-b1510a1f1cb9">B</surname></name>, <fn fn-type="corresp-address" id="f1f1e8eb-a14b-4433-9cf7-f17609c05d9e"><p><named-content content-type="dept" id="410ed665-e9f9-463a-a715-063ecd860420">Engineering1</named-content>, <named-content content-type="institution" id="1a28a6a6-6615-4c1e-9675-d9cce91810b2">Exeter</named-content>, <named-content content-type="city" id="d00b3d51-076f-40a2-a326-8fa4711f1965">Chennai</named-content>, <named-content content-type="state" id="0f463e44-34a6-4476-9d76-201bb2373b6b">Tamilnadu</named-content>, <named-content content-type="country" id="4d091792-04b3-4d68-a9da-91a7b7f11820">India</named-content></p></fn>;</corresp><xref id="2da6358c-a5ef-4d1a-8cc3-f6ff9c966c54" rid="aff3, aff4" ref-type="aff">3,4</xref><xref ref-type="corresp" rid="cor1" id="8d3fe51d-405e-40e8-b431-26a12ea39d72">*</xref><xref id="5c31dae8-8c6c-41b5-b7cb-e7781b932241" rid="pa1" ref-type="present-address">&#x2020;</xref><email id="03f27867-5c01-484c-8f07-aac14819f0a7">martin.aringer@uniklinikum-dresden.de</email><email id="f707f181-aaef-4fda-baac-30d32b4fe0ab">martin.aringer@uniklinikum-dresden.de</email><contrib-id contrib-id-type="orcid" data-retain="true" id="ae21ad3e-c122-45cd-97e2-f8ac8eead843">http://orcid.org/0000-0001-8501-4054</contrib-id><on-behalf-of id="e7a0f724-d821-4d07-85b3-e1e09f38028d">Karthik</on-behalf-of><contrib contrib-type="author" id="author-79405886" data-id="author-79405886" data-edited-node="true"><name id="79f60917-6b81-4435-8f8c-f522d9df067d"><surname id="e1dd298d-0637-4789-a8d2-b5e5140f5467">Whitlam</surname><given-names id="4bf7ebdd-2ac4-4c6f-b315-0390acf6d397">John B</given-names><prefix id="0993d5ea-d810-44ef-a8d1-6d4eab089ae9">Dr</prefix></name><xref id="0d3c8341-3d54-448d-97ab-b2bfea814880" rid="aff1, aff5" ref-type="aff">1,5</xref><email id="48581882-0bec-49b5-8ea1-689f526d5589">john.whitlam@austin.org.au</email></contrib><p/><aff node-insert-xpath="//front//contrib-group" node-insertafter-xpath="//front//contrib[last()]" id="aff1" data-id="aff1" data-edited-node="true"><label id="05fc49fd-e0b7-41e0-be02-f0ea735b47cf">1</label><named-content content-type="dept" id="7643dbe7-de93-410e-b9f5-f2714d0e6cbc">Engineering3</named-content>, <named-content content-type="institution" id="27a3cf70-d094-4240-8665-c1baeb6b1c95">Exeter</named-content>, <named-content content-type="city" id="6b3bee96-8b10-4974-9ece-1b0534adf605">Chennai</named-content>, <named-content content-type="state" data-valid-state="true" id="88357f1b-45f7-427f-ace9-17aed22c8254">Tamilnadu</named-content>, <named-content content-type="country" id="b30e752f-0536-4f53-a49d-fe7e72b372f9">India</named-content></aff><aff node-insert-xpath="//front//contrib-group" node-insertafter-xpath="//front//contrib[last()]" id="aff2" data-id="aff2"><label id="3fa14c0d-bb99-42d4-bdee-1a24fc8ab93c">2</label><named-content content-type="dept" id="a0d84e71-d06a-4c01-8f06-586861a77811">Department of General Medicine</named-content>, <named-content content-type="institution" id="0622be2e-d63d-41d7-a693-027a422afb8e">Austin Health</named-content>, <named-content content-type="city" id="4072130f-3dc2-42eb-96be-8a56e3f1afdd">Heidelberg</named-content>, <named-content content-type="state" data-valid-state="true" id="e50c1dc8-0fa6-4889-b02c-02a71937186f">Victoria</named-content>, <named-content content-type="country" id="ef767b68-2828-43c4-a06b-010de280cc53">Australia</named-content></aff><aff node-insert-xpath="//front//contrib-group" node-insertafter-xpath="//front//contrib[last()]" id="aff3" data-id="aff3"><label id="54093ed2-1c48-4d06-8796-cee3013a1f2b">3</label><named-content content-type="dept" id="2a72a178-5b4a-41ba-b0ed-b748e2147674">Infectious Diseases</named-content>, <named-content content-type="institution" id="57dc7bd1-8193-4a40-9cc1-547c81457392">Austin Health</named-content>, <named-content content-type="city" id="a4d2b06f-c1bb-4321-80bf-232f48bfa8ca">Heidelberg</named-content>, <named-content content-type="state" data-valid-state="true" id="faa721cd-ecb3-4a64-9543-3ae612a44208">Victoria</named-content>, <named-content content-type="country" id="f1cff63c-99a2-44c5-affd-37cd98aba3dc">Australia</named-content></aff><aff node-insert-xpath="//front//contrib-group" node-insertafter-xpath="//front//contrib[last()]" data-id="aff4" id="5e8bb314-e3ca-4f8a-8b17-ff8af5cdf88b" data-track="ins" data-cid="1614319966033" data-username="Copyeditor (COPYEDITOR)" data-userid="copyeditor 8196318a-db6e-4c08-9abb-fa8ece94f452" data-time="1614319966032"><label id="7ef9b061-d227-44ee-826a-b108e64858e3">4</label><named-content content-type="institution" id="e09714c8-38e8-465a-9e64-1ed405125e76">University of Warwick</named-content>, <named-content content-type="city" id="f78be1a8-c118-4510-9ba3-0c5c7b5bf3ab">West Midlands</named-content>, <named-content content-type="state" id="d47d3439-5203-437a-abc3-6cb26511c33d">Coventry</named-content>, <named-content content-type="country" id="76ee76a2-005f-45d1-97f2-53b3583137e9">UK</named-content></aff><aff node-insert-xpath="//front//contrib-group" node-insertafter-xpath="//front//contrib[last()]" id="aff4" data-id="aff5"><label id="a790dd12-71e2-4005-837b-5e48a2813b36">5</label><named-content content-type="dept" id="a289b80f-a3f8-4023-98e9-03c60765ce8c">Department of Medicine</named-content>, <named-content content-type="institution" id="8ca15c67-2253-4bc8-9741-45f87ba5b8b6">Austin Health</named-content>, <named-content content-type="city" id="b27e0f81-8ac4-4e5c-950d-aa79e91bb549">Heidelberg</named-content>, <named-content content-type="state" data-valid-state="true" id="780f36fd-9856-4e80-83c3-8c94b9661c91">Victoria</named-content>, <named-content content-type="country" id="da920583-2500-478d-b786-588cefc5101d">Australia</named-content></aff></contrib-group><contrib-group content-type="section" id="77ce2955-d792-4ef2-829c-34a9b9bc6813"><contrib contrib-type="editor" id="author-21206540"><name id="4ee8a904-f4f5-46ad-a3b0-2730f7a1d829"><surname id="086b9d14-c52a-4386-999b-c221ae3c86be">Biswas</surname><given-names id="7207b99c-1f04-40e6-844b-4398b3d6a3df">Seema</given-names></name><xref ref-type="aff" rid="ae-aff1" id="b07196b2-7c0e-4e6a-8f1a-3778fce32a05"/></contrib><contrib contrib-type="editor" id="author-21206540"><name id="c779cd3f-d4dd-46f3-9f88-14d69657068b"><surname id="abbc10e1-1bc1-477d-8fb7-566e584d7127">Biswas</surname><given-names id="496fe776-8b82-4f1c-b901-73caca999154">Seema</given-names></name><xref ref-type="aff" rid="ae-aff2" id="e2a179f3-2a05-463c-a678-801305b106d6"/></contrib><aff id="ae-aff1" data-id="ae-aff1"><institution id="be5f6cb6-c09a-44d6-8e21-8f8771a2d663">BMJ Case Reports</institution>, <city id="07c4dec1-6b32-476f-ad30-ca79c524a9e7">London</city>, <country id="109ffa40-21e4-4316-b0c9-1e7e96962f7a">UK</country></aff><aff id="ae-aff2" data-id="ae-aff2"><institution id="e9b6e7a5-567a-41b6-886b-708619771385">BMJ Case Reports</institution>, <city id="28f6c8cf-bc41-46b0-a50d-0c7225531810">London</city>, <country id="d5f3e239-471c-4a9c-862b-e4a5bf509e82">UK</country></aff></contrib-group><author-notes id="31e5b589-d3ce-4848-acb3-139a952a371a"><fn fn-type="con" data-label="Contributors" id="fn1" data-id="fn1"><label id="f6280291-58a5-4730-9ef4-bde38b8711ac">Contributors</label><p id="1696abd1-9d23-4c11-b230-894ad196c630">All authors contributed to the preparation of this article. The were involved in conception and design, drafting and revising the article and final approval of the version published.They agree to be accountable for the article and to ensure that all questions regarding the accuracy or integrity of the article are investigated and resolved.</p></fn><fn fn-type="data-sharing-statement" data-label="Data availability statement" id="fn2" data-id="fn2"><label id="8f510ce2-88ef-4074-a1d5-9c0d42861880">Data availability statement</label><p id="6865d237-f98c-4fd4-a0ea-531f4ff24935"/></fn><fn fn-type="conflict" data-label="Competing interests" id="fn3" data-id="fn3"><label id="3367f48b-1a9a-4a30-bdd4-a2f496e04a91">Competing interests</label><p id="e28b9eb3-664a-475f-b0bc-e0b685787750">None declared.</p></fn><fn fn-type="consent" data-label="Patient consent for publication" id="fn4" data-id="fn4"><label id="7477283b-144e-4258-b153-869a5e3dba4f">Patient consent for publication</label><p id="5ee42f9e-4b65-4874-8591-6cbb5747029b">Obtained.</p></fn><fn fn-type="provenance-and-peer-review" data-label="Provenance and peer review" id="fn5" data-id="fn5"><label id="f38170a1-2e58-47e8-89fd-e115059bb990">Provenance and peer review</label><p id="7e330e7a-007e-48c6-98c2-55feda3081e4">Not commissioned; externally peer reviewed.</p></fn><fn fn-type="deceased" node-parent-node="author-notes" node-parent-insertafter-xpath="//front//contrib-group[last()]" node-parent-insert-xpath="//front//article-meta" data-label="Deceased" id="d2b269aa-15aa-430a-9b5c-cf02e20ae31d"><label>Deceased</label><p add-data-inserted="true" id="a7007308-f90b-48a7-a4bc-2a6f9e0dbe76"/></fn><fn fn-type="present-address" node-parent-node="author-notes" node-parent-insertafter-xpath="//front//contrib-group[last()]" node-parent-insert-xpath="//front//article-meta" data-id="pa1" id="d8dc2016-282a-4eaa-b98d-c6e77886cf29" data-track="ins" data-cid="1614319970172" data-username="Copyeditor (COPYEDITOR)" data-userid="copyeditor 8196318a-db6e-4c08-9abb-fa8ece94f452" data-time="1614319970172"><label>&#x2020;</label><p id="d2b577fd-c1d9-4efe-bd5f-9436c41f6ac9"><named-content content-type="dept" id="cf64fb98-ee28-4b30-af9f-aab793ae9892">Engineering2</named-content>, <named-content content-type="institution" id="bf2df9b2-7745-424e-bf7d-ead38142cbd7">Exeter</named-content>, <named-content content-type="state" id="39eaaa7b-dca0-493d-80aa-5614538a47c2">Tamilnadu</named-content>, <named-content content-type="city" id="46cb0dea-c9dd-41be-b1d6-d851cd633b6c">Chennai</named-content>, <named-content content-type="country" id="a2589a3f-965b-4d64-8a91-5e468a17e81c">India</named-content></p></fn></author-notes><pub-date pub-type="ppub" id="b1bcade6-2571-414b-855b-b8ea32b72fdd"/><pub-date pub-type="epub" id="3f075b56-2a6b-4882-b879-30487b2a2d98"/><volume id="97df4da5-f7cd-46d6-aca4-5b153fc6cf75"/><issue id="45adfa0b-4a7a-445b-81f6-daba3ea59b8b"/><elocation-id id="f6737902-a6a6-4f21-8598-fd8917aa7dfe">e238413</elocation-id><history id="3f2bc1f7-e64b-420f-ad39-e4e2f4a23fdc"><date date-type="accepted" id="c90b9d7f-a77f-47e0-98dd-1c730a04ae55"><day id="7c0b4a0c-a55e-4443-9acf-e9ba82a0cd48">10</day><month id="eb101e45-14dc-4603-8923-f6c793ef48e8">12</month><year id="0d576369-f81b-4ba2-bb6e-a97ea2019124">2020</year></date></history><permissions data-type="nonOA" id="3357f844-6ef8-4798-83b0-626c9b866659"><copyright-statement data-statement="new" id="90767312-e321-4150-b82f-f531b4dc6314">&#xa9; BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement><copyright-year id="94800bad-2692-4453-af44-a23dbc5e00c1">2020</copyright-year><license id="47db193c-2563-425a-b057-4e4d021c6dd9"><license-p id="7954c5eb-0173-44c8-aa79-4e536adc0437"/></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="companion" xlink:href="http://&#x200b;dx.&#x200b;doi.&#x200b;org/&#x200b;10.&#x200b;1136/annrheumdis-2020-217062" id="0f1ad477-8158-4bcc-9f07-9d3eb4408389" data-edited-node="true" data-element-added="true"><comment data-class="jrnlRelArtComment" id="7d58b109-1fab-46a9-a8ab-9a147bf6e26f">sample</comment><article-title data-class="jrnlRelArtTitle" id="a6a234e6-9ea2-4f6b-8813-17131d24c168">Anticipated impacts of brexit scenarios</article-title><source data-class="jrnlRelArtSource" id="59922c68-a7c4-456b-addd-80e344fb3f2e">new</source><volume data-class="jrnlRelArtVolume" id="1a6752a2-f8d0-41ae-a0fe-37bf1f3fc8b8">1</volume><fpage data-class="jrnlRelArtFPage" id="f67556e1-e9b6-4039-b4e7-566a0aa0617a">1</fpage><lpage data-class="jrnlRelArtLPage" id="234ba6d6-54b1-4cef-a04f-4bec35e0311d">100</lpage><elocation-id data-class="jrnlRelArtELocation" id="7080ec1c-b96e-4f95-937f-ed327f15d3b8">None</elocation-id><pub-id pub-id-type="doi" data-class="jrnlRelArtDOI" id="b5f4a5c8-13aa-40b4-99cf-4accb9b3880d">annrheumdis-2020-217062</pub-id><year id="0637f080-4256-401e-9c27-c2a999176910" data-class="jrnlRelArtYear">2010</year></related-article><files id="86ab6eb1-ddee-471d-bcf2-a933ffc341f4"><file file-type="Full Cases template" file_category="" file_name="bcr-2020-238413-File001.docx" submission_medium="online" id="c9451926-e985-4329-a085-315b0c1474fd"><file_createddate id="d5dad5ca-a2d7-4795-bace-ca49e12010c6">2020-11-18 05:29:52.52</file_createddate><file-format id="cdb7a62b-c3e3-4c6a-8ff5-a1a03081c461">docx</file-format><file-extension id="63a4a5fc-da8d-43d1-9f94-7eaba8b43ad6">docx</file-extension><file-name id="a9babd5f-4e84-41f6-9c6c-e890979e0486">Heron_October_2020.docx</file-name><file-caption id="3fa49b5d-c8a5-4967-9a14-a449679e672f"/><file_tag id="7b40068c-5ed6-4d55-ab34-fab5a8f4799a"/><attribute attr_name="File Designations" id="a0a3f174-14f5-4df8-9d1b-042a39336663">Full Cases template</attribute></file></files><abstract id="6f72660a-52ae-422d-8424-69f584c320c6"><title data-level="1" data-authors="true" id="8205fab8-959a-461a-a290-91ef7c719310">SUMMARY</title><p id="8d43d721-ceb9-420b-93d9-112c69c7a0a3">We present a kidney-pancreas transplant recipient who achieved a complete recovery from COVID-19. The 45-year-old T3 paraplegic underwent kidney-pancreas transplantation <named-content xmlns:xlink="http://www.w3.org/1999/xlink" id="cf7773bf-e0a3-4266-b4fe-550f671faca7" data-cid="cf7773bf-e0a3-4266-b4fe-550f671faca7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="170" data-match="18 years" data-replace="18" data-pattern="$1" data-tag-index="1_1" data-time="" data-username="" data-userid="">18</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" id="d35e4288-7b18-41ca-b592-a0f8463c9e2f" data-cid="d35e4288-7b18-41ca-b592-a0f8463c9e2f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from ' years' to ' years'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="172" data-match="18 years" data-replace=" years" data-pattern=" $2" data-tag-index="1_1" data-function="addTrackChanges" data-time="" data-username="" data-userid=""> years</named-content> ago, followed by a subsequent kidney transplant <named-content xmlns:xlink="http://www.w3.org/1999/xlink" id="25c7128c-61f1-4ccb-b8f7-a79649478fed" data-cid="25c7128c-61f1-4ccb-b8f7-a79649478fed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="227" data-match="9 years" data-replace="9" data-pattern="$1" data-tag-index="1_2" data-time="" data-username="" data-userid="">9</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" id="0a6e631b-27bc-4755-9b85-445fea67217c" data-cid="0a6e631b-27bc-4755-9b85-445fea67217c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from ' years' to ' years'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="228" data-match="9 years" data-replace=" years" data-pattern=" $2" data-tag-index="1_2" data-function="addTrackChanges" data-time="" data-username="" data-userid=""> years</named-content> ago, and presented with fevers, hypoxia and hypotension after exposure to two confirmed cases of COVID-19. History of <named-content xmlns:xlink="http://www.w3.org/1999/xlink" id="0d4be511-e995-472a-838e-3f7337ea2147" data-cid="0d4be511-e995-472a-838e-3f7337ea2147" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="353" data-match="solid organ transplant" data-pattern="" data-tag-index="" data-abbr="SOT" data-time="" data-username="" data-userid="">solid organ transplant</named-content>, pre-existing renal impairment, asthma and an elevated <named-content xmlns:xlink="http://www.w3.org/1999/xlink" id="a346968c-6e86-4ae1-9faf-a230466bb158" data-cid="a346968c-6e86-4ae1-9faf-a230466bb158" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SMCP" data-track-detail="" data-tag-desc="SMCP" data-tag-type="SMCP" data-offset="431" data-match="d-" data-pattern="" data-tag-index="1_3" data-function="smallCaps" data-time="" data-username="" data-userid="">d</named-content>-dimer were identified as established risk factors for severe COVID-19 disease. Supportive management was provided, baseline immunosuppression with everolimus was continued, and oral prednisolone was increased. A complete recovery was observed. Given the favourable outcome despite risk factors for COVID-19 disease severity, we identify and review the potential mitigating roles of immunosuppression and mTOR-inhibitors in this disease. Further investigation is required to establish whether mTOR inhibitors could be used as therapeutic agents to treat COVID-19, or as alternative immunosuppression implemented early in the COVID-19 disease course.</p></abstract><kwd-group id="bca123e7-32fb-497d-a8b7-aecc59ab2f78"><kwd data-class="jrnlKeyword" id="3d94c9c3-93a0-4f60-9bc3-fb76c04f5c7a"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691770" id="65b779d1-35cd-437c-a1fb-4408cfdacc14" content-type="changeCase sty cts-2" specific-use="1607691837120" xlink:title="Priyanka (PREEDITOR)" alt="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-title="lowercase Added by Priyanka (PREEDITOR) - 12/11/2020 6:33pm" data-track-hint="lowercase Added" data-userid="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-username="Priyanka (PREEDITOR)" data-time="1607691837120">re<span data-class="hidden" hidden-track="track" id="8bc05018-8026-40d2-ad4c-25e356cd143b">Re</span></named-content>nal transplantation</kwd><kwd data-class="jrnlKeyword" id="21de2865-c092-4fbb-8579-25d8dc95fb11"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691771" id="14d07f4d-ffea-4896-90db-3fc10b10bc8f" content-type="changeCase sty cts-2" specific-use="1607691840819" xlink:title="Priyanka (PREEDITOR)" alt="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-title="lowercase Added by Priyanka (PREEDITOR) - 12/11/2020 6:34pm" data-track-hint="lowercase Added" data-userid="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-username="Priyanka (PREEDITOR)" data-time="1607691840819">dru<span data-class="hidden" hidden-track="track" id="0d4090c3-c2cc-430f-af17-4d4829f31b68">Dru</span></named-content>gs: infectious diseases</kwd></kwd-group><custom-meta-group id="9abcdc89-ac12-4885-94a7-61f4973cd4ed"><custom-meta id="786807b5-72c4-44f7-be81-aa610bbf702e"><meta-name id="b658d89c-f9b7-4e75-af22-373df80465e0">Copy editing requirement</meta-name><meta-value id="663415aa-fb69-4ed6-97b0-af2a4ff90db3">2</meta-value></custom-meta><custom-meta id="fdd2b52a-4318-4b64-aadc-f610efc0ca31"><meta-name id="17548ec8-aa09-487e-8da7-65ef1832ec3e">Author requirement</meta-name><meta-value id="e2ee2f1e-79e5-47cb-b46d-b001a76b00cb">2</meta-value></custom-meta><custom-meta id="30f1bff6-4a18-4d1b-b762-0732556b1e77"><meta-name id="3930bdf2-bea8-4d2f-863d-44d97ce4f1e9">payment method</meta-name><meta-value holdtype="NoHold" id="a3c33e41-27e5-48e6-9fca-c27b48ef0f97">No APC</meta-value></custom-meta><custom-meta id="c0c94c3d-c308-46ab-ba60-677cc9d2a713"><meta-name id="d81aeb92-0f34-46d2-9466-aad591ed298e">license type</meta-name><meta-value id="9b9f3d50-1e0d-43af-9350-f0128c7d9708">nonOA</meta-value></custom-meta><custom-meta id="7ef31838-0155-4e73-8e5b-d81583cf048a"><meta-name id="18ea628c-78a9-4b6c-8ecc-3165eeb6dd29">Spelling language</meta-name><meta-value id="8deef74e-8aa9-4b3f-8104-73eb3d068953">en-GB</meta-value></custom-meta><custom-meta id="a87da706-a8ed-4760-800e-c1b272adcf9c"><meta-name id="f4108287-22c3-482f-9748-9eea4557e690">Keywords - Expertise</meta-name><meta-value id="ca447032-eff6-4377-9019-065e076c034f">Renal medicine</meta-value><meta-value id="41e63e7d-b9d9-4faf-9349-ab202561d0f0">Renal transplantation</meta-value><meta-value id="ccffcc6e-00ff-4a7f-88a6-fdc56561a9bc">Infectious diseases</meta-value><meta-value id="c09c35ad-5a22-4a3d-807c-2b866578019c">Drugs: infectious diseases</meta-value></custom-meta><custom-meta id="2e8ae5a8-75a4-4b38-8239-1dcd33a4264b"><meta-name id="32710d88-8ee1-472d-97fc-11c76606b71c">priority</meta-name><meta-value id="0a4748c2-6e14-4463-b641-a5c0a0ab5220">on</meta-value></custom-meta><custom-meta id="7f5e9fc6-b7d1-499e-9c25-141f8ea6d0fb"><meta-name id="9f3f7e43-4dbb-456f-9e9c-29091bbbac3c">access-type</meta-name><meta-value id="7d9f89b8-1aea-4ce5-8843-d09d5f1fc586">free</meta-value></custom-meta><custom-meta id="c55a465d-ff3a-42df-8aad-0279e32357ab"><meta-name id="1747a840-eeee-4d2c-9db7-196d9ecaf29b">covid-related-article</meta-name><meta-value id="ac00be0e-3f1f-49bb-9b45-3715ecc28cbd">yes</meta-value></custom-meta><custom-meta id="a44b46ec-8c50-4d28-bee6-1ce721106372"><meta-name id="681c6111-e6a5-4020-a65a-ebfa3f7781a9">proofingEngine</meta-name><meta-value id="d207bd9b-359a-4d3d-a105-0e82f6d7fa2f">InDesignSetterCC</meta-value></custom-meta><custom-meta id="433ba7a8-6753-41ac-b884-908bdf283821"><meta-name id="2f1dd649-de2d-476d-8bf9-dfc227b544f8">Job Loaded At</meta-name><meta-value id="76e89dee-d61c-4458-98ef-81f229a5fca4">1607671808776</meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="1607691718041" node-insert-xpath="//article-meta//custom-meta-group" xlink:type="action" data-type="action"><meta-value id="d78171a5-b9b1-48f2-af74-0f5d56253868"><named-content xlink:title="Exeter Pre-editing" specific-use="Dec 11 2020 (18:32)" content-type="Author" alt="preeditor" id="1a351b19-7341-4b42-a2c0-e7ed721c7a22">Corrections at this stage should be limited to those that are essential. Extensive corrections will delay the time to publication and may also have to be approved by the Editor. Changes can not be made after the article has published online. Please acknowledge that you have read this message.</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="1607691718042" node-insert-xpath="//article-meta//custom-meta-group" xlink:type="action" data-type="action"><meta-value id="a44432fb-c44c-4a2b-a9c0-e36fa8350586"><named-content xlink:title="Exeter Pre-editing" specific-use="Dec 11 2020 (18:32)" content-type="Author" alt="preeditor" id="0c78a28b-b6a0-4d4b-8f3a-ad5cd99ee2a9">Please verify the level of the section headings within the main text of the article.</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="1607691718043" node-insert-xpath="//article-meta//custom-meta-group" xlink:type="action" data-type="action"><meta-value id="746d88c0-89bf-48c2-9673-74e3b67b9701"><named-content xlink:title="Exeter Pre-editing" specific-use="Dec 11 2020 (18:32)" content-type="Author" alt="preeditor" id="48964b04-a84d-4e52-9c07-65879009ac93">Author names and affiliations are listed according to the information you submitted to the ScholarOne site and NOT as written in your submitted Word document. To update or correct any affiliation just click on the relevant author name or affiliation address within the proofing system.</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="1607691718044" node-insert-xpath="//article-meta//custom-meta-group" xlink:type="action" data-type="action"><meta-value id="c794a567-b761-422e-966c-cf158140416e"><named-content xlink:title="Exeter Pre-editing" specific-use="Dec 11 2020 (18:32)" content-type="Author" alt="preeditor" id="83115805-5184-41c0-83f6-aba6fc4a9669">Please verify/crosscheck that all data (if provided) in the Abstract, Figures, Tables and main text of the article are accurate and consistent.</named-content></meta-value></custom-meta><custom-meta id="481d0003-1c0e-471a-b581-150e29d606d1"><meta-name id="a2206cbf-48ec-44ff-9830-2749e828ccfe">Copy editing requirement</meta-name><meta-value id="f1e9699e-e2e4-4336-a16e-0686f3298561">2</meta-value></custom-meta><custom-meta><meta-name>Copyediting_user_level</meta-name><meta-value>undefined</meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="1d01e216-5eb8-41d8-8d6a-3d9aeb92421c" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="0637f080-4256-401e-9c27-c2a999176910" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="50675376-8766-4efe-84ed-a46e473762e4"><named-content specific-use="change-person" data-title="" id="acd6e2cb-b695-4371-9149-b4216408b503">Copyeditor</named-content> <named-content specific-use="" data-title="" id="0af65a55-68e3-469f-9493-2ea0107af602">inserted</named-content> <named-content specific-use="newVal" data-title="" id="9c3526ca-9e9a-489c-b75f-6046183bdbe8">2010</named-content> <named-content specific-use="" data-title="" id="c5290dc1-58e8-4547-aecc-77c76b11daf1"> in Year field on</named-content> <named-content specific-use="change-time" data-title="" id="4118136b-bad5-4459-a54a-797f09035f70">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="742aa880-7405-4f51-886e-21bf35d9b6f0" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="7080ec1c-b96e-4f95-937f-ed327f15d3b8" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="b49b88da-dcdb-4bb4-9d90-4479e55d7d78"><named-content specific-use="change-person" data-title="" id="574d085e-359f-4f25-ace0-3ba4426993dc">Copyeditor</named-content> <named-content specific-use="" data-title="" id="21357f04-2d78-4889-89f6-24d782936424">changed</named-content> <named-content specific-use="oldVal" data-title="e10.1136/dtb.2019.000074" id="3cbe47d8-bb65-400d-b45a-f5267aa6171c">e10.1136/dtb.2019.000074</named-content> <named-content specific-use="" data-title="" id="60bbdb96-a8ce-44dd-bfd3-e97a10e0b04f">to</named-content> <named-content specific-use="newVal" data-title="" id="ac49b21b-f4cc-4aee-a9f7-9292b0d7916b">None</named-content> <named-content specific-use="" data-title="" id="99bf4977-29a9-4952-9955-cf4427a2308e"> in Elocation field on</named-content> <named-content specific-use="change-time" data-title="" id="4707bb0a-97a3-4e90-953f-2e54bb9202a5">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="c67571d6-075a-4ce8-8e34-7163727dff68" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="234ba6d6-54b1-4cef-a04f-4bec35e0311d" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="72ba9258-6565-498a-be2f-bec5dcddc745"><named-content specific-use="change-person" data-title="" id="8c3253b2-8da7-417d-b605-128ddd0370dd">Copyeditor</named-content> <named-content specific-use="" data-title="" id="27d1e196-d45f-402e-bc3f-61d75d143de2">inserted</named-content> <named-content specific-use="newVal" data-title="" id="7960c6ba-58d2-4b45-b402-d773c300be1f">100</named-content> <named-content specific-use="" data-title="" id="de6d15dd-93fc-464f-9a15-add6a81b66db"> in Last Page field on</named-content> <named-content specific-use="change-time" data-title="" id="61982922-ac6a-48c8-9676-5dec44f2cc39">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="3a493424-0a41-498c-9c16-7b3d8ee3b8e4" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="f67556e1-e9b6-4039-b4e7-566a0aa0617a" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="cb06adc1-0a75-4302-b404-54273bc564f3"><named-content specific-use="change-person" data-title="" id="20c51f5a-b901-4896-af91-c68a2cc6f4ba">Copyeditor</named-content> <named-content specific-use="" data-title="" id="f172dcbe-abae-42d7-ad13-154bbdc04e00">inserted</named-content> <named-content specific-use="newVal" data-title="" id="7d5d5802-c28d-4a1d-a9e7-1f5d8275d587">1</named-content> <named-content specific-use="" data-title="" id="9657fe54-5fb8-4c80-b7fa-b50711cf847e"> in First Page field on</named-content> <named-content specific-use="change-time" data-title="" id="ad8d5b6f-af80-426a-be56-c9b84dfb1bcf">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="c4905b27-1f09-4710-af89-bde27e2e908a" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="1a6752a2-f8d0-41ae-a0fe-37bf1f3fc8b8" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="6760dd9d-ccc5-4c69-bc9a-9161c9d3609f"><named-content specific-use="change-person" data-title="" id="622a6aa9-0b12-4a57-ba32-d338a13dd1d6">Copyeditor</named-content> <named-content specific-use="" data-title="" id="20e22562-f35b-4801-af17-c10843453373">inserted</named-content> <named-content specific-use="newVal" data-title="" id="230ad955-7931-442d-8f69-bebd864cfd41">1</named-content> <named-content specific-use="" data-title="" id="d20349a3-4845-40b9-a222-ed16b67a19d8"> in Volume field on</named-content> <named-content specific-use="change-time" data-title="" id="ecf7fda1-6244-498b-ba27-56e25d74efcc">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="a7a8f795-8b34-4c61-9f9a-b92f7679097e" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="bd9cd5f2-2c74-484f-b22a-98985a9354cd" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="9e93b155-f364-461f-8acb-c68fb5c07cb1"><named-content specific-use="change-person" data-title="" id="6e801f3b-ac2e-493a-9865-76b96808c7ae">Copyeditor</named-content> <named-content specific-use="" data-title="" id="11def0ef-0d9a-4a8e-98ae-78f5a3ad4ed2">inserted</named-content> <named-content specific-use="newVal" data-title="" id="45daedf5-b81b-4d79-8a40-7e56a87d3270">2010</named-content> <named-content specific-use="" data-title="" id="35a2e32c-34a0-4f21-a073-a6b0a4bc8db3"> in Year field on</named-content> <named-content specific-use="change-time" data-title="" id="d334c675-b8ae-4c9b-a7b4-cdd5f1c0815c">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="715102bf-cf77-4b95-ba11-c9556f142be8" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="7080ec1c-b96e-4f95-937f-ed327f15d3b8" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="a7b64e57-cf3d-448a-9900-b682fea5423e"><named-content specific-use="change-person" data-title="" id="87b2a83f-401a-4cf6-9872-51641e543ef3">Copyeditor</named-content> <named-content specific-use="" data-title="" id="bfadf495-0317-43f6-9e33-47599d61c67a">inserted</named-content> <named-content specific-use="newVal" data-title="e10.1136/dtb.2019.000074" id="bf9fe04c-eb34-4064-881a-a4137efa1657">e10.1136/dtb.2019.000074</named-content> <named-content specific-use="" data-title="" id="8a333ed5-48ca-42bf-8091-bc6b4d6528b6"> in Elocation field on</named-content> <named-content specific-use="change-time" data-title="" id="9335126a-5427-403f-9bd8-f63937c8361a">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="839012be-96d7-4244-9c26-e0c2654bb787" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="abe01425-747a-4407-ae15-dd7c7f4705d0" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="fed88a5e-0467-4833-87e4-71f7c33d9b5d"><named-content specific-use="change-person" data-title="" id="bae16402-89dc-4a6a-99fd-8170eadacdee">Copyeditor</named-content> <named-content specific-use="" data-title="" id="3bdc5e3a-8530-4609-8cff-351d62642e63">inserted</named-content> <named-content specific-use="newVal" data-title="http://&#x200b;dx.&#x200b;doi.&#x200b;org/&#x200b;10.&#x200b;1136/annrheumdis-2020-217062" id="4656c205-f689-4766-b8e4-a05a2902c8f5">http://&#x200b;dx.&#x200b;doi.&#x200b;org/&#x200b;10.&#x200b;1136/annrheumdis-2020-217062</named-content> <named-content specific-use="" data-title="" id="6cf1ab99-d7bb-4aa1-ac09-755c9832fa56"> in Link field on</named-content> <named-content specific-use="change-time" data-title="" id="c5217060-1452-4e8b-9462-ce4a1fc05e9f">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="8939c0f7-d3b1-408e-9f7c-c6edbb934d67" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="abe01425-747a-4407-ae15-dd7c7f4705d0" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="a169de06-5929-4936-9407-5e08a3590063"><named-content specific-use="change-person" data-title="" id="c6867257-3b27-4be5-8a66-91887fddddeb">Copyeditor</named-content> <named-content specific-use="" data-title="" id="cfa801c4-4e1d-45d1-8393-4bdf0894bbd4">inserted</named-content> <named-content specific-use="newVal" data-title="DTB drug review" id="5d004917-a2e0-4049-9eb7-90a88ed2cae4">DTB drug review</named-content> <named-content specific-use="" data-title="" id="943287fc-1eec-4450-85bc-9a820a2a84bf"> in Related Article Type field on</named-content> <named-content specific-use="change-time" data-title="" id="8dd7e64b-17f8-4a3f-8f3e-0d9d868087bc">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="dd7e949b-131a-4fe6-98ed-e23882e89313" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="b5f4a5c8-13aa-40b4-99cf-4accb9b3880d" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="641c6b89-5788-489f-8651-545e4bb6b155"><named-content specific-use="change-person" data-title="" id="3ce0be2a-249f-44d0-be17-43d9df1ea178">Copyeditor</named-content> <named-content specific-use="" data-title="" id="9e624ef0-25be-4781-a61d-c5465e4eefa6">inserted</named-content> <named-content specific-use="newVal" data-title="DTB-2019-000074" id="b1c68d8f-1d3e-4f0e-97e3-9db9df2f0640">DTB-2019-000074</named-content> <named-content specific-use="" data-title="" id="3a10ab55-4a73-496e-a415-c7bf622452ad"> in DOI field on</named-content> <named-content specific-use="change-time" data-title="" id="1024a8f9-bdca-41b2-ad8b-cbd5fa79795d">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="fcb8bab5-8049-443d-a03c-82c3e62d2925" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="7d58b109-1fab-46a9-a8ab-9a147bf6e26f" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="2a0d095e-f1b6-4cf5-9832-9d20ebdad6e6"><named-content specific-use="change-person" data-title="" id="9cffe0d4-1064-4bdd-8c34-0b26a8f86c0b">Copyeditor</named-content> <named-content specific-use="" data-title="" id="5812e29c-070a-4b87-931f-792d570b60d4">inserted</named-content> <named-content specific-use="newVal" data-title="" id="bd28a6e8-54da-4ce1-a505-49972d16adfb">sample</named-content> <named-content specific-use="" data-title="" id="60f646b4-dffc-47d8-877c-28cd69ae8a6c"> in Comment field on</named-content> <named-content specific-use="change-time" data-title="" id="20909692-1e84-44cb-a79d-0386fd4edfe0">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="9e169efa-3379-4393-bdf4-5aca47731e85" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="59922c68-a7c4-456b-addd-80e344fb3f2e" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="216c0070-718a-42ca-b9d1-da5c3802445d"><named-content specific-use="change-person" data-title="" id="3767ac1a-74de-4724-bc86-8980c9a8a3fa">Copyeditor</named-content> <named-content specific-use="" data-title="" id="680da1b2-2611-48f0-bccd-634d9c94a612">inserted</named-content> <named-content specific-use="newVal" data-title="Drug and Therapeutics Bulletin" id="b273db25-a4e4-4f44-a45a-7bece701ac7d">Drug and Therapeutics Bulletin</named-content> <named-content specific-use="" data-title="" id="cffa5eff-181e-4602-9af0-5b4a524f9454"> in Journal Title field on</named-content> <named-content specific-use="change-time" data-title="" id="446fb712-e9fe-42cc-b259-25fe6657ea87">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="45445381-f55d-4219-8a71-afa48ab6372a" xlink:title="0f1ad477-8158-4bcc-9f07-9d3eb4408389" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="a6a234e6-9ea2-4f6b-8813-17131d24c168" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="929a4ea1-f216-408e-ad79-355281cd2b0c"><named-content specific-use="change-person" data-title="" id="06b6e805-765a-4d6e-ae77-8d7186a17823">Copyeditor</named-content> <named-content specific-use="" data-title="" id="75b9896f-34af-47da-8bf8-169319020d0a">inserted</named-content> <named-content specific-use="newVal" data-title="Formulation: 3 mg film-coated tablets and 1mg/mL oral solution" id="392367a2-0855-4f80-af96-f2314254c09f">Formulation: 3 mg film-coated tablets and 1mg/mL oral solution</named-content> <named-content specific-use="" data-title="" id="a5939479-c328-43b3-b71f-afb964a8f0ad"> in Article Title field on</named-content> <named-content specific-use="change-time" data-title="" id="a182d78e-0439-47cd-a441-9738bf49c978">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="cba72348-085b-4735-badc-5821d8055801" xlink:title="aff1" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="b30e752f-0536-4f53-a49d-fe7e72b372f9" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="531845f9-d0a4-4d8c-a8f2-855fd658aa17"><named-content specific-use="change-person" data-title="" id="b56fb4a3-e94d-46f1-9e20-022b41a24a9c">Copyeditor</named-content> <named-content specific-use="" data-title="" id="829426b6-caef-42ae-bd5e-454b75879999">inserted</named-content> <named-content specific-use="newVal" data-title="" id="c01ad89b-fd67-47c0-b7b8-5840ff979aef">India</named-content> <named-content specific-use="" data-title="" id="ff039161-8c90-404f-85e7-63a41b0e8c5d"> in Country field on</named-content> <named-content specific-use="change-time" data-title="" id="440f5ad9-febc-44d6-8f52-e5193d3073c4">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="ec30bc91-cdb7-4ffe-a616-109940e9b1a4" xlink:title="aff1" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="88357f1b-45f7-427f-ace9-17aed22c8254" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="05bac057-9753-48d8-91e1-d4be8cecfe79"><named-content specific-use="change-person" data-title="" id="c770864a-5aed-4c3b-a955-0d235841da58">Copyeditor</named-content> <named-content specific-use="" data-title="" id="0b698b7d-02af-4843-8114-a3a61e5d4866">inserted</named-content> <named-content specific-use="newVal" data-title="" id="a3a4722d-301c-4231-b520-233b209a57d7">Tamilnadu</named-content> <named-content specific-use="" data-title="" id="9fc15ebe-dabf-4828-b033-98f65ffc9eb4"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="67155596-dd4c-4a4d-bc2c-d9dc79884453">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="4036e996-b045-40c1-a2e3-5fdba3ab199e" xlink:title="aff1" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="6b3bee96-8b10-4974-9ece-1b0534adf605" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="b2ce61c1-0333-411b-b965-1805a406107d"><named-content specific-use="change-person" data-title="" id="57f877a0-4c49-48dd-bbbb-64965aa94ce0">Copyeditor</named-content> <named-content specific-use="" data-title="" id="ac428de6-70d9-445f-984d-e49dc14f03aa">inserted</named-content> <named-content specific-use="newVal" data-title="" id="03bf52bc-52e3-4762-9b44-2ba109685595">Chennai</named-content> <named-content specific-use="" data-title="" id="5fcc40a2-b574-49de-9d6b-bfa16a4e4781"> in City field on</named-content> <named-content specific-use="change-time" data-title="" id="94653266-bedb-4918-ba28-7acef6467b88">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="f47d16a4-47b4-4524-a5f7-0cebc6272929" xlink:title="aff1" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="27a3cf70-d094-4240-8665-c1baeb6b1c95" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="c1bfa11b-2f5c-418a-a1be-924f627f9ec7"><named-content specific-use="change-person" data-title="" id="1cfbf588-bfee-4e01-9c73-761505a220cb">Copyeditor</named-content> <named-content specific-use="" data-title="" id="a1279f56-a9da-4619-beb2-599ef970b462">inserted</named-content> <named-content specific-use="newVal" data-title="" id="fc3e5fa5-2f94-407e-89b7-9f8d3e711b0e">Exeter</named-content> <named-content specific-use="" data-title="" id="262610d1-2cd0-479b-abda-fa42fc4235d8"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="fc774e3f-b8bb-48e0-8d86-d39e9c7132cf">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="68d679be-e6aa-44ef-9e33-03fec11749ba" xlink:title="aff1" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="7643dbe7-de93-410e-b9f5-f2714d0e6cbc" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="b162c37e-f9df-45bf-8107-c6ff677bce47"><named-content specific-use="change-person" data-title="" id="ae347723-fb75-4aa2-b741-bfc332d726c5">Copyeditor</named-content> <named-content specific-use="" data-title="" id="133404a8-18f6-4f4e-b110-ca661b9eaf9b">inserted</named-content> <named-content specific-use="newVal" data-title="" id="09e5e248-6467-43a8-a25e-40659e0cb929">Engineering3</named-content> <named-content specific-use="" data-title="" id="ffba4830-94e1-4827-ba22-0cd64eaa5a2f"> in Department field on</named-content> <named-content specific-use="change-time" data-title="" id="10084a68-57ea-4811-8832-daba42cc77b5">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="fb77b32a-6bc0-4dd9-8860-cf3df05d88a0" xlink:title="author-44403352" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="5c31dae8-8c6c-41b5-b7cb-e7781b932241" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="f6ae79c5-e6f4-4c4d-93be-5765a49d7333"><named-content specific-use="change-person" data-title="" id="b93ed1f1-cda3-451f-b25c-47f8fb7d559e">Copyeditor</named-content> <named-content specific-use="" data-title="" id="5c4feb65-bb81-451c-96d0-364a7ae2639d">inserted</named-content> <named-content specific-use="newVal" data-title="&#x2020;Engineering2, Exeter, Tamilnadu, Chennai, India" id="2e533db8-69cc-4744-8a15-13ac90514684">&#x2020;Engineering2, Exeter, Tamilnadu, Chennai, India</named-content> <named-content specific-use="" data-title="" id="70ea6e1a-5bda-4fcd-9769-0023d7ebeebc">in Present address on</named-content> <named-content specific-use="change-time" data-title="" id="bdcb4f1e-406c-4afc-8f42-649ed6078d75">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="33e250ee-d9d9-418e-858f-cbbfebed8aa1" xlink:title="author-44403352" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="fc57e06e-5fb0-4470-9184-961827d67c8c" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="04e8dd29-6ea9-4d50-bbb4-187ce3769e25"><named-content specific-use="change-person" data-title="" id="9a99e8fc-141a-48a9-b5ee-f639ec0ba2ae">Copyeditor</named-content> <named-content specific-use="" data-title="" id="8336b539-dc53-4c06-9ef4-c0e97b583455">inserted</named-content> <named-content specific-use="newVal" data-title="University of Warwick, West Midlands, Coventry, UK" id="69133d50-40bf-45b1-9d33-3058140648ff">University of Warwick, West Midlands, Coventry, UK</named-content> <named-content specific-use="" data-title="" id="015348a1-774e-4426-b478-8010b156fc91">in Affiliations on</named-content> <named-content specific-use="change-time" data-title="" id="e4aa2cf2-3a60-432d-a77c-38894000168f">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="ff51547d-cebc-4e91-8ccd-8ac51a9f2633" xlink:title="author-44403352" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="03f27867-5c01-484c-8f07-aac14819f0a7" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="bac65f56-2248-4f3d-b965-88eec8b3c018"><named-content specific-use="change-person" data-title="" id="edad17d8-cba8-45bb-9b0f-0b444aae1adc">Copyeditor</named-content> <named-content specific-use="" data-title="" id="9e90eb60-5a78-40fc-87a5-c64bf2917b74">changed</named-content> <named-content specific-use="oldVal" data-title="natasha.holmes@austin.org.au" id="069e7e03-5c14-49e3-94fa-39b23b623047">natasha.holmes@austin.org.au</named-content> <named-content specific-use="" data-title="" id="58a94477-1c0a-4215-999b-b64a1ccef6cf">to</named-content> <named-content specific-use="newVal" data-title="martin.aringer@uniklinikum-dresden.de" id="8dc99bf5-0963-404d-840b-8bd8f31540ad">martin.aringer@uniklinikum-dresden.de</named-content> <named-content specific-use="" data-title="" id="c9db16ef-1eab-4f66-8770-dd7d4e325323"> in Email field on</named-content> <named-content specific-use="change-time" data-title="" id="630064b9-1d64-4485-be92-f07cedee92ad">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="f82664e2-9253-46ce-90a6-1126d27b2953" xlink:title="author-44403352" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="8d3fe51d-405e-40e8-b431-26a12ea39d72" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="147ab70c-1c4d-48e3-bcdb-0447273f5130"><named-content specific-use="change-person" data-title="" id="3294d45d-d0eb-4ec2-9bb5-d570a4a7b43e">Copyeditor</named-content> <named-content specific-use="newVal" data-title="" id="539ffb26-6f50-41d8-b6c7-140afd40eba3">checked</named-content> <named-content specific-use="" data-title="" id="046c9f7a-a3ab-4fd6-9ed0-aaae5e302056">Corresponding on</named-content> <named-content specific-use="change-time" data-title="" id="ecd06b69-9dfc-4783-9ca3-141358d8e411">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="cc95f313-c575-4e05-9083-c5a863985dfc" xlink:title="author-44403352" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="6eeaadc3-1514-4fc9-90fe-66b0c99c4505" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="0fce9e4d-6961-4138-83d4-75401d3c053e"><named-content specific-use="change-person" data-title="" id="6b673900-c42d-4028-8d51-4b67d26de75f">Copyeditor</named-content> <named-content specific-use="" data-title="" id="c230fa9d-1bae-4058-a653-68b1fee4f7c9">inserted</named-content> <named-content specific-use="newVal" data-title="" id="fa2f6f67-f0ea-42b9-b414-26715f6695a8">@Karthik</named-content> <named-content specific-use="" data-title="" id="fa19aad2-11e3-42e2-8036-821b217229b7"> in Twitter field on</named-content> <named-content specific-use="change-time" data-title="" id="0af22105-69cd-40a3-b1e2-a679d710da1f">26 Feb 2021 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="history" id="6304a1c9-c7c9-4043-b992-7f12eb62340c" xlink:title="author-79405886" xlink:actuate="8196318a-db6e-4c08-9abb-fa8ece94f452" xlink:role="copyeditor" xlink:href="bd89d63e-3a58-41f4-b5df-1037a3fe7833" xlink:fn-type=""><meta-value><named-content specific-use="historyContent" data-title="" id="47ae71d8-c7f9-4616-a20f-d4b7909c6f21"><named-content specific-use="change-person" data-title="" id="80ab6eea-bcf1-43c2-a454-a48ee537e642">Copyeditor</named-content> <named-content specific-use="newVal" data-title="" id="6fb36ae6-db84-40b0-b7c4-44327fd5fc0c">unchecked</named-content> <named-content specific-use="" data-title="" id="7944c51d-683a-45d0-8794-d42274b76914">Corresponding on</named-content> <named-content specific-use="change-time" data-title="" id="930d46a7-c945-4539-9880-64d871b4cded">26 Feb 2021 11:18 AM</named-content></named-content></meta-value></custom-meta></custom-meta-group><counts id="03be8532-3ba7-4019-8759-2e596b4ded1a"><fig-count count="0" id="573e1fcf-ae69-41b4-8547-61cfc9c6af6d"/><table-count count="0" id="7ecb8790-e254-4369-954f-d50e9ec05907"/><equation-count count="0" id="85eb9f3f-c2d3-4aa5-b097-f658306de10d"/><ref-count count="20"/><page-count count="3.3"/><word-count count="3036"/></counts><funding-group id="dfdda14c-df9f-4b3c-8173-eb60d257bf76"><funding-statement fn-type="funding" data-label="Funding" id="50ea4b37-91cd-40fd-aa28-5f770745218f">The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</funding-statement></funding-group><fpage id="d4e3e0f1-1402-481e-a4b1-24eb66f175be">1</fpage><lpage id="318766c7-b625-4dc4-8775-d27d4e27ad0d">3</lpage></article-meta></front><body id="e7bde157-ddd1-4db4-9ae5-e431c36ced68" data-edited="true" data-edited-version="2"><title data-level="1" data-class="jrnlHead1" data-affs="true" id="06b28fd4-d9a1-466f-8b33-e90a46a2f463"><named-content rid="1607691718042" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="preeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="a7b383e7-01e9-4b95-8a61-5e5c052bdd0d"> </named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718035" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase" id="cde53b75-fc20-4c07-8474-b45869f80baf">BACKGROUND</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718035" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase" id="ed59d400-4fa8-4159-b63a-f95b3cb5160b">Background</named-content></title><p data-class="jrnlSecPara" id="ea645f9b-2346-44d3-9410-07caec962766"><named-content rid="1607691718044" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="preeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="4f1dee97-8fb7-4e48-8604-808ae1cb3fbe"> </named-content>The first case of coronavirus disease <named-content content-type="jrnlPatterns" data-title="THSE" data-tag-desc="THSE" data-tag-type="THSE" data-offset="38" data-match="2019" data-replace="2019" data-pattern="2019" data-tag-index="3_12" id="49fb46d8-95c6-407a-a0d8-1d6ba0543838">2019</named-content> (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was described in December 2019<xref id="9bba586e-00fc-41c2-864e-3b1b295deb0f" ref-type="bibr" rid="R1" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="156" data-match="1" data-pattern="" data-tag-index="3_1" data-citation-string=" R1 " data-track-change="1"><sup id="e5a21229-eb8b-406e-997a-36081c54e6d6">1</sup></xref> and was declared a pandemic by the <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718024" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="ce56ab63-8e11-40b1-b43c-9754baf1d7ad">World Health Organisation (WHO)</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718024" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'World&#x2423;Health&#x2423;Organisation&#x2423;(WHO)' to 'WHO'" data-tag-desc="ABBRV" data-tag-type="ABBRV" data-offset="194" data-match="World Health Organisation (WHO)" data-replace="WHO" data-pattern="WHO" data-tag-index="3_14" data-function="addTrackChanges" data-track-change="World Health Organisation (WHO)" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="d067f7ad-b064-4ef8-85ed-8f725cf3b610">WHO</named-content> on March 11 <named-content content-type="jrnlPatterns" data-title="THSE" data-tag-desc="THSE" data-tag-type="THSE" data-offset="238" data-match="2020" data-replace="2020" data-pattern="2020" data-tag-index="3_13" id="1e354dba-50a5-4df6-a3f4-1ad361846187">2020</named-content>.<xref id="d8af8719-754d-491a-8f06-3b7b6fdbb41a" ref-type="bibr" rid="R2" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="244" data-match="2" data-pattern="" data-tag-index="3_2" data-citation-string=" R2 " data-track-change="2"><sup id="7529c987-b3dd-4811-b4ed-f7781161b85f">2</sup></xref> There is evidence that the elderly, those with existing comorbidities, and those with compromised immune systems<xref id="0c552461-cba9-48f0-9af0-7b4a0daa1cd7" ref-type="bibr" rid="R3" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="360" data-match="3" data-pattern="" data-tag-index="3_3" data-citation-string=" R3 " data-track-change="3"><sup id="3b02cddf-b89e-4205-9b7a-739d119c78cb">3</sup></xref> are at greater risk of severe disease. The outcomes of <named-content content-type="jrnlPatterns" data-title="EXPN" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="418" data-match="solid organ transplant" data-pattern="" data-tag-index="" data-abbr="SOT" id="226423f7-eb14-473c-89e8-ca5293510b99">solid organ transplant</named-content> (<named-content content-type="jrnlPatterns" data-title="ABBR" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="442" data-match=" (SOT)" data-pattern="" data-tag-index="3_10" id="29bc4221-2586-4f97-8020-cabec260c2a7">SOT</named-content>) recipients infected with COVID-19 remain under study, but preliminary reports indicate that they are significantly poorer than the general population.<xref id="158d446b-789e-48f0-94b3-64bf625f4d28" ref-type="bibr" rid="R4" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="598" data-match="4" data-pattern="" data-tag-index="3_4" data-citation-string=" R4 " data-track-change="4"><sup id="cd7ef2d0-bce9-4b39-a1db-083318fbeee1">4</sup></xref> While immunosuppression has been hypothesised to be associated with poor prognosis, <named-content content-type="jrnlPatterns" data-title="EXPN" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="685" data-match="mammalian target of rapamycin" data-pattern="" data-tag-index="" data-abbr="mTOR" id="face1072-efd6-4133-a6a8-fdb5eb791ffd">mammalian target of rapamycin</named-content> (<named-content content-type="jrnlPatterns" data-title="ABBR" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="716" data-match=" (mTOR)" data-pattern="" data-tag-index="3_11" id="3ad1a5f1-83a2-4443-84d6-ae9075e82647">mTOR</named-content>) inhibitors, which can be used for transplant immunosuppression, may influence outcomes of SOT recipients with COVID-19. mTOR inhibitors have been previously investigated as potential antiviral therapeutics including to treat coronaviruses and influenza.<xref id="b746152c-7e1e-44b1-a823-e2763bfe21b2" ref-type="bibr" rid="R5" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="976" data-match="5" data-pattern="" data-tag-index="3_5" data-citation-string=" R5 " data-track-change="5"><sup id="832e0cba-458d-49f8-946e-b7068ff43dd0">5</sup></xref></p><title data-level="1" data-class="jrnlHead1" id="f4a24267-e4fe-46fe-b861-2e0b821d53a0"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718036" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase" id="04c8b84a-9203-4ff2-86cc-aff25689122c">CASE PRESENTATION</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718036" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase" id="ed777a15-cd45-4626-af05-f6f9b02c3475">Case presentation</named-content></title><p data-class="jrnlSecPara" id="f3719623-1e3a-436c-85a7-2d4095fd6536">A 45-year-old man presented with a <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718027" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="fa129851-5a80-49a8-aae7-59a14c599e5b">two</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718027" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'two' to '2'" data-tag-desc="NUM,TIME" data-tag-type="NUM" data-offset="35" data-match="two-day" data-pattern="" data-tag-index="5_13" data-function="textToNumber,addTrackChanges" data-track-change="two" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="901dc80b-2645-459f-8ffe-5d4b6cd5a80a">2</named-content><named-content content-type="jrnlPatterns" data-title="changed '-day' to '&#x2009;day'" data-tag-desc="NUM,TIME" data-tag-type="TIME" data-offset="38" data-match="two-day" data-replace="&#x2009;day" data-pattern="&#x2009;$2" data-tag-index="5_13" data-track-change="-day" id="255eafb8-96b8-4d9b-b001-554eff61c166">&#x2009;day</named-content> history of fevers for investigation on the background of a simultaneous kidney-pancreas transplant <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="142" data-match="18 years" data-replace="18" data-pattern="$1" data-tag-index="5_3" id="29489d87-db9b-4a6d-ac6e-2c6d14ce1561">18</named-content><named-content content-type="jrnlPatterns" data-title="changed from ' years' to ' years'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="144" data-match="18 years" data-replace=" years" data-pattern=" $2" data-tag-index="5_3" data-function="addTrackChanges" id="51ba49d8-3f86-40ca-adf4-3f5fb2728b4b"> years</named-content> ago complicated by allograft-associated renal cell carcinoma. He had undergone a graft nephrectomy and a subsequent living-related kidney transplant <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718028" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="d8e176b2-2e1a-4ed2-ab43-1d12413d1ba1">nine</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718028" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'nine' to '9'" data-tag-desc="NUM,TIME" data-tag-type="NUM" data-offset="300" data-match="nine years" data-pattern="" data-tag-index="5_14" data-function="textToNumber,addTrackChanges" data-track-change="nine" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="9dbf6442-0d47-40cc-8c36-7dd01c326c2b">9</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;years' to '&#x2009;years'" data-tag-desc="NUM,TIME" data-tag-type="TIME" data-offset="304" data-match="nine years" data-replace="&#x2009;years" data-pattern="&#x2009;$2" data-tag-index="5_14" data-track-change=" years" id="c1e0c06d-7391-49b7-8093-955430632377">&#x2009;years</named-content> ago. A motor vehicle accident <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="341" data-match="4 years" data-replace="4" data-pattern="$1" data-tag-index="5_4" id="7cbcbf0b-4c98-44fe-a971-fcaf45d50fd1">4</named-content><named-content content-type="jrnlPatterns" data-title="changed from ' years' to ' years'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="342" data-match="4 years" data-replace=" years" data-pattern=" $2" data-tag-index="5_4" data-function="addTrackChanges" id="91c5de95-b269-45b8-9987-cb8816c15059"> years</named-content> ago caused complete T3 paraplegia with requirement for long-term intermittent self-catheterisation. The medical history also included previous type <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718015" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="b522bb63-b647-4f54-941f-524ff281f3ac">1</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718015" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="497" data-match="1" data-pattern="" data-tag-index="5_12" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="e3fff2b3-24ac-493c-9451-067aebd72a92">one</named-content> diabetes, EBV-associated post-transplant cerebral lymphoma that was treated with rituximab <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="590" data-match="9 years" data-replace="9" data-pattern="$1" data-tag-index="5_5" id="23c7148d-cfc6-4b95-bc5a-e8e149497624">9</named-content><named-content content-type="jrnlPatterns" data-title="changed from ' years' to ' years'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="591" data-match="9 years" data-replace=" years" data-pattern=" $2" data-tag-index="5_5" data-function="addTrackChanges" id="0a1d48ef-32a8-4e9a-9c8a-762f8a4fafbc"> years</named-content> ago (now in remission), BK and CMV viraemia, pulmonary embolus (on rivaroxaban), asthma, and thalassaemia trait. His transplant immunosuppressive regimen comprised everolimus <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="773" data-match="2mg" data-replace="2" data-pattern="$1" data-tag-index="5_6" id="73f9c3b3-0f90-4a13-9b2a-896adae642b8">2</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718001" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="fd17682f-2cac-4644-abd9-cac20cf64c3e">mg</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718001" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'mg' to '&#x2009;mg'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="774" data-match="2mg" data-replace="&#x2009;mg" data-pattern="&#x2009;$2" data-tag-index="5_6" data-function="addTrackChanges" data-track-change="mg" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="96aa48b2-31a3-43e6-9adc-84e29086c8ce">&#x2009;mg</named-content> twice-daily and prednisolone <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="806" data-match="5mg" data-replace="5" data-pattern="$1" data-tag-index="5_7" id="91eff8b1-5047-405e-868d-bab0d5bbe793">5</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718002" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="529e3ec0-570d-4164-a4b0-8d965506bfd0">mg</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718002" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'mg' to '&#x2009;mg'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="807" data-match="5mg" data-replace="&#x2009;mg" data-pattern="&#x2009;$2" data-tag-index="5_7" data-function="addTrackChanges" data-track-change="mg" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="b8a82583-02fd-4a2a-877e-029f36800d95">&#x2009;mg</named-content> daily. The pre-admission baseline creatinine was <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="859" data-match="79 umol/L" data-replace="79" data-pattern="$1" data-tag-index="5_8" id="47aa6195-3056-4bb1-a0e9-081a1c0450f0">79</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718003" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="a94805f2-2e6b-4d08-a732-d0f87bf2a81e"> umol/L</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718003" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from '&#x2423;umol/L' to '&#x2009;umol/L'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="861" data-match="79 umol/L" data-replace="&#x2009;umol/L" data-pattern="&#x2009;$2" data-tag-index="5_8" data-function="addTrackChanges" data-track-change=" umol/L" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="eb3a3ee7-855b-445d-a36a-0737907869d5">&#x2009;umol/L</named-content> <named-content content-type="jrnlPatterns" data-title="RNGS" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="869" data-match="(60 &#x2013; 110 umol/L" data-replace="(60" data-pattern="$2" data-tag-index="5_2" id="6b4c3c6c-b187-435c-b6d8-d7f19e335105">(60</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;&#x2013;&#x2423;' to '&#x2013;'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="872" data-match="(60 &#x2013; 110 umol/L" data-replace="&#x2013;" data-pattern="&#x2013;" data-tag-index="5_2" data-track-change=" &#x2013; " id="e7b9748c-783b-4de5-9e79-84f6f5e9ff60">&#x2013;</named-content><named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="877" data-match="(60 &#x2013; 110 umol/L" data-replace="110" data-pattern="$1" data-tag-index="5_2" id="07cf96f3-3ae9-4ccd-a587-93b1d43fcfd5">110</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;umol/L' to '&#x2009;umol/L'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="880" data-match="(60 &#x2013; 110 umol/L" data-replace="&#x2009;umol/L" data-pattern="&#x2009;$2" data-tag-index="5_2" data-track-change=" umol/L" id="cab261b7-fc06-4a25-a8dd-c089f1fe7a5b">&#x2009;umol/L</named-content>), CKD-EPI eGFR<named-content content-type="jrnlPatterns" data-title="changed '&#x2423;&gt;' to '&#x237d;&gt;'" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="902" data-match="eGFR &amp;gt;90 ml/min" data-replace="&#xa0;&gt;" data-pattern="&#xa0;$2" data-tag-index="5_1" data-track-change=" &amp;gt;" id="5803a4a6-5726-44a8-872a-6449eb9de965">&#xa0;&gt;</named-content><named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="904" data-match="eGFR &amp;gt;90 ml/min" data-replace="90" data-pattern="$3" data-tag-index="5_1" id="d6233929-8150-4cb5-a881-ecd09ce07458">90</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;ml/min' to '&#x2009;mL/min'" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="906" data-match="eGFR &amp;gt;90 ml/min" data-replace="&#x2009;mL/min" data-pattern="&#x2009;$6" data-tag-index="5_1" data-track-change=" ml/min" id="ecac0807-1ca2-41f2-9ae5-fb7e39dbc825">&#x2009;mL/min</named-content>/<named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="914" data-match="1.73m2" data-replace="1.73" data-pattern="$1" data-tag-index="5_10" id="149b5007-7290-47a5-9ff9-ee3e37e8e0f5">1.73</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718004" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="4d0b2ff8-19ca-4d0e-b32d-8499f961ecd8">m<sup id="4a8d20e3-9854-4c64-a649-0f92ce4c1be7">2</sup></named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718004" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'm&lt;sup&gt;2&lt;/sup&gt;' to '&#x2009;m2'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="918" data-match="1.73m2" data-replace="&#x2009;m2" data-pattern="&#x2009;$2" data-tag-index="5_10" data-function="addTrackChanges" data-track-change="m&lt;sup&gt;2&lt;/sup&gt;" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="593354ec-8fcd-4471-b22e-2e2e767487e6">&#x2009;m2</named-content>, and everolimus level <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="943" data-match="4.3 ug/L" data-replace="4.3" data-pattern="$1" data-tag-index="5_11" id="bb29cedb-b023-4422-823c-c125f9f63ccb">4.3</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718005" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="9389e69c-7f10-46fe-a6f3-2f50082d3de0"> ug/L</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718005" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from '&#x2423;ug/L' to '&#x2009;ug/L'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="946" data-match="4.3 ug/L" data-replace="&#x2009;ug/L" data-pattern="&#x2009;$2" data-tag-index="5_11" data-function="addTrackChanges" data-track-change=" ug/L" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="ccc0d0c3-c571-42f0-88ac-37e28fad36f1">&#x2009;ug/L</named-content>. Other medications included fludrocortisone, pantoprazole, pregabalin, tapentadol, and sertraline.</p><p data-class="jrnlSecPara" id="53533c8f-f074-45ad-bf95-fb2fc569ed65">Vital signs <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718019" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="b29bd5d6-0bf9-4730-a241-07c445576198">upon</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718019" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'upon' to 'on'" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="12" data-match="upon" data-replace="on" data-pattern="on" data-tag-index="6_8" data-function="addTrackChanges" data-track-change="upon" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="4ada9d97-ac65-4b91-b3f0-ab393ff444c4">on</named-content> presentation included: temperature <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="52" data-match="40.1&#xb0;C" data-replace="40.1" data-pattern="$1" data-tag-index="6_2" id="d954f554-4ca8-4b9a-ae99-f173ef8e3c87">40.1</named-content><named-content content-type="jrnlPatterns" data-title="changed from '&#xb0;C' to '&#xb0;C'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="56" data-match="40.1&#xb0;C" data-replace="&#xb0;C" data-pattern="&#xb0;C" data-tag-index="6_2" data-function="addTrackChanges" id="3d8ee270-7008-4463-8076-60b101345bf7">&#xb0;C</named-content>, blood pressure 130/80, <named-content content-type="jrnlPatterns" data-title="JRNM" data-tag-desc="JRNM" data-tag-type="JRNM" data-offset="84" data-match="heart" data-pattern="" data-tag-index="6_9" data-function="addItalics" id="68475ea3-22fb-45f5-b215-02ea15906787">heart</named-content> rate 97 beats per minute, and oxygen saturation <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="138" data-match="97%" data-replace="97" data-pattern="$1" data-tag-index="6_3" id="8618eddc-2ba4-4578-9e52-69705abbe8d2">97</named-content><named-content content-type="jrnlPatterns" data-title="changed from '%' to '%'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="140" data-match="97%" data-replace="%" data-pattern="%" data-tag-index="6_3" data-function="addTrackChanges" id="3341c313-dca1-4f17-a100-abef3470e7b6">%</named-content> on ambient room air that dropped to <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="178" data-match="87%" data-replace="87" data-pattern="$1" data-tag-index="6_4" id="3607b64f-8aa6-48ff-ade9-f0fcc85562f4">87</named-content><named-content content-type="jrnlPatterns" data-title="changed from '%' to '%'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="180" data-match="87%" data-replace="%" data-pattern="%" data-tag-index="6_4" data-function="addTrackChanges" id="55f6b2d1-965f-4180-aed5-4a5bffac5829">%</named-content> several hours after admission. He required <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="225" data-match="2L/minute" data-replace="2" data-pattern="$1" data-tag-index="6_5" id="b23a0fd1-c43e-47c5-bd51-0567620fe37e">2</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718006" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="e1f9ecd9-f45f-41ce-8d27-b1f9fb37e6b0">L/minute</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718006" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'L/minute' to '&#x2009;L/minute'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="226" data-match="2L/minute" data-replace="&#x2009;L/minute" data-pattern="&#x2009;$2" data-tag-index="6_5" data-function="addTrackChanges" data-track-change="L/minute" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="7adebd15-b0e5-49a1-9b03-af08a637f665">&#x2009;L/minute</named-content> of oxygen administered by nasal prongs to maintain oxygen saturation<named-content content-type="jrnlPatterns" data-title="changed '&#x2423;&#x2265;&#x2423;' to '&#x237d;&#x2265;'" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="303" data-match="saturation &#x2265; 96%" data-replace="&#xa0;&#x2265;" data-pattern="&#xa0;$2" data-tag-index="6_1" data-track-change=" &#x2265; " id="21e97c04-a161-4181-a8db-4894c78dfecc">&#xa0;&#x2265;</named-content><named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="308" data-match="96%" data-replace="96" data-pattern="$3" data-tag-index="6_1" id="61451cdd-fc92-4a5e-87cb-76ce7fd1eb82">96</named-content><named-content content-type="jrnlPatterns" data-title="changed from '%' to '%'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="310" data-match="96%" data-replace="%" data-pattern="%" data-tag-index="6_6" data-function="addTrackChanges" id="81299577-3bae-4afc-96d9-d85a4def086c">%</named-content>. He did not require any supplemental oxygen after the first day of admission. He became hypotensive (BP 80/50) <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718029" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="7b0f4d2b-3ee2-4ae9-a3b5-6d6a2256e8cf">three</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718029" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'three' to '3'" data-tag-desc="NUM,TIME" data-tag-type="NUM" data-offset="423" data-match="three hours" data-pattern="" data-tag-index="6_10" data-function="textToNumber,addTrackChanges" data-track-change="three" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="cbd44a03-060f-4d2c-bab7-bd9c739f3d54">3</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;hours' to '&#x2009;hours'" data-tag-desc="NUM,TIME" data-tag-type="TIME" data-offset="428" data-match="three hours" data-replace="&#x2009;hours" data-pattern="&#x2009;hours" data-tag-index="6_10" data-track-change=" hours" id="cd9fd987-5be3-44df-8664-e5b281c257e2">&#x2009;hours</named-content> after admission, and this was managed with intravenous crystalloids and increased dose of oral prednisolone to <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="546" data-match="15mg" data-replace="15" data-pattern="$1" data-tag-index="6_7" id="06bfb3f9-0fd1-41e7-a33d-56fec8b52497">15</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718007" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="50b63eea-2f44-4c83-a865-bf2a8f9f96e1">mg</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718007" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'mg' to '&#x2009;mg'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="548" data-match="15mg" data-replace="&#x2009;mg" data-pattern="&#x2009;$2" data-tag-index="6_7" data-function="addTrackChanges" data-track-change="mg" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="1d3d735f-780a-406f-a3f3-eebd92e82674">&#x2009;mg</named-content> daily. Intravenous fluids were not continued due to concern about the potential for worsening his respiratory status in the setting of COVID-19.</p><title data-level="1" data-class="jrnlHead1" id="bbc5dd8d-f6c9-4487-9be1-3fcb1a499b84"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718037" id="ebb49ff8-d110-46ae-9158-a874902f8602" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="Deleted by Exeter - 1607691718001" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase">INVESTIGATIONS </named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718037" id="4429dc90-db73-4a48-a059-9981806385d4" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="Inserted by Exeter - 1607691718001" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase">Investigations<named-content data-cid="1607691772" id="6ba301de-3855-419f-be7e-5c969b769055" content-type="del cts-2" specific-use="1607691859259" xlink:title="Priyanka (PREEDITOR)" alt="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-title="Deleted by Priyanka (PREEDITOR) - Dec 11 2020 6:34pm" data-userid="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-username="Priyanka (PREEDITOR)" data-time="1607691859259"> </named-content></named-content><italic id="88d47e59-4fc4-46b5-934a-d085edd78abe"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691772" id="e849f794-05bb-456c-af32-e315f6911ec1" content-type="del cts-2" specific-use="1607691859259" xlink:title="Priyanka (PREEDITOR)" alt="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-title="Deleted by Priyanka (PREEDITOR) - Dec 11 2020 6:34pm" data-userid="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-username="Priyanka (PREEDITOR)" data-time="1607691859259">If relevant</named-content></italic></title><p data-class="jrnlSecPara" id="62d0ef14-35f4-4b2a-9b22-89a8f1f65470">Investigations revealed a stable anaemia (haemoglobin <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="54" data-match="102 g/L" data-replace="102" data-pattern="$1" data-tag-index="8_14" id="3a6e030a-e931-4bc9-ac7f-06e928e65d7c">102</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718008" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="c4907a4c-a7cf-44b1-bab3-99c4d4a1c66e"> g/L</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718008" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from '&#x2423;g/L' to '&#x2009;g/L'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="57" data-match="102 g/L" data-replace="&#x2009;g/L" data-pattern="&#x2009;$2" data-tag-index="8_14" data-function="addTrackChanges" data-track-change=" g/L" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="e8a9a1cd-978f-4549-aa49-0ac9db002c04">&#x2009;g/L</named-content> <named-content content-type="jrnlPatterns" data-title="RNGS" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="62" data-match="(130 - 170 g/L" data-replace="(130" data-pattern="$2" data-tag-index="8_6" id="0b038b8c-faf6-4358-8969-62bc8a896eb2">(130</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;-&#x2423;' to '&#x2013;'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="66" data-match="(130 - 170 g/L" data-replace="&#x2013;" data-pattern="&#x2013;" data-tag-index="8_6" data-track-change=" - " id="97226b00-2c7c-46bd-a117-3d6ec4f21ce5">&#x2013;</named-content><named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="69" data-match="(130 - 170 g/L" data-replace="170" data-pattern="$1" data-tag-index="8_6" id="4bbfe9c6-ce43-4721-b93f-3fdf6bd03323">170</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;g/L' to '&#x2009;g/L'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="72" data-match="(130 - 170 g/L" data-replace="&#x2009;g/L" data-pattern="&#x2009;$2" data-tag-index="8_6" data-track-change=" g/L" id="77b52d77-9265-4945-bb04-8b6099061dd0">&#x2009;g/L</named-content>)) with a normal white cell (<named-content content-type="jrnlPatterns" data-title="VAR" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="105" data-match="9.4 x 109" data-replace="9.4" data-pattern="$1" data-tag-index="8_1" id="1ccd99be-f6ee-477d-9a85-88d20404e301">9.4</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;x&#x2423;' to '&#xd7;'" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="108" data-match="9.4 x 109" data-replace="&#xd7;" data-pattern="&#xd7;" data-tag-index="8_1" data-track-change=" x " id="7f87ce75-7b53-47d3-af21-f3b703f3f067">&#xd7;</named-content><named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="111" data-match="9.4 x 109" data-replace="109" data-pattern="$3" data-tag-index="8_1" id="2a9b322c-8825-4aed-85e0-ce9483ab9867">10<sup id="e25cd25a-b685-46fe-98a5-a2b43b71cbeb">9</sup></named-content> <named-content content-type="jrnlPatterns" data-title="RNGS" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="115" data-match="109 (4 - 11 x" data-replace="(4" data-pattern="$2" data-tag-index="8_7" id="d07ca022-7977-43df-a8ee-ce1e7427f5a5">(4</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;-&#x2423;' to '&#x2013;'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="117" data-match="109 (4 - 11 x" data-replace="&#x2013;" data-pattern="&#x2013;" data-tag-index="8_7" data-track-change=" - " id="753569fd-ba36-48ed-889a-923211000a2c">&#x2013;</named-content><named-content content-type="jrnlPatterns" data-title="RNGE" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="120" data-match="109 (4 - 11 x" data-replace="11" data-pattern="$4" data-tag-index="8_7" id="7216f59a-55ec-43f5-b546-f2ddf8cae62d">11</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;x' to '&#x2009;x'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="122" data-match="109 (4 - 11 x" data-replace="&#x2009;x" data-pattern="&#x2009;$5" data-tag-index="8_7" data-track-change=" x" id="114fd412-1d2e-45fa-acb2-e7edd1ae20d1">&#x2009;x</named-content> <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="125" data-match="11 x 109" data-replace="109" data-pattern="$3" data-tag-index="8_2" id="f5341360-2f45-4c47-8876-ec0770bb2c3b">10<sup id="0cea5e74-2035-4c08-a0a1-d96c7935911f">9</sup></named-content>)) and lymphocyte count (<named-content content-type="jrnlPatterns" data-title="VAR" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="153" data-match="2.5 x 109" data-replace="2.5" data-pattern="$1" data-tag-index="8_3" id="36af3086-6387-463e-9282-c4f474bd705b">2.5</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;x&#x2423;' to '&#xd7;'" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="156" data-match="2.5 x 109" data-replace="&#xd7;" data-pattern="&#xd7;" data-tag-index="8_3" data-track-change=" x " id="78069ec2-2ea6-402f-a40c-63cae36ad76b">&#xd7;</named-content><named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="159" data-match="2.5 x 109" data-replace="109" data-pattern="$3" data-tag-index="8_3" id="9b17dce4-7978-48ce-802d-cf291e85df7a">10<sup id="62ee4ce4-ce62-4054-8ab7-17757e0565aa">9</sup></named-content> <named-content content-type="jrnlPatterns" data-title="RNGS" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="163" data-match="109 (1 - 3.5 x" data-replace="(1" data-pattern="$2" data-tag-index="8_8" id="f8b6e526-969e-4071-882a-7934d67be5f7">(1</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;-&#x2423;' to '&#x2013;'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="165" data-match="109 (1 - 3.5 x" data-replace="&#x2013;" data-pattern="&#x2013;" data-tag-index="8_8" data-track-change=" - " id="ec3e1cc0-4ba5-477a-bef7-a0a69cc72426">&#x2013;</named-content><named-content content-type="jrnlPatterns" data-title="RNGE" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="168" data-match="109 (1 - 3.5 x" data-replace="3.5" data-pattern="$4" data-tag-index="8_8" id="35346180-1dbc-42cc-9310-dae6ca474aec">3.5</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;x' to '&#x2009;x'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="171" data-match="109 (1 - 3.5 x" data-replace="&#x2009;x" data-pattern="&#x2009;$5" data-tag-index="8_8" data-track-change=" x" id="829da59b-11f8-4ab8-9e7a-4dc29d5b62ed">&#x2009;x</named-content> <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="174" data-match="3.5 x 109" data-replace="109" data-pattern="$3" data-tag-index="8_4" id="f4a7adff-4a94-43e3-88ae-1bbeea4b38f2">10<sup id="f448c29b-c2f2-464f-a6a0-49bb533dd2da">9</sup></named-content>)). His creatinine was <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="200" data-match="93 umol/L" data-replace="93" data-pattern="$1" data-tag-index="8_20" id="55fa3bf8-ff82-4de3-80ac-5acfc773b272">93</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718009" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="abdd8f1c-4f12-4b02-a5c3-38ab5fb5c301"> umol/L</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718009" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from '&#x2423;umol/L' to '&#x2009;umol/L'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="202" data-match="93 umol/L" data-replace="&#x2009;umol/L" data-pattern="&#x2009;$2" data-tag-index="8_20" data-function="addTrackChanges" data-track-change=" umol/L" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="3bac50c4-6450-4141-a92c-79f4a8ed0b3a">&#x2009;umol/L</named-content> <named-content content-type="jrnlPatterns" data-title="RNGS" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="210" data-match="(60 - 110 umol/L" data-replace="(60" data-pattern="$2" data-tag-index="8_9" id="befa53d0-8da2-499a-9fde-8366847fd372">(60</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;-&#x2423;' to '&#x2013;'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="213" data-match="(60 - 110 umol/L" data-replace="&#x2013;" data-pattern="&#x2013;" data-tag-index="8_9" data-track-change=" - " id="07d74151-eb48-45d2-8717-d445e58e1b3d">&#x2013;</named-content><named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="216" data-match="(60 - 110 umol/L" data-replace="110" data-pattern="$1" data-tag-index="8_9" id="2650df67-c79b-4eda-b79f-7b02cfce138c">110</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;umol/L' to '&#x2009;umol/L'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="219" data-match="(60 - 110 umol/L" data-replace="&#x2009;umol/L" data-pattern="&#x2009;$2" data-tag-index="8_9" data-track-change=" umol/L" id="d1fecd3a-0217-4326-8923-bd791608c9eb">&#x2009;umol/L</named-content>), and his lipase was normal at 28 units/L <named-content content-type="jrnlPatterns" data-title="RNGS" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="269" data-match="(10 - 60" data-replace="(10" data-pattern="$2" data-tag-index="8_10" id="ee646082-eb62-4634-a015-278115b7b1fb">(10</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;-&#x2423;' to '&#x2013;'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="272" data-match="(10 - 60" data-replace="&#x2013;" data-pattern="&#x2013;" data-tag-index="8_10" data-track-change=" - " id="af223ca5-16d7-4216-8139-1c124afedd66">&#x2013;</named-content><named-content content-type="jrnlPatterns" data-title="RNGE" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="275" data-match="(10 - 60" data-replace="60" data-pattern="$4" data-tag-index="8_10" id="2d70141c-616b-47cd-bb4e-b310e08ce6ea">60</named-content> units/L). His CRP was elevated (<named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="310" data-match="91 mg/L" data-replace="91" data-pattern="$1" data-tag-index="8_22" id="9bbe8098-49b5-47cb-8c5d-dbb434770c93">91</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718010" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="dce2b1ec-a704-49fa-923a-b8ce3527c12b"> mg/L</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718010" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from '&#x2423;mg/L' to '&#x2009;mg/L'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="312" data-match="91 mg/L" data-replace="&#x2009;mg/L" data-pattern="&#x2009;$2" data-tag-index="8_22" data-function="addTrackChanges" data-track-change=" mg/L" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="fc0d18d4-981a-40d0-9e51-c6c4d005faf7">&#x2009;mg/L</named-content> <named-content content-type="jrnlPatterns" data-title="RNGS" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="318" data-match="(0 - 5 mg/L" data-replace="(0" data-pattern="$2" data-tag-index="8_11" id="cc8004cb-1053-433d-816c-4104ec13c9e5">(0</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;-&#x2423;' to '&#x2013;'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="320" data-match="(0 - 5 mg/L" data-replace="&#x2013;" data-pattern="&#x2013;" data-tag-index="8_11" data-track-change=" - " id="c54e77df-0d0f-40ca-bd4e-845aeacf7bf5">&#x2013;</named-content><named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="323" data-match="(0 - 5 mg/L" data-replace="5" data-pattern="$1" data-tag-index="8_11" id="a374c735-da75-498d-95dd-6440d74d12b3">5</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;mg/L' to '&#x2009;mg/L'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="324" data-match="(0 - 5 mg/L" data-replace="&#x2009;mg/L" data-pattern="&#x2009;$2" data-tag-index="8_11" data-track-change=" mg/L" id="0f1f4693-2514-48f5-b48f-31a9492dc3f7">&#x2009;mg/L</named-content>)). Given his presentation with a febrile illness and recent exposure to two confirmed cases of COVID-19, combined oropharyngeal and nasopharyngeal swab was obtained and SARS-CoV-2 was detected by <named-content content-type="jrnlPatterns" data-title="EXPN" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="526" data-match="nucleic acid testing" data-pattern="" data-tag-index="" data-abbr="NAT" id="8a851317-c950-4939-a01e-6a636c3abef9">nucleic acid testing</named-content> (<named-content content-type="jrnlPatterns" data-title="ABBR" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="548" data-match=" (NAT)" data-pattern="" data-tag-index="8_28" id="df62c4eb-9add-462a-8e6b-5c35d0a2004f">NAT</named-content>). A chest x-ray at admission and after <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="591" data-match="48 hours" data-replace="48" data-pattern="$1" data-tag-index="8_24" id="8f600086-e170-42f6-8355-f9923c698b84">48</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718011" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="ccebfaf6-808d-4ed8-ace9-7d0d5a52e957"> hours</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718011" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from '&#x2423;hours' to '&#x2009;hours'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="593" data-match="48 hours" data-replace="&#x2009;hours" data-pattern="&#x2009;hours" data-tag-index="8_24" data-function="addTrackChanges" data-track-change=" hours" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="cac2f4c5-fb82-46fc-8a54-43f3cbf045a8">&#x2009;hours</named-content> did not demonstrate any evidence of pneumonia or pulmonary infiltrates, and he did not require further supplemental oxygen after day one of admission. He had an elevated <named-content content-type="jrnlPatterns" data-title="SMCP" data-tag-desc="SMCP" data-tag-type="SMCP" data-offset="770" data-match="d-" data-pattern="" data-tag-index="8_29" data-function="smallCaps" id="a8feca80-6e2c-418d-a779-c25699e9692d">d</named-content>-dimer of <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="781" data-match="1163 ng/mL" data-replace="1163" data-pattern="1163" data-tag-index="8_25" id="58ab098d-55ba-425b-8277-f0994862edde">1163</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718012" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="9bfda15f-6dfd-40d0-8086-528ff127887e"> ng/mL</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718012" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from '&#x2423;ng/mL' to '&#x2009;ng/mL'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="785" data-match="1163 ng/mL" data-replace="&#x2009;ng/mL" data-pattern="&#x2009;$2" data-tag-index="8_25" data-function="addTrackChanges" data-track-change=" ng/mL" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="4a42f693-d057-4f3d-b742-cbb1ae1891bc">&#x2009;ng/mL</named-content> (<named-content content-type="jrnlPatterns" data-title="OPR" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="793" data-match="&amp;lt;500 ng/mL" data-replace="&lt;" data-pattern="$2" data-tag-index="8_5" id="92ab54f8-92ea-48e1-9781-d224e02f7203">&lt;</named-content><named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="794" data-match="&amp;lt;500 ng/mL" data-replace="500" data-pattern="$3" data-tag-index="8_5" id="b678ebad-115e-4ca9-b5c3-428543bb63f4">500</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;ng/mL' to '&#x2009;ng/mL'" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="797" data-match="&amp;lt;500 ng/mL" data-replace="&#x2009;ng/mL" data-pattern="&#x2009;$6" data-tag-index="8_5" data-track-change=" ng/mL" id="eaf5d467-687a-43e5-8f96-ca7728577db8">&#x2009;ng/mL</named-content>), ferritin of <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="818" data-match="429 ug/L" data-replace="429" data-pattern="$1" data-tag-index="8_26" id="e5c12407-da84-4a08-a2ce-46a60ec85f70">429</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718013" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="3db380cf-5ee6-4e5b-ad2b-44c94661eabb"> ug/L</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718013" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from '&#x2423;ug/L' to '&#x2009;ug/L'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="821" data-match="429 ug/L" data-replace="&#x2009;ug/L" data-pattern="&#x2009;$2" data-tag-index="8_26" data-function="addTrackChanges" data-track-change=" ug/L" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="6df9a39e-919c-4beb-be55-9e3570547592">&#x2009;ug/L</named-content> <named-content content-type="jrnlPatterns" data-title="RNGS" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="827" data-match="(30 &#x2013; 340 ug/L" data-replace="(30" data-pattern="$2" data-tag-index="8_12" id="668c008e-dd08-4c91-ab13-cdc94e178e75">(30</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;&#x2013;&#x2423;' to '&#x2013;'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="830" data-match="(30 &#x2013; 340 ug/L" data-replace="&#x2013;" data-pattern="&#x2013;" data-tag-index="8_12" data-track-change=" &#x2013; " id="4474faa3-4509-480c-8e35-e75409131eae">&#x2013;</named-content><named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="835" data-match="(30 &#x2013; 340 ug/L" data-replace="340" data-pattern="$1" data-tag-index="8_12" id="20704577-fc11-4500-9850-cc0d3aecae29">340</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;ug/L' to '&#x2009;ug/L'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="838" data-match="(30 &#x2013; 340 ug/L" data-replace="&#x2009;ug/L" data-pattern="&#x2009;$2" data-tag-index="8_12" data-track-change=" ug/L" id="cf994253-74b9-4579-9469-34b0edd04d48">&#x2009;ug/L</named-content>), and LDH of 310 units/L <named-content content-type="jrnlPatterns" data-title="RNGS" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="869" data-match="(120-250" data-replace="(120" data-pattern="$2" data-tag-index="8_13" id="ffcb602e-2b5b-4eef-be12-48c1b304e7a8">(120</named-content><named-content content-type="jrnlPatterns" data-title="changed '-' to '&#x2013;'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="873" data-match="(120-250" data-replace="&#x2013;" data-pattern="&#x2013;" data-tag-index="8_13" data-track-change="-" id="2bb34090-b524-426a-a95b-3aca606a5a22">&#x2013;</named-content><named-content content-type="jrnlPatterns" data-title="RNGE" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="874" data-match="(120-250" data-replace="250" data-pattern="$4" data-tag-index="8_13" id="b993387b-d4d7-4c9b-a66c-b2a68fa0dffa">250</named-content> units/L).</p><title data-level="1" data-class="jrnlHead1" id="cd28ce2e-7a8d-42b9-8a99-65c14a466c4c"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718038" id="ff439e02-9ce9-4239-83c4-4afb8eaeae43" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="Deleted by Exeter - 1607691718001" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase">TREATMENT </named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718038" id="e4b748e2-fda0-4700-8fc7-aa1718d877f2" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="Inserted by Exeter - 1607691718001" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase">Treatment<named-content data-cid="1607691773" id="49012f25-3a6e-44a7-9b27-ed9b8fd6289a" content-type="del cts-2" specific-use="1607691861793" xlink:title="Priyanka (PREEDITOR)" alt="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-title="Deleted by Priyanka (PREEDITOR) - Dec 11 2020 6:34pm" data-userid="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-username="Priyanka (PREEDITOR)" data-time="1607691861793"> </named-content></named-content><italic id="13e0695a-19da-47cc-bd0f-3c959df2f52e"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691773" id="b827e6d8-34f4-4f78-b4b6-1a07fa78b39c" content-type="del cts-2" specific-use="1607691861793" xlink:title="Priyanka (PREEDITOR)" alt="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-title="Deleted by Priyanka (PREEDITOR) - Dec 11 2020 6:34pm" data-userid="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-username="Priyanka (PREEDITOR)" data-time="1607691861793">If relevant</named-content></italic></title><p data-class="jrnlSecPara" id="031c900c-bab5-4825-9e0e-e98571e2653c">Baseline immunosuppression was continued apart from the short course of stress-dose prednisolone given for <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718030" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="87a26ea2-2e3a-4099-8c50-5cdb478fd247">three</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718030" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'three' to '3'" data-tag-desc="NUM,TIME" data-tag-type="NUM" data-offset="107" data-match="three days" data-pattern="" data-tag-index="10_3" data-function="textToNumber,addTrackChanges" data-track-change="three" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="1a9da4d9-10cd-4a14-b7ec-45082194cc95">3</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;days' to '&#x2009;days'" data-tag-desc="NUM,TIME" data-tag-type="TIME" data-offset="112" data-match="three days" data-replace="&#x2009;days" data-pattern="&#x2009;$2" data-tag-index="10_3" data-track-change=" days" id="b5eb1b1b-79db-45d7-aa23-ce8570d024a2">&#x2009;days</named-content> due to hypotension shortly after admission. Meropenem was initiated for treatment a polymicrobial <named-content content-type="jrnlPatterns" data-title="EXPN" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="216" data-match="urinary tract infection" data-pattern="" data-tag-index="" data-abbr="UTI" id="90026445-3cb0-4660-b997-83eb6735bec6">urinary tract infection</named-content> (<named-content content-type="jrnlPatterns" data-title="ABBR" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="241" data-match=" (UTI)" data-pattern="" data-tag-index="10_2" id="1edb8566-689d-460e-a55b-7d973f87acae">UTI</named-content>) in setting of recurrent UTIs and intermittent self-catheterisation. He did not receive other medications with putative activity against COVID-19 such as lopinavir/ritonavir or hydroxychloroquine in accordance with local treatment guidelines at the time. In the absence of supportive criteria for cytokine release syndrome, an IL-6 inhibitor was not given. His everolimus level was <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="627" data-match="6.7 ug/L" data-replace="6.7" data-pattern="$1" data-tag-index="10_1" id="87570b56-288c-4a50-a745-9b0f78ac343d">6.7</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718014" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="25e3d287-8ebf-4808-86b9-34de2da9d5dd"> ug/L</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718014" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from '&#x2423;ug/L' to '&#x2009;ug/L'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="630" data-match="6.7 ug/L" data-replace="&#x2009;ug/L" data-pattern="&#x2009;$2" data-tag-index="10_1" data-function="addTrackChanges" data-track-change=" ug/L" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="c6dfa8cc-55e8-4087-83d7-71f315fe7f6e">&#x2009;ug/L</named-content>.</p><title data-level="1" data-class="jrnlHead1" id="a4f2c7a5-5584-4b7a-8791-bbe2b65538aa"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718039" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase" id="f2ef98b2-d6a8-4192-bdee-55f1d339226f">OUTCOME AND FOLLOW-UP</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718039" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase" id="968e061f-cad7-4f3f-bac7-6bb656bf4a90">Outcome and follow-up</named-content></title><p data-class="jrnlSecPara" id="641cdc18-c6f5-4a03-a742-e7ab2887e4c9">With supportive care, he was discharged home <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="45" data-match="8 days" data-replace="8" data-pattern="$1" data-tag-index="12_1" id="d55111c8-6bdb-4a82-9df9-312b407f0cfd">8</named-content><named-content content-type="jrnlPatterns" data-title="changed from ' days' to ' days'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="46" data-match="8 days" data-replace=" days" data-pattern=" $2" data-tag-index="12_1" data-function="addTrackChanges" id="99f803cd-8bba-4f2f-a815-5a503854a6f4"> days</named-content> after admission (day 10 of COVID-19 illness), and he remains well in the community <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718031" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="fae642a3-d1d3-4f8b-8115-948d981bcbba">three</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718031" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'three' to '3'" data-tag-desc="NUM,TIME" data-tag-type="NUM" data-offset="135" data-match="three months" data-pattern="" data-tag-index="12_6" data-function="textToNumber,addTrackChanges" data-track-change="three" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="75125528-46db-416c-a001-9345733357a9">3</named-content><named-content content-type="jrnlPatterns" data-title="changed '&#x2423;months' to '&#x2009;months'" data-tag-desc="NUM,TIME" data-tag-type="TIME" data-offset="140" data-match="three months" data-replace="&#x2009;months" data-pattern="&#x2009;$2" data-tag-index="12_6" data-track-change=" months" id="bf456506-956f-438f-bd26-6ab48affc52b">&#x2009;months</named-content> after his initial presentation. The <named-content content-type="jrnlPatterns" data-title="changed from 'patient' to 'patient'" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="184" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="12_5" data-function="addTrackChanges" id="b8809837-a270-42f1-bc12-035eafbefb11">patient</named-content> had presumed low level viral shedding, as evidenced by discrepant <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718025" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="7aa96f5c-401b-4a85-875e-6521ade99e3d">polymerase chain reaction (PCR)</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718025" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'polymerase&#x2423;chain&#x2423;reaction&#x2423;(PCR)' to 'PCR'" data-tag-desc="ABBRV" data-tag-type="ABBRV" data-offset="258" data-match="polymerase chain reaction (PCR)" data-replace="PCR" data-pattern="PCR" data-tag-index="12_4" data-function="addTrackChanges" data-track-change="polymerase chain reaction (PCR)" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="d1f4e709-5d73-47ad-a618-74e2460dce08">PCR</named-content> results (detected/not detected) on different platforms, up until <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="355" data-match="3 months" data-replace="3" data-pattern="$1" data-tag-index="12_2" id="fd878ac6-d2cf-46c4-8464-e1c4432bc3aa">3</named-content><named-content content-type="jrnlPatterns" data-title="changed from ' months' to ' months'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="356" data-match="3 months" data-replace=" months" data-pattern=" $2" data-tag-index="12_2" data-function="addTrackChanges" id="d5e0fd43-2f6c-49b3-9ed3-416b9660adb3"> months</named-content> after initial admission.</p><title data-level="1" data-class="jrnlHead1" id="fd4b786f-75fc-436a-ac24-1b8b7cd1f8bc"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718040" id="749a6cb0-49c0-4f63-8c22-0dd90126e9ef" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="Deleted by Exeter - 1607691718001" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase">DISCUSSION </named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718040" id="2bf20f87-dac1-45f1-b142-ddfcd79aa17e" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="Inserted by Exeter - 1607691718001" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1607691718001" data-reason="truecase">Discussion<named-content data-cid="1607691774" id="5463316f-7d75-40f8-85db-e0cfc97387b9" content-type="del cts-2" specific-use="1607691865757" xlink:title="Priyanka (PREEDITOR)" alt="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-title="Deleted by Priyanka (PREEDITOR) - Dec 11 2020 6:34pm" data-userid="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-username="Priyanka (PREEDITOR)" data-time="1607691865757"> </named-content></named-content><italic id="57ae5ab8-ad99-4c69-acce-7a72643cc78a"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691774" id="e78b2496-d7e3-42ce-a002-76141056d4b1" content-type="del cts-2" specific-use="1607691865757" xlink:title="Priyanka (PREEDITOR)" alt="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-title="Deleted by Priyanka (PREEDITOR) - Dec 11 2020 6:34pm" data-userid="preeditor 109a18d1-8758-4a9d-8bc5-ce4429d9f518" data-username="Priyanka (PREEDITOR)" data-time="1607691865757">Include a very brief review of similar published cases</named-content></italic></title><p data-class="jrnlSecPara" id="2392fea1-5f0b-46e6-b5ec-4670cf795b12">The first case reports of COVID-19 in SOT recipients came from China, where two <named-content content-type="jrnlPatterns" data-title="JRNM" data-tag-desc="JRNM" data-tag-type="JRNM" data-offset="80" data-match="heart" data-pattern="" data-tag-index="14_2" data-function="addItalics" id="f715ea9d-2ddb-44cf-8bc5-ad326acaf858">heart</named-content> transplant recipients made a complete recovery from their illness.<xref id="f216bd85-bdca-4c44-9979-803a648a81b1" ref-type="bibr" rid="R2" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="153" data-match="2" data-pattern="" data-tag-index="14_1" data-citation-string=" R2 " data-track-change="2"><sup id="4b661eb6-0fc5-4fa5-be51-dba8c36555f1">2</sup></xref></p><p data-class="jrnlSecPara" id="ff27c64e-6a44-44b6-880b-f6eaea495f71">The outcomes of COVID-19 infected kidney transplant recipients remain under study. Columbia University reported 15 cases in kidney transplant recipients.<xref id="b86c0016-9f46-4589-b587-585537f36038" ref-type="bibr" rid="R6" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="154" data-match="6" data-pattern="" data-tag-index="15_1" data-citation-string=" R6 " data-track-change="6"><sup id="4fd93619-bd48-44ce-a1e0-42dd6a5e5a01">6</sup></xref> Twenty-seven percent needed mechanical ventilation and two died, however not all cases had recovered at the time of publication. This group concluded that the outcomes in this cohort were similar to the general population.<xref id="2665e639-7a4b-4341-b99d-d39dafdce9d5" ref-type="bibr" rid="R6" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="380" data-match="6" data-pattern="" data-tag-index="15_2" data-citation-string=" R6 " data-track-change="6"><sup id="7b531881-f9f6-42d1-94e7-50d0bcfffdd5">6</sup></xref> On the other hand, an Italian cohort including 20 kidney transplant recipients reported a <named-content content-type="jrnlPatterns" data-title="VAL" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="473" data-match="25%" data-replace="25" data-pattern="$1" data-tag-index="15_5" id="9c0588be-8599-4558-87cf-2ed339b295c3">25</named-content><named-content content-type="jrnlPatterns" data-title="changed from '%' to '%'" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="475" data-match="25%" data-replace="%" data-pattern="%" data-tag-index="15_5" data-function="addTrackChanges" id="3288894f-050d-444d-b3c4-dee6120879eb">%</named-content> mortality rate and hypothesised that kidney transplantation may be associated with unfavourable outcomes.<xref id="8b4878f5-5479-4a10-b961-2d00563deb08" ref-type="bibr" rid="R4" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="583" data-match="4" data-pattern="" data-tag-index="15_3" data-citation-string=" R4 " data-track-change="4"><sup id="bac5545c-d893-4588-87de-1b7e997e894a">4</sup></xref> Seven cases have been reported in South London hospitals, including one death.<xref id="f2ec3d16-ecc9-4e72-9db0-12ac47c8ae8a" ref-type="bibr" rid="R7" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="665" data-match="7" data-pattern="" data-tag-index="15_4" data-citation-string=" R7 " data-track-change="7"><sup id="36b70289-dcd1-4a0c-a240-9088ac2da695">7</sup></xref> Long-term outcomes and consequences for kidney transplant function remain to be seen.</p><p data-class="jrnlSecPara" id="6dbf6a81-9959-427b-a1b5-51395419bd67">According to United States <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718026" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="468288aa-3d82-4275-bd87-361eb52a3335">Centers</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718026" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Centers' to 'Centres'" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="27" data-match="Centers" data-replace="Centres" data-pattern="Centres" data-tag-index="16_5" data-function="addTrackChanges" data-track-change="Centers" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="f5044c3f-9a0c-4f06-ba4f-8f4b7054db76">Centres</named-content> for Disease Control and Prevention, SOT recipients are at high risk of severe COVID-19 disease.<xref id="177e50e4-d20d-4ce6-9796-44cb48d5ff11" ref-type="bibr" rid="R8" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="131" data-match="8" data-pattern="" data-tag-index="16_1" data-citation-string=" R8 " data-track-change="8"><sup id="b377addd-6490-4637-8d95-f1fec39bd05e">8</sup></xref> Pre-existing chronic kidney disease, prior haematological malignancy, chronic lung disease, and the presence of an elevated <named-content content-type="jrnlPatterns" data-title="SMCP" data-tag-desc="SMCP" data-tag-type="SMCP" data-offset="258" data-match="d-" data-pattern="" data-tag-index="16_4" data-function="smallCaps" id="5d8ec8d8-686e-4c42-b369-905e9447ddd2">d</named-content>-dimer are all features of the described case associated with increased likelihood of severe disease.<xref id="10dfe12b-1eeb-41aa-a94c-6c9d7e658aa2" ref-type="bibr" rid="R9" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="361" data-match="9" data-pattern="" data-tag-index="16_2" data-citation-string=" R9 " data-track-change="9"><sup id="3b76c0f4-4356-4764-9888-dc61468e567d">9</sup></xref> Additionally, there was a history of several opportunistic viral infections in our case. The impact of spinal cord injury on COVID-19 outcomes is not known. Unexpectedly, apart from the initial hypoxia and hypotension that responded quickly to conservative measures, this case did not have a severe or complicated disease course. This may be because COVID-19 has a variable clinical presentation and may not necessarily follow a serious course of infection despite underlying risk factors or organ transplantation.<xref id="4f943ad7-ce99-4606-a9e2-96f38ce327c7" ref-type="bibr" rid="R10" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="879" data-match="10" data-pattern="" data-tag-index="16_3" data-citation-string=" R10 " data-track-change="10"><sup id="9467256b-8d72-495a-9694-2540b8063dcf">10</sup></xref> However, it is plausible that outcomes in SOT recipients are influenced by the type of baseline immunosuppression.</p><p data-class="jrnlSecPara" id="1d0bef1a-1779-48f6-9142-b385eda5f717">There is debate about whether immunosuppression is protective or harmful in COVID-19. It has been suggested that there are two phases of the disease.<xref id="66076d04-e7ff-4c02-953c-01db0071bc1d" ref-type="bibr" rid="R11" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="150" data-match="11" data-pattern="" data-tag-index="17_1" data-citation-string=" R11 " data-track-change="11"><sup id="e34422ab-2d7d-4ad9-b315-d272f296f1eb">11</sup></xref> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718020" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="c143f5cf-a191-4ef8-9f32-dfa206dbffea">Firstly</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718020" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Firstly' to 'First'" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="154" data-match="Firstly" data-replace="First" data-pattern="First" data-tag-index="17_4" data-function="addTrackChanges" data-track-change="Firstly" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="f0c1e9b7-b0de-4c2a-88a3-a643bf58d521">First</named-content>, there is an incubation period and viral replication. During the second phase, there is systemic inflammation, driven by T cell activation, which can cause a cytokine storm and lung injury.<xref id="d595a41d-97dd-4668-84eb-edb08fd4adde" ref-type="bibr" rid="R11" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="352" data-match="11" data-pattern="" data-tag-index="17_2" data-citation-string=" R11 " data-track-change="11"><sup id="4307f4ad-13e7-49d2-99d8-58be97c5e1d3">11</sup></xref> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718021" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="56eb9b88-653d-4ce2-95e0-2010be139db6">Whilst</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718021" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Whilst' to 'While'" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="356" data-match="Whilst" data-replace="While" data-pattern="While" data-tag-index="17_5" data-function="addTrackChanges" data-track-change="Whilst" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="7542ecc3-8ba3-4217-b3b9-e5e5d537fa66">While</named-content> immunosuppressive medications may promote viral replication, the anti-inflammatory effects could dampen the systemic inflammatory response and lessen the disease severity during the second phase of illness.<xref id="5a22c302-6a4b-4120-90f3-f5d4593711ef" ref-type="bibr" rid="R11 R12" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="570" data-match="11,12" data-pattern="" data-tag-index="17_3" data-citation-string=" R11 R12 " data-track-change="11,12"><sup id="9655b040-e064-4bec-a583-f3bd6f0636ef">11 12</sup></xref> The modification of immunosuppression may therefore have variable effects at different stages of the disease, and the withdrawal of immunosuppression at the point of critical illness may be counterproductive.</p><p data-class="jrnlSecPara" id="bb08dcf0-a4e1-4d94-9997-0a13dad43d5d">Many case reports of infected transplant recipients describe management with immunosuppression reduction.<xref id="0d5e8a47-5bd2-460e-a1d9-b53d339d6314" ref-type="bibr" rid="R4 R7 R8 R13" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="106" data-match="4,7,8,13" data-pattern="" data-tag-index="18_1" data-citation-string=" R4 R7 R8 R13 " data-track-change="4,7,8,13"><sup id="b13a1e87-6acf-4982-9abf-7b6f2b05d095">4 7 8 13</sup></xref> Of the forty cases of COVID-19 infected transplant <named-content content-type="jrnlPatterns" data-title="changed from 'patients' to 'patients'" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="167" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="18_6" data-function="addTrackChanges" id="42ccb94c-5e66-4163-bfc6-0e4548a3efd3">patients</named-content> Johnson, <named-content content-type="jrnlPatterns" data-title="changed 'et&#x2423;al' to '&lt;i&gt;et&#x2423;al&lt;/i&gt;'" data-tag-desc="ETL" data-tag-type="ETL" data-offset="185" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="18_3" data-track-change="et al" id="f35184df-6eba-4ffd-925a-d36ad2499511"><italic id="460f90f2-edcd-4012-a271-762df9955d12">et al</italic></named-content><named-content content-type="jrnlPatterns" data-title="ETLDOT" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="190" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="18_5" id="c1b471d4-14de-4402-bb2f-e3ef37e79de0"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" content-type="del cts-1" specific-use="1607691718001 data-cid=" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001 data-cid=" id="576d0ce7-bde8-4a2b-b0df-614d82db4d59">.</named-content></named-content> reviewed in the literature, only three were managed without alteration to pre-existing immunosuppression doses, with 30 cases completely ceasing calcineurin inhibitor (<named-content content-type="jrnlPatterns" data-title="ABBR" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="360" data-match=" (CNI)" data-pattern="" data-tag-index="18_4" id="62a602a0-62a3-4169-9392-e5b1cb481546">CNI</named-content>) and antiproliferative treatment.<xref id="7dda2d1e-eb0f-40e6-b67d-722d74ecdbbb" ref-type="bibr" rid="R9" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="398" data-match="9" data-pattern="" data-tag-index="18_2" data-citation-string=" R9 " data-track-change="9"><sup id="5e5a0c4d-9d17-4772-99f4-e7f1b3232c24">9</sup></xref> Given the stable clinical picture and the relatively low level of baseline immunosuppression in the presented case, a decision was made to continue immunosuppression without modification.</p><p data-class="jrnlSecPara" id="f7556bd6-9ff6-4a73-84fb-0cbaa2602aec">There are few cases of COVID-19 in kidney transplant recipients treated with mTOR inhibitors. Guillen <named-content content-type="jrnlPatterns" data-title="changed 'et&#x2423;al' to '&lt;i&gt;et&#x2423;al&lt;/i&gt;'" data-tag-desc="ETL" data-tag-type="ETL" data-offset="102" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="19_2" data-track-change="et al" id="6ebc1e27-9626-4082-84fd-78e6347ca2ee"><italic id="bc43a7b1-8a5d-411c-bcb3-90b12015160f">et al</italic></named-content><named-content content-type="jrnlPatterns" data-title="ETLDOT" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="107" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="19_3" id="fcd71c0e-832e-4d1e-87b5-a4b9fbcc5314"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" content-type="del cts-1" specific-use="1607691718001 data-cid=" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001 data-cid=" id="b64f7b76-2036-4ec6-a1be-c77136ce6403">.</named-content></named-content> reported a case of a 50-year-old male with a history of kidney transplant, splenectomy and post-transplant lymphoproliferative disease managed with tacrolimus, everolimus and prednisolone. Following a COVID-19 diagnosis, the tacrolimus and everolimus were stopped, and he was treated with lopinavir, ritonavir and hydroxychloroquine. On day 6 of admission (day 10 of illness), he was intubated and interferon beta was commenced. His outcome is unknown.<xref id="43181072-73a8-4e61-b7d4-abe3ae5ed9f9" ref-type="bibr" rid="R13" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="562" data-match="13" data-pattern="" data-tag-index="19_1" data-citation-string=" R13 " data-track-change="13"><sup id="17a057de-f700-4d9e-933d-1421c655669b">13</sup></xref></p><p data-class="jrnlSecPara" id="59a95d2c-5396-4078-b472-7be62c204a48"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718022" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="36e2cb7d-f8ad-4cb3-b186-7da226bb82d6">Whilst</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718022" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Whilst' to 'While'" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="0" data-match="Whilst" data-replace="While" data-pattern="While" data-tag-index="20_3" data-function="addTrackChanges" data-track-change="Whilst" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="1e7a885c-0f18-4506-b5fc-05c3dfcad160">While</named-content> mTOR-inhibitors are less commonly used as first line immunosuppression, case series of kidney transplant recipients with COVID-19 appear to be under-represented by individuals on mTOR-inhibitors. From a series of twenty kidney transplant recipients two were on mTOR-inhibitor maintenance immunosuppression.<xref id="b7f591ea-8a32-4150-aa12-d0d3ab0749d1" ref-type="bibr" rid="R4" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="314" data-match="4" data-pattern="" data-tag-index="20_1" data-citation-string=" R4 " data-track-change="4"><sup id="616abef6-7c10-4f8f-9a3f-a0b303cb0d8d">4</sup></xref> This included a 70-year-old female, also on a CNI, who survived to home discharge, and a 44-year-old male on a CNI and mTOR inhibitor who was an inpatient at time of reporting but stable on room air. The first case was managed with lopinavir/ritonavir and hydroxychloroquine, while the second received darunavir, ritonavir and hydroxychloroquine. Both cases had their baseline immunosuppression withdrawn.<xref id="a9d90ac2-65ed-43a6-aa70-8a9eef27206c" ref-type="bibr" rid="R4" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="723" data-match="4" data-pattern="" data-tag-index="20_2" data-citation-string=" R4 " data-track-change="4"><sup id="8e80beb9-b245-462b-a7f5-f5e45461c8eb">4</sup></xref></p><p data-class="jrnlSecPara" id="c00c203e-c265-4aa3-97dc-f0c435b9a657">A Spanish group reported one kidney transplant recipient and two liver transplant recipients treated with everolimus in a cohort of 18 <named-content content-type="jrnlPatterns" data-title="changed from 'patients' to 'patients'" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="135" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="21_2" data-function="addTrackChanges" id="19df50b8-7d6a-4003-aea9-dec2e98adbf1">patients</named-content>. The kidney transplant recipient was also taking prednisolone and tacrolimus, and developed severe acute respiratory distress syndrome necessitating high flow oxygen administration. Some radiological improvement was noted prior to publication. One liver transplant recipient usually managed with everolimus alone recovered, while another died.<xref id="f36ebc25-c836-4462-88d8-4039b23b0778" ref-type="bibr" rid="R14" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="488" data-match="14" data-pattern="" data-tag-index="21_1" data-citation-string=" R14 " data-track-change="14"><sup id="e27e5816-5542-4f45-913c-1031b8157b2e">14</sup></xref></p><p data-class="jrnlSecPara" id="c19af94f-1f6c-4465-9ef0-bc41cba98393">The prior emergence of Middle East Respiratory Syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) prompted investigation into therapeutic targets for coronaviruses. mTOR inhibitors have been identified as potential therapeutic agents given their known antiviral properties. Everolimus has been used to treat Kaposi&#x2019;s sarcomas associated with human gammaherpesvirus 8 (HHV-8).<xref id="cbd65a5c-bb5d-4a61-8b08-bcedf9d0c8c4" ref-type="bibr" rid="R15" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="420" data-match="15" data-pattern="" data-tag-index="22_1" data-citation-string=" R15 " data-track-change="15"><sup id="d2f3eac9-bfa0-4b40-9845-ec25d16896fb">15</sup></xref> Furthermore, analysis of the MERS-CoV infection found that it modulated the ERK/MAPK and PI3K/AKT/mTOR signalling responses, which play a significant role in the host response to infection.<xref id="ec157dc4-15ae-4983-9aa5-229af1bdd6b0" ref-type="bibr" rid="R5" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="614" data-match="5" data-pattern="" data-tag-index="22_2" data-citation-string=" R5 " data-track-change="5"><sup id="d767e1e5-b8bb-4f28-a7dd-03af982027bf">5</sup></xref> Everolimus was found to have an inhibitory activity against MERS-CoV.<xref id="d32d1f25-96c5-4cac-8354-2bf815237ddc" ref-type="bibr" rid="R5" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="687" data-match="5" data-pattern="" data-tag-index="22_3" data-citation-string=" R5 " data-track-change="5"><sup id="a834c6d3-bd46-40fc-8504-521962e935e7">5</sup></xref> Additionally, sirolimus, another mTOR inhibitor, was found to stop viral protein expression and virion release in MERS-CoV.<xref id="4f902093-6971-471b-a866-8cedf80caa5d" ref-type="bibr" rid="R16 R17" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="814" data-match="16,17" data-pattern="" data-tag-index="22_4" data-citation-string=" R16 R17 " data-track-change="16,17"><sup id="91a26c58-b3b0-4e8b-a728-7178d2e69784">16 17</sup></xref> mTOR signalling also appears to be important in H1N1 influenza infections, where sirolimus administration in those with respiratory failure improved prognosis.<xref id="25a12130-9bd5-4fee-9835-9fe571a338ba" ref-type="bibr" rid="R16" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="981" data-match="16" data-pattern="" data-tag-index="22_5" data-citation-string=" R16 " data-track-change="16"><sup id="30849a76-c07d-4b98-98b0-d2ac68d10353">16</sup></xref> Studies have shown that sirolimus in addition to steroids improved outcomes in humans infected with H1N1,<xref id="c2857645-b6ff-48b5-8af9-ceddb908d95b" ref-type="bibr" rid="R17 R18" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1091" data-match="17,18" data-pattern="" data-tag-index="22_6" data-citation-string=" R17 R18 " data-track-change="17,18"><sup id="16d64c19-0b31-4492-b28b-51234d32c4a4">17 18</sup></xref> although this was not replicated in a subsequent study.<xref id="39e07a32-5556-42ed-8ccf-6dcbb5369798" ref-type="bibr" rid="R19" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1154" data-match="19" data-pattern="" data-tag-index="22_7" data-citation-string=" R19 " data-track-change="19"><sup id="0cbafb93-d978-4ff3-859a-504fb91ba38b">19</sup></xref> Martins <named-content content-type="jrnlPatterns" data-title="changed 'et&#x2423;al' to '&lt;i&gt;et&#x2423;al&lt;/i&gt;'" data-tag-desc="ETL" data-tag-type="ETL" data-offset="1166" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="22_9" data-track-change="et al" id="d424046f-9577-403c-a709-94348c2d57a3"><italic id="31ee5f83-a1aa-4f85-ab9f-9b20bdb64e23">et al</italic></named-content><named-content content-type="jrnlPatterns" data-title="ETLDOT" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="1171" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="22_11" id="9c98cb8d-3e77-4b1c-a24b-07dec922e085"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" content-type="del cts-1" specific-use="1607691718001 data-cid=" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001 data-cid=" id="e901bec6-a314-4fff-8372-2f28c16b9f97">.</named-content></named-content> found <named-content content-type="jrnlPatterns" data-title="changed from 'in vitro' to 'in vitro'" data-tag-desc="FNW" data-tag-type="FNW" data-offset="1179" data-match="in vitro" data-pattern="" data-tag-index="22_10" data-function="removeItalics" id="aca4c3f4-b30e-40a7-a814-30400966dbdc">in vitro</named-content> that the mTOR pathway played a role in internalising the parasite Trypanosoma cruzi.<xref id="6d9d3a92-8be8-4c4e-8751-1a30ceed507b" ref-type="bibr" rid="R20" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1273" data-match="20" data-pattern="" data-tag-index="22_8" data-citation-string=" R20 " data-track-change="20"><sup id="ac19141b-63e7-439a-ad7b-6c41a18d1fb5">20</sup></xref> It remains to be demonstrated if mTOR inhibitors could hinder the internalisation of a virus such as SARS-CoV-2, thereby modifying the disease course. However, it is plausible that everolimus, given as maintenance immunosuppression, could have contributed to the favourable outcome in this case, despite risk factors for severe disease and prior evidence of poor anti-viral immune responses. Continuation of pre-existing maintenance everolimus immunosuppression should therefore be considered in transplant recipients that have contracted SARS-CoV-2.</p><p data-class="jrnlSecPara" id="dd3bf9a9-bf24-43fe-95de-e4eef5276055">In conclusion, a case of COVID-19 infection in a kidney-pancreas transplant recipient and identify and review the potential mitigating role of mTOR-inhibitors in this disease. We hypothesise that the relatively low level of baseline immunosuppression, in addition to the antiviral properties of everolimus, contributed to the relatively mild disease course in this case, despite multiple predictors for severe disease. This proposition is supported by previous research showing that mTOR inhibitors can have anti-viral effects, including for coronaviruses. Further investigation is required to establish whether mTOR inhibitors could be used as therapeutic agents to treat COVID-19, or as alternative immunosuppression implemented early in the COVID-19 disease course. Until further research is available clinicians should continue or adjust immunosuppression based on the clinical course, risk factors for severe disease and immunosuppressive regime.</p><boxed-text id="BLK_BX1" data-id="BLK_BX1" data-stream-name="a_BX1"><caption id="dff42955-7610-4924-be17-3af1e1eb6739"><title id="BX1" data-id="BX1" data-uncited="true"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718000" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="d4807aef-edcd-45a6-8ad4-8fb8585b75cc">LEARNING POINTS/TAKE HOME MESSAGES <italic id="784b13c9-fb96-492c-aa3b-922317eee5bc"><named-content content-type="jrnlPatterns" data-title="RNGS" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="35" data-match="3-5" data-replace="3" data-pattern="$2" data-tag-index="1_1" id="da412611-f8b8-49c3-aedf-fbe830187e96">3</named-content><named-content content-type="jrnlPatterns" data-title="changed '-' to '&#x2013;'" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="36" data-match="3-5" data-replace="&#x2013;" data-pattern="&#x2013;" data-tag-index="1_1" data-track-change="-" id="a047af9f-eeec-4ebf-8b27-ca24735630ab">&#x2013;</named-content><named-content content-type="jrnlPatterns" data-title="RNGE" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="37" data-match="3-5" data-replace="5" data-pattern="$4" data-tag-index="1_1" id="e1e7c3e0-a664-41d5-ae5e-a77d99262dd2">5</named-content> bullet points</italic></named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718000" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="d57123b9-a995-4912-8e2d-bffc81dcd439">Learning points</named-content></title></caption><list list-content="ul" list-type="bullet" id="94b5ad4c-deec-41e3-be6c-3e8e147a7522"><list-item id="cbbacc08-1e9d-4633-b8d5-4d912fa79089"><p colorcode="#" headweightage="14" leftmargin="18" textindent="18" listchar="&#xb7;" list-style-type="disc" nodetype="ul" listnode="true" id="4c562509-dce2-4c4c-b2ce-e5707f51682d"><named-content content-type="del cts-1" id="d40a5e11-2ace-43c4-a5aa-83656d431546">&#xb7; </named-content>mTOR inhibitors can have anti-viral effects, including for coronaviruses.</p></list-item><list-item id="ac5477c2-a325-448c-ac4f-a7049aed66df"><p data-class="Normal1" data-class-name="SecPara" leftmargin="18" textindent="18" listchar="&#xb7;" list-style-type="disc" nodetype="ul" listnode="true" id="cd2edec3-23fd-4dcb-843a-9e1ccf6c6f18"><named-content content-type="del cts-1" id="c039a643-6b6b-4ea7-820a-59265eafb5d4">&#xb7; </named-content>Further investigation is required to establish whether mTOR inhibitors could be used as therapeutic agents to treat COVID-19, or as mitigating alternative immunosuppression implemented early in the COVID-19 disease course.</p></list-item><list-item id="c5961199-3dc9-46be-8dde-c55419b22947"><p data-class="Normal1" data-class-name="SecPara" leftmargin="18" textindent="18" listchar="&#xb7;" list-style-type="disc" nodetype="ul" listnode="true" id="f733e61b-0612-4dab-b101-8302fc3945d6"><named-content content-type="del cts-1" id="22c5cba9-aacf-4700-97c9-358709010869">&#xb7; </named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718023" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="93f13f83-7d63-4606-9690-f625aac1c55e">Whilst</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718023" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Whilst' to 'While'" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="6" data-match="Whilst" data-replace="While" data-pattern="While" data-tag-index="27_1" data-function="addTrackChanges" data-track-change="Whilst" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="056d25da-ec52-47c5-860b-67fd0292c445">While</named-content> immunosuppressive medications may promote viral replication, the anti-inflammatory effects could dampen the systemic inflammatory response and lessen the disease severity during the second phase of the COVID-19 illness.</p></list-item><list-item id="57281be2-eaf0-48db-ae7a-daf60cf3affd"><p data-class="Normal1" data-class-name="SecPara" leftmargin="18" textindent="18" listchar="&#xb7;" list-style-type="disc" nodetype="ul" listnode="true" id="37d12ea2-58ce-4d1b-ac91-d99c3c12ab41"><named-content content-type="del cts-1" id="cc89635e-1cf5-4f1d-ab64-b82f7da87e87">&#xb7; </named-content>The modification of immunosuppression may have variable effects at different stages of COVID-19, and the withdrawal of immunosuppression at the point of critical illness may be counterproductive.</p></list-item></list></boxed-text></body><back data-edited="true" data-edited-version="2" id="281b6ea1-a0ad-40f1-92db-a32c6d491ce6"><ack node-insert-xpath="//article/back" node-insertbefore-xpath="//article/back//ref-list" id="fe7c61c1-cc74-46ac-af4e-2e1772c63abd"><title data-level="1" data-class="jrnlAckHead" id="406b93fb-80d0-480e-a978-420846dc79b4"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718032" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="0e14231c-8ce2-4be0-a46c-62eaade74dbd">Acknowledgements</named-content></title><p data-class="jrnlAckPara" id="4471cb07-b36b-4881-a7f7-9f59e3758389"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718033" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="235f7c49-6c50-4bcc-bd19-add7941d9f76">The authors wish to acknowledge Dr Olivia Smibert for her assistance with preparation of the manuscript.</named-content></p></ack><ref-list node-insert-xpath="//back" id="a999164a-c396-4437-8bee-e779413abc97"><title data-level="1" id="70b8eacf-b240-411b-8b42-b40f01edf0cd"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718034" content-type="del cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="5035eff4-7224-4a23-a699-6b07a3a61b0f"><named-content data-cid="1607691718000_s" content-type="del" specific-use="1607691718000" xlink:title="Exeter" alt="preediting" data-type="s-case" data-userid="preediting" data-username="Exeter" data-time="1607691718000" id="59d11802-cc55-4c30-8db2-921ea846635d">REFERENCES</named-content><named-content data-cid="1607691718000_s" content-type="ins" specific-use="1607691718000" xlink:title="Exeter" alt="preediting" data-type="s-case" data-userid="preediting" data-username="Exeter" data-time="1607691718000" id="c7724405-907a-4cf9-8ca9-1efd989977d0">References</named-content></named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691718034" content-type="ins cts-1" specific-use="1607691718001" xlink:title="Exeter" alt="preediting" data-userid="preediting" data-username="Exeter" data-time="1607691718001" id="86b30c99-33de-4d78-9810-cb41a4d3af1c">References</named-content></title><ref data-class="jrnlRefText" seqid="R1" id="R1" data-id="R1" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R1" data-doi="10.1002/jmv.25722" data-validated="true"><label id="019b1d85-170c-4d1c-ab17-c3ff4f6bc616">1</label><element-citation publication-type="journal" id="ff1f0fc8-77b0-4dc5-a8c0-4412ff65ef78"><person-group person-group-type="author" id="c2f5327a-9f5e-4a14-b782-52971ee419f3"><name id="871a48ce-dda4-4062-a5ef-18ecab167f3e"><surname id="af610181-65e1-46af-8d98-2e65ee569ed9">Sun</surname> <given-names id="2225cdba-4775-4a12-84c9-240649c8a87c">P</given-names></name><x id="f40106e6-baa5-4351-8c76-eacefe7eca04">, </x><name id="091652e1-27a6-41b3-90ce-b3c8717a2bf6"><surname id="9b17d830-0403-4265-9411-90b52a209c06">Lu</surname> <given-names id="f651f383-6c97-459c-b586-ecc7d20a451b">X</given-names></name><x id="efbd4b3e-1d04-4039-aa2e-7d4b80684d8e">, </x><name id="d17d4ed8-b6b6-4dba-ae2b-b2803a528933"><surname id="88983d58-c3e2-4874-8033-7fd1df24116e">Xu</surname> <given-names id="d322b52f-5b48-45fc-a5bc-74f6a2b0f4df">C</given-names></name><x id="f5b73b2c-8368-451e-bb79-90f54722af5e">, </x><etal data-class="RefEtal" id="f96c82bb-3c68-4092-96c1-2ed88aef76d0">et al</etal></person-group><x id="778b2073-8c5b-4abb-b56d-0c1e5b19361c">. </x><article-title id="6642d3a1-8b90-4a14-b149-dd7da0119fe8">Understanding of COVID<named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729002" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="36379fc5-a6e5-41c8-b04f-99c98ce16e17">-</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729002" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="e3120aaa-4ebc-412a-821d-3437f25c9e6e">&#x2010;</named-content>19 based on current evidence</article-title><x id="4d335af3-b1c5-4864-a95e-6cbd67d25996">. </x><source id="f78621a2-f4ef-499a-b67c-f58c2573136c">J Med Virol</source><x id="c7234718-3a0c-46d5-bec3-3ab09f7fafb6"> </x><year id="5d953e0c-91bc-49d1-9097-bfc8ecf36438">2020</year><x id="2016bf55-1c35-4e87-b417-004fa383fc8e">;</x><volume id="3b54263e-1d94-4ffc-a7c5-97189a5dc0d3">92</volume><x id="36685655-ecf3-468a-8eee-d9d6e25fa3a7">:</x><fpage id="d2bb9b82-08b7-4c52-8c97-140d926d66fe">548</fpage><x id="98252930-a08c-4578-a407-a34b4c20d951">&#x2013;</x><lpage id="a7805653-3b7d-49cd-8f4d-28d75c05d8a0">51</lpage><x id="042b03fb-9373-45ca-ab32-df65ef02fce0">.</x><pub-id pub-id-type="doi" id="5f7ba28b-5b75-4d5d-abdd-a7ad362e59c0">10.1002/jmv.25722</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R2" id="R2" data-id="R2" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R2" data-validated="true"><label id="10ecda8a-4198-40fa-bb90-4f9e2534196d">2</label><element-citation publication-type="journal" id="9998b307-c64f-4f7a-af08-cc25eadd9b1d"><person-group person-group-type="author" id="1425604d-3fb6-4587-b550-958835c253cc"><name id="8b3c1e86-fb9e-403f-a047-0d288537d273"><surname id="52698f5e-9cc8-4cb4-a8d5-b5c5a419271b">Li</surname> <given-names id="c0f54a33-b367-4f78-b0ef-5fb6468197f0">F</given-names></name><x id="270bbb2e-c7ab-45c5-8327-3378bb1ae7fd">, </x><name id="e6fd120f-7744-4bb1-bbb2-74bf1601c863"><surname id="bc10a6b5-8710-4498-857b-c511a3ba09af">Cai</surname> <given-names id="1e09f0ba-9f34-43d4-a079-0d852c84d865">J</given-names></name><x id="7fc3fb6c-d737-4522-8337-7b0d1bb1f0b4">, </x><name id="aedeaf1e-fcdd-4b0d-86d8-6d437ab5ab65"><surname id="aadfbf7e-9361-4e02-85e1-d351b5c8c880">Dong</surname> <given-names id="4d82488e-054c-40f1-8a33-e7c4a34f4c61">N</given-names></name></person-group><x id="2a011ae6-97bb-44e0-8414-77d522267a7c">. </x><article-title id="60f4393f-0a6f-4d8a-ad5a-d0cd939ab300">First cases of COVID-19 in heart transplantation from China</article-title><x id="a103edb1-da21-40e0-99b8-742a69c3f966">. </x><source id="472d216e-9dcf-4e32-b8c7-58e9727dc3f0">J Heart Lung Transplant.</source><x id="c7208316-f745-401e-99e6-f96b7fe95d49"> </x><year id="5f4bde17-0893-42fc-b016-623123b762a7">2020</year><x id="fbfae0fa-1805-4886-8550-5949a4b01b18">.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R3" id="R3" data-id="R3" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R3" data-validated="true"><label id="74a970b9-913b-4446-be2f-12a6e2cbf4a8">3</label><element-citation publication-type="journal" id="ef21ace4-c9b9-4945-9ec5-145566b5b9d2"><person-group person-group-type="author" id="75f2eae3-76b1-474c-a47f-c9392a660319"><name id="7ec0625b-db26-4cfd-b9e2-23a8a656edc9"><surname id="c60b6595-4f48-48e6-89d5-87fcdd3284a4">Zhu</surname> <given-names id="7dbe9016-d7ed-47a9-a616-b1415679fa41">WJ</given-names></name><x id="cbff9434-b6d4-4139-b4a3-613905eb79b2">, </x><name id="c2f795e3-bf0d-4cc3-af99-9f4f7c217f86"><surname id="8ed08671-26e6-4c80-a601-74c9175473c9">Wang</surname> <given-names id="c30cbc64-7912-4e70-b221-717811f56b83">J</given-names></name><x id="b100bec0-1232-4d24-a3fa-125663400f45">, </x><name id="7fc9dc89-7b82-4c33-9211-ca63f1afa297"><surname id="3525adf9-a886-41b2-9016-468c0aa4a345">XH</surname> <given-names id="4d94df78-aff1-4c8a-9884-4a0cebb3958a">H</given-names></name><x id="53050271-50f5-4da9-af10-96b5fa975c8c">, </x><etal data-class="RefEtal" id="2e75c4b4-cf53-4359-818f-b64720540e7f">et al</etal></person-group><x id="c34f2649-20be-446b-b471-cb4b7c6111ab">. </x><article-title id="7f7ed138-deb8-4f62-bb90-90c830939769">The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease</article-title><x id="a1b722fc-1e64-4cab-a2d8-fa9c0771dad9">. </x><source id="085d66f8-af2a-4114-a02d-0daf00b8bf97">Zhonghua Zhong Liu Za Zhi</source><x id="e9210a29-0895-4293-9c4d-a10ee11f9566"> </x><year id="d7081a26-71c6-47d8-b82d-56ad9d4d1d7c">2020</year><x id="31276b9e-c5b4-40ae-8376-41db71a4bbd8">;</x><volume id="1f365eed-a68a-47b0-8dab-b1d54771959e">42</volume><x id="26de1570-1fa0-4a99-889c-b28d0730661e">:</x><fpage id="78157a21-346c-4735-8d3f-568bfdd27e34">E008</fpage><x id="72f61297-3b15-477b-9bcb-250be39ffedd">.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R4" id="R4" data-id="R4" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R4" data-validated="true"><label id="6626c124-d1a0-46fb-b29c-e8276c4b888f">4</label><element-citation publication-type="journal" id="926cbb3f-6beb-4ddc-8c7d-55b054e487b0"><person-group person-group-type="author" id="9098bdad-f06f-4f2d-8a64-72cde3ae40b0"><name id="a7ffc6c3-5341-4dff-83eb-5ad761cda396"><surname id="1e75955c-f9cf-4acf-90dc-31175fcaea55">Alberici</surname> <given-names id="ab9db60f-a7bf-4c62-8c53-ec93e2141f3a">F</given-names></name><x id="d79057a8-473d-44e7-a8db-48c159ccd9f2">, </x><name id="5d2c5c9a-a35a-4c2f-b9fb-988062a63d78"><surname id="93bb4b42-3bd7-4dc8-8750-4dbfb42f3e41">Delbarba</surname> <given-names id="211f7147-8d00-4f97-9b1b-ac6213e3141f">E</given-names></name><x id="f01f83f6-2af8-41d2-b629-5728c2a38d1a">, </x><name id="8c24e7fc-cc27-4fb3-b20c-06900d7847ae"><surname id="1e11df03-1377-493a-93a3-475e5893191d">Manenti</surname> <given-names id="fd0f8883-9145-4780-ac66-4140092d00c8">C</given-names></name><x id="9a8a91e6-71a2-4dfc-82b1-cb9606048560">, </x><etal data-class="RefEtal" id="85ca02ff-cfe4-4f77-a66f-ad36a243373d">et al</etal></person-group><x id="aa82c6c6-6fe6-489d-820b-e55375224b27">. </x><article-title id="2d89f96f-61f4-4652-a1f0-78ef9e10e1b1">A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia</article-title><x id="62b98919-0b21-4c00-9b94-670d0febc834">. </x><source id="7e43ee68-e833-4294-983d-23eec7a9956c">Kidney Int</source><x id="b32ba03a-c3b6-4eb2-8c80-2180462264ad"> </x><year id="6a514a42-9325-4e24-ac4f-25552a615d6b">2020</year><x id="7fd5fc14-0ebe-41cc-817b-c3571df18b49">.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R5" id="R5" data-id="R5" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R5" data-doi="10.1128/AAC.03659-14" data-validated="true"><label id="a2fbc75f-6e8b-4c65-a8d2-abaad7e826f8">5</label><element-citation publication-type="journal" id="625ae95e-2a84-486f-a8ca-703a2a3c508d"><person-group person-group-type="author" id="4049a5f3-7d18-44db-b5a3-8a08a5d6c12e"><name id="f8d49e67-0a43-4c08-ab44-67dfbcba441f"><surname id="f99d7c1c-8ab1-4011-8712-d54c1349df1f">Kindrachuk</surname> <given-names id="098256b9-4781-4be2-94f2-34b5f09658ae">J</given-names></name><x id="0233fa76-7f16-472c-a0b6-236ebdc0e694">, </x><name id="5fad8999-2ed9-4093-84f4-efc9f6d5827b"><surname id="8a4a74af-b658-438d-ac7c-760458bde1bc">Ork</surname> <given-names id="2a9620f1-44cc-4318-b6a5-2b993d4b792b">B</given-names></name><x id="78b0314d-f0bb-4351-af10-e506787633d7">, </x><name id="6ad96eed-34cb-444d-8751-eaa8a6369716"><surname id="039d7e11-1a00-4eb1-be71-9e820fedc3cb">Hart</surname> <given-names id="35892bcf-f47d-4ac6-b169-064aa1d91164">BJ</given-names></name><x id="0de2c6a0-d60c-4b03-888a-635ca0322834">, </x><etal data-class="RefEtal" id="eb325407-ff8d-43f4-a040-0d4dabaeaab6">et al</etal></person-group><x id="889cf714-91c0-4377-b1d8-a69149251d3b">. </x><article-title id="27a151c8-7967-4d1b-aff5-16d30c218445">Antiviral <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729003" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="73dbd24d-e3d1-4a94-abe4-e7832256b5ab">Potential</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729003" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="34bd43bb-1298-4c3b-bc78-d7324d1d952d">potential</named-content> of ERK/MAPK and PI3K/<named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729004" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="c331e9e7-8dd5-421e-96ec-ef9db86875eb">AKT</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729004" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="d025a4ed-801a-4df8-b175-e5832e2ed8a2">Akt</named-content>/mTOR <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729005" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="be93136c-c6d8-474e-ac0a-a095a633469f">Signaling</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729005" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="f72954e4-b3f8-449a-96f5-eaeb8e7306cd">signaling</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729006" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="92530f98-125f-46a5-949c-56cde02447b9">Modulation</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729006" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="5661c62e-13e8-4b64-a506-eb30899d4403">modulation</named-content> for <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729007" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R105" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="ae461a1c-6cba-4add-8a95-42618b74ebe5">Middle</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729007" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R105" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="256061e9-1341-4bf4-bf9f-7fe39ac9d45c">middle</named-content> East <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729008" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R106" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="afe2cb6e-73c6-41b6-bec2-7ceb58981c34">Respiratory</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729008" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R106" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="c5f6029c-2d6f-4beb-95eb-a7c66fe1330c">respiratory</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729009" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R107" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="2cb7c6af-dce0-4fd6-bd73-050425dfe733">Syndrome</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729009" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R107" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="f6dea8c1-3d03-4d4f-8d87-764c24813a26">syndrome</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729010" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R108" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="1c77248f-39ce-46c5-8cf9-bc8d19c97b3c">Coronavirus</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729010" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R108" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="6567ffe5-ea7a-417b-8de9-1c38acae157b">coronavirus</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729011" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R109" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="d5ad63eb-b535-42f9-83fd-1d6c6aebc610">Infection</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729011" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R109" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="e3647add-10a0-45c5-bede-961f2befe74b">infection</named-content> as <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729012" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R1010" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="73530484-eac6-4356-ac98-464b0c1712f8">Identified</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729012" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R1010" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="37f6ae73-afc2-4bf3-9cd6-4705cb757537">identified</named-content> by <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729013" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R1011" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="48e2a851-9399-4737-b6c9-347c77672ee3">Temporal</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729013" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R1011" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="87f1106d-b0a7-4542-b4bd-ac1f8f76efcc">temporal</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729014" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R1012" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="d45de2af-4544-422d-9555-560f98e790a8">Kinome</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729014" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R1012" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="33d0bc67-8941-4f1c-96d4-1df280c06b0a">kinome</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729015" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R1013" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="07ec4c9b-fde4-46f7-87eb-2159a61897f7">Analysis</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729015" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R1013" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="638ad42f-4ce5-4e8e-956f-9b0fce7948ac">analysis</named-content></article-title><x id="57896377-3d18-4601-a48a-dd85291277dc">. </x><source id="3e819500-0c12-4aee-a906-ce3a52220339">Antimicrob Agents Chemother</source><x id="074de320-65b3-4d81-86ad-b0f90cf3dda4"> </x><year id="5ce569a4-29e1-46cf-9b26-235c83f49b1b">2015</year><x id="47095f9f-333f-41ac-8e38-3c1641be8214">;</x><volume id="fe1746bf-278b-42e2-bd7f-096febf1a194">59</volume><x id="e05aa662-1601-433e-82d9-853339406f99">:</x><fpage id="030c9d3a-6743-41ae-a78e-29e9be1dc23b">1088</fpage><x id="58d749a0-c244-4643-8fbe-0b399a31fc90">&#x2013;</x><lpage id="4ed5db53-5357-4764-8411-ac208a77d566">99</lpage><x id="f14f803d-96de-476c-9cc3-2ea257ab96b7">.</x><pub-id pub-id-type="doi" id="aeecee33-4c6c-4094-a5ff-6cf9c5293e0c">10.1128/AAC.03659-14</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R6" id="R6" data-id="R6" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R6" data-validated="true"><label id="7dc078ed-7aad-41bf-9eff-321549cc912e">6</label><element-citation publication-type="journal" id="cceb1cfb-f206-41dc-877c-35d26389043c"><person-group person-group-type="author" id="0b77ce51-5ffd-40d9-9c9a-f9ffee4bb74d"><collab id="5f1f566d-8fa4-4acb-8957-06ba86e4b9f1">Columbia University Kidney Transplant Program</collab></person-group><x id="07c1d275-8e50-435c-a53b-2be6f7e62b4f">. </x><article-title id="4030ccf2-021d-4e21-a4da-660be775a1a3">Early <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729016" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R81" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="653640ff-47e6-4851-9bbf-6faba538baa9">Description</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729016" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R81" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="36b272d8-2076-461d-b1b3-d1f1b43cd056">description</named-content> of <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729017" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R82" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="c81e31af-233e-45e7-9616-be0fc590f749">Coronavirus</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729017" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R82" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="9385c0db-fb95-42f8-8236-ae9c754696c0">coronavirus</named-content> 2019 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729018" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R83" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="6fb32ef0-3ff9-4e55-882a-dc193c7644aa">Disease</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729018" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R83" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="6789f469-4945-4781-acfe-33c6ace1f4b1">disease</named-content> in <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729019" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R84" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="e06640c2-68cd-4ca8-b01b-99697511c82f">Kidney</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729019" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R84" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="8c89d70d-4a00-47c8-8c2e-f506feceec97">kidney</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729020" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R85" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="11f5455b-49de-4618-bc13-8a4e88d3b2c3">Transplant</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729020" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R85" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="e617b58f-0a0f-4e5b-9be8-0939cf04275d">transplant</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729021" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R86" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="4af0e969-bada-4aa0-8333-4025234e4e9b">Recipients</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729021" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R86" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="8c9c56af-9e5b-4901-8803-d26d800d2865">recipients</named-content> in New York</article-title><x id="e1b4952d-c543-467a-9898-3b48f274dcf4">. </x><source id="bccce165-92e7-4d44-8626-e0cb344635c0">J Am Soc Nephrol</source><x id="3fc37c52-1453-4243-856c-cbac74071754"> </x><year id="346796a1-375b-4a3d-a0cd-2b5d59f77679">2020</year><x id="de31e57f-806f-4aab-9929-601de016d054">;</x><volume id="ab1dd377-2fca-44c1-8eed-fc6d6a6dad94">31</volume><x id="c2123de7-5db2-4a94-aaf1-a39bf4f9db42">:</x><fpage id="1c8b25b2-83cf-48aa-81cb-49b372bfb670">1</fpage><x id="87a2e6e9-0050-4b12-81a8-5a6c6d2a22b4">&#x2013;</x><lpage id="fec4def5-ab10-420f-be6d-27e27f9c82a4">7</lpage><x id="750dd02b-a8d5-4921-a950-caad59650ca5">.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R7" id="R7" data-id="R7" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R7" data-validated="true"><label id="219125c1-a9d0-4cb4-99da-f4beadf77e1a">7</label><element-citation publication-type="journal" id="54302758-1b7d-48e0-adbc-8272058479de"><person-group person-group-type="author" id="d8562f2d-23e0-489e-b346-7ecc8a5b9f9c"><name id="704247b3-4bb5-443e-a93a-09fc1c5e487d"><surname id="6e952d27-4f13-45cb-a15b-69b730036c82">Banerjee</surname> <given-names id="d3915c1c-e601-4b88-9e26-948e5a51fb8d">D</given-names></name><x id="3d079719-e527-4243-894b-d4e51ac840c7">, </x><name id="d57fa88d-2c80-434a-a685-06302aa3175e"><surname id="7cb9c2e1-1273-4608-94a6-cbf23b0d1f3e">Popoola</surname> <given-names id="d627eeb9-c2cf-42c4-86fd-661ec01f54a6">J</given-names></name><x id="68835b66-87ea-4f0e-92d9-3f3178f06c4e">, </x><name id="35347ffb-cb6b-4ba3-92b8-778cb11b982c"><surname id="3bafd8ba-fce6-4bf8-8f30-a805acab7add">Sha</surname> <given-names id="09f3a055-d62e-47f3-8ea8-47573633350a">S</given-names></name><x id="902dc28c-9be9-40e4-903c-21d137084c5e">, </x><etal data-class="RefEtal" id="ed15705a-3329-475a-8d6d-df7fda2fcc27">et al</etal></person-group><x id="59143f23-110e-453d-9574-b8c5e913c8a5">. </x><article-title id="c2f21d84-f534-4c1d-a428-92b85492a639">COVID-19 infection in kidney transplant recipients</article-title><x id="2f49a994-0c0d-4f6e-ac77-1cf8646e25e0">. </x><source id="668eeedd-1c50-4351-ad6a-33bfdf37e4de">Kidney Int</source><x id="5f7040e0-a103-4ae4-9611-f584dd265a72"> </x><year id="bf0e522a-5bcb-4f12-9a86-cac5669534b0">2020</year><x id="ecb9fb4d-64bb-4115-a1ec-8552cae077e7">.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R8" id="R8" data-id="R8" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R8" data-validated="true"><label id="6c248a58-c640-4c8a-94a6-9cee042de6c9">8</label><element-citation publication-type="journal" id="115307d1-3966-4f9f-ab81-cd4dbba07738"><person-group person-group-type="author" id="24ed059f-d78d-4748-a99f-6df728ac0dc0"><name id="7467d593-73fb-4f3c-a7e8-b78fc667220a"><surname id="f8ec5ce2-196e-4870-88bb-7fc98fa9ebe2">Johnson</surname> <given-names id="5f032762-a6f1-490d-9f26-dbcac71270b7">KM</given-names></name><x id="9be45780-6a86-4b67-acd9-6983ea7345fa">, </x><name id="8a787b1c-a067-482b-821e-b26cd2417d6f"><surname id="c4caf5eb-a6bd-4115-85a0-b501b1abfe7b">Belfer</surname> <given-names id="f3501bab-56cd-46df-9689-a08eedaca87a">JJ</given-names></name><x id="1259d6a1-8012-4a3e-a0fb-c7c6533498bf">, </x><name id="cf8d46d3-8ee4-4548-b936-2d51eb55cadc"><surname id="8ac5c46e-936e-46eb-9faf-d63c62395f66">Peterson</surname> <given-names id="a35abc34-b216-447e-a994-64d3932092d7">GR</given-names></name><x id="00b3897a-67ca-4b48-ac6e-154bac83b31c">, </x><etal data-class="RefEtal" id="55f1ba54-0ccf-44af-9ce2-6407478ad477">et al</etal></person-group><x id="81c2eca1-32fb-4ec4-b8f4-d82e6799f10e">. </x><article-title id="665a1f87-7f47-433f-ab57-b526b1b807d6">Managing COVID-19 in <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729022" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R71" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="baef1fef-9f2e-4484-b92d-4958c3f4f3c7">Renal</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729022" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R71" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="c052326d-a0bd-41f3-9b63-985558537281">renal</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729023" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R72" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="5ae87af0-79be-445f-b5f4-1d1d13d31c18">Transplant</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729023" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R72" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="d83ae50a-d1b7-45b0-ab39-c1cdd7523867">transplant</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729024" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R73" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="6f4a5bf9-79dc-4d97-a5a4-3b64e1167e29">Recipients</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729024" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R73" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="0ee65fbb-c68e-4c3e-aafa-24f0e2b668cd">recipients</named-content>: <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729025" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R74" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="6a795577-64e5-48c9-9af1-e18d3429b353">A</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729025" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R74" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="a6efff76-bd81-4d29-ad8d-e877e66cb86b">a</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729026" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R75" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="d82b2862-eb74-418f-a684-b936bcfdb5aa">Review</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729026" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R75" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="123796b1-1eba-4688-984e-b81eca36693a">review</named-content> of <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729027" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R76" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="017c3c68-2202-42a5-a97d-8465928ea61c">Recent</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729027" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R76" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="de1e411e-5953-41a4-aaa3-7c75168bb78f">recent</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729028" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R77" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="10f1da4b-9f02-4592-87ca-4f183e305f57">Literature</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729028" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R77" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="d7cc673d-8023-4a52-96da-db4aef3c62aa">literature</named-content> and <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729029" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R78" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="36e6d1b5-1de5-49f2-978a-551ca62535bb">Case</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729029" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R78" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="d1e836ee-18a4-4182-bc95-37d6690c38fd">case</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729030" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R79" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="c6f405a2-7b1d-422a-9d18-34c8460356cb">Supporting</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729030" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R79" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="5dd885d0-ac34-479e-a16f-9335b10c3062">supporting</named-content> Corticosteroid-sparing <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729031" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R710" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="d6f075a3-a84b-4c32-9599-17dfc6f2c65f">Immunosuppression</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729031" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R710" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="284b0c4a-50b7-4f00-9dc6-1bc832c2b8b8">immunosuppression</named-content></article-title><x id="faa7036c-4086-4c22-b45e-c170ea0c0d84">. </x><source id="f9af17d4-b1b6-43d0-9a78-834b60192a25">Pharmacotherapy</source><x id="39cd8e63-71fc-40ee-bc14-32071a263e55"> </x><year id="b79bb1bf-07b2-4f9a-b683-961988ef0ec3">2020</year><x id="bcc90da6-4321-4dc4-84ac-7dbc23d4ac1f">.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R9" id="R9" data-id="R9" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R9" data-doi="10.1016/S0140-6736(20)30566-3" data-validated="true"><label id="91ea08d2-460d-4f66-a1f6-78cc275e0677">9</label><element-citation publication-type="journal" id="e578915c-a14f-4d62-a172-8d39f749e232"><person-group person-group-type="author" id="c21e0a0a-0623-4f40-974a-6cb8115de4c1"><name id="3321b662-a44a-40d2-a87d-d434b1485602"><surname id="670f4314-a295-4b4e-b255-23f0d763e1a8">Zhou</surname> <given-names id="8b0d1781-7cd5-4bc8-9499-7edaf0bdb2c4">F</given-names></name><x id="f5e85df0-d6d6-4895-8efd-7683349d459c">, </x><name id="aefd99f4-378d-45db-a476-c1fd0377b35a"><surname id="920e84fd-8796-4eef-8481-b061d15514d1">Yu</surname> <given-names id="ba245682-4953-4dcb-b48d-5efe3e48e446">T</given-names></name><x id="d35aab0e-e16f-413d-bdb4-57bbfb6f32b6">, </x><name id="99a886eb-f2a7-42de-a87d-3e3598bcbf8a"><surname id="7ec8c700-6626-4994-b9bd-48c40cb17989">Du</surname> <given-names id="5d371609-edc0-4bb2-b293-90fbd94adc1b">R</given-names></name><x id="48cbfe67-9b3c-4494-b1d6-2a06b6fbe8e7">, </x><etal data-class="RefEtal" id="f02d4844-1236-4fb2-863b-57b862f158fe">et al</etal></person-group><x id="6cbb7ff9-17bd-42a1-bde1-9e6f52626dd5">. </x><article-title id="ba0be006-a20b-4770-a7db-6eeceee13fff">Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</article-title><x id="95513c57-5156-4d9a-9c17-90116cd5a274">. </x><source id="83923203-d067-4f8b-b177-132d9ab7d2f9"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729032" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="6fbbdd4a-7991-4a51-990e-09e2d4fad5b0">The </named-content>Lancet</source><x id="3ecc8489-3092-42cf-9b7e-3e8da9658a01"> </x><year id="d3bc4f5f-4629-41c3-baff-acaa7719f33d">2020</year><x id="b0b6319c-0adb-4aac-ad12-0b83e5e34c8b">;</x><volume id="9c92985b-d6cb-4574-b571-be8e2775c73d">395</volume><x id="174d9a5e-a858-4649-b34b-302259e5f30d">:</x><fpage id="e51878e1-1810-40e1-9b23-7813862b5652">1054</fpage><x id="89384e25-643a-4145-b1a4-d69c548478b0">&#x2013;</x><lpage id="51acf05f-3dc3-4c63-ae03-6192f8b59890">62</lpage><x id="5ae524e1-403e-4335-81b8-b7cce03876fc">.</x><pub-id pub-id-type="doi" id="69d81b08-e1d4-438f-99f3-2e1eafe70375">10.1016/S0140-6736(20)30566-3</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R10" id="R10" data-id="R10" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R10" data-doi="10.1016/j.transproceed.2020.09.006" data-validated="true"><label id="dfbfc94a-4a77-40a9-95a1-b5a475a8774a">10</label><element-citation publication-type="journal" id="429f688f-f3ac-4c10-9a8b-859ebfc0bdbe"><person-group person-group-type="author" id="a0edf090-a202-42d7-b054-288a78b4a333"><name id="8f347af0-d7a9-4c38-bd90-b29e13b9434f"><surname id="5c9a5bec-b581-47c2-be18-23f49a301a7d">Aziz</surname> <given-names id="cddd5c74-6b5f-45d3-9680-16b9f6de2840">H</given-names></name><x id="67347760-b860-4457-8fa5-de5169cf50dd">, </x><name id="94f73edd-ce88-4c93-8aab-7d323ab08b19"><surname id="486aed31-1b22-4761-bee2-adad6c37cbc3">Lashkari</surname> <given-names id="1ecf4cf7-06e1-40bc-8a7b-05f820167bcb">N</given-names></name><x id="396afdcd-5f88-4c80-8478-4b9efee8a8f4">, </x><name id="54d006b8-1114-4f86-a5d1-44019abc9613"><surname id="feb196d7-b333-4dc6-98b9-2d5cab3b5028">Yoon</surname> <given-names id="58c14aee-a130-4d66-9c43-abcafde5d526">YC</given-names></name><x id="ee5700f5-6821-4754-a876-c214782fc962">, </x><etal data-class="RefEtal" id="ed60303a-e8b5-4b83-acd4-4efcbd09e791">et al</etal></person-group><x id="ea2561d9-ffae-4ee7-b78d-166f23fd083e">. </x><article-title id="6daa98e5-7ad1-43db-80bd-08efed2085be">Effects of <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729033" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="855cf2e9-e98f-45ad-be9a-e5afc2318b81">Coronavirus</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729033" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="0ea14800-a9e2-45b8-b6e4-7f6d8e7cb987">coronavirus</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729034" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="f58f51d2-8602-4f2d-b801-b9ab7b0e1966">Disease</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729034" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="78d80677-cb1d-4140-8742-3162be4d848d">disease</named-content> 2019 on <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729035" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="38e72c90-6460-4c2a-9f9d-4790083722c2">Solid</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729035" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="457c3578-09a5-4775-b810-047c9037df2c">solid</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729036" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="3529d3c4-c1ca-4971-b7ea-91df02017eb4">Organ</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729036" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="e53b6b55-58e6-4e69-a4f8-a0c5bf52a6a6">organ</named-content> <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729037" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R105" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="2c26e77b-4533-4225-be45-415b318522b8">Transplantation</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729037" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R105" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="0117df4d-01e6-47b9-a86d-02337c68761d">transplantation</named-content></article-title><x id="17b65eaa-2235-4ea9-9d53-c94190a6dcb3">. </x><source id="47efc2c7-e08d-4952-a03b-01f135e431a2">Transplant Proc</source><x id="8a99351a-dfc7-493a-ba95-04eec2c7c574"> </x><year id="9ddd4290-bcdf-47d7-b3ca-4750f0299e29">2020</year><x id="2daa87ce-ace4-4a41-822f-0d6f6b7eb4ad">;</x><volume id="bf2530d4-bc90-4ecb-a845-7890699caad8">52</volume><x id="6ba33f5e-115e-4e02-b940-7682ba325d97">:</x><fpage id="2234aa48-4985-4030-995d-2b6a3bfe1a18">2642</fpage><x id="337cea4f-2b64-4c65-b22c-06c669985eca">&#x2013;</x><lpage id="372108b2-3fad-44d2-8a53-97ef068c0d9f">53</lpage><x id="91418c84-1d54-4d58-87aa-e8ff2193ab07">.</x><pub-id pub-id-type="doi" id="00c4f0e3-18c4-4536-ac50-9ba78c12a8ce">10.1016/j.transproceed.2020.09.006</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R11" id="R11" data-id="R11" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R11" data-validated="true"><label id="ff7ce13c-1916-466f-baa2-1c00d95ca008">11</label><element-citation publication-type="journal" id="8e7af977-ac9f-4432-8e6a-4f82eeccf881"><person-group person-group-type="author" id="a717d2f8-1b74-4b18-bef7-d90d79074047"><name id="7ae09328-9609-4743-ac31-70ad3d8701df"><surname id="4bd3444a-078d-4dae-a2d4-e01c0f6f0129">Romanelli</surname> <given-names id="f1acfb25-9c08-4565-a835-866713044054">A</given-names></name><x id="b57e51b6-602a-4206-82f4-8ccfc03586c4">, </x><name id="4521ee32-873d-488f-a305-5b7d283dd632"><surname id="b6827203-e547-40b7-b77a-3d15f5d5f5e6">Mascolo</surname> <given-names id="8b2bef71-da3d-4227-acab-8850458306fb">S</given-names></name></person-group><x id="24d419ef-246c-49e7-9bed-b7a306268d6d">. </x><article-title id="05f9a730-1691-47e4-a360-165f16e8aa39">Immunosuppression drug-related and clinical manifestation of <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729038" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R61" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="9e067b11-b2d5-45c2-a745-dbc582d80405">Coronavirus</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729038" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R61" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="2a372a42-9f69-4c0f-82a1-bd4c489e68cb">coronavirus</named-content> disease 2019: <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729039" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R62" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="1eef4d0b-3718-42a4-8b06-722a9d4f0afe">A</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729039" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R62" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="dc9378fb-a280-4ee9-be60-cfa92590bbaf">a</named-content> therapeutical hypothesis</article-title><x id="f07dbf1b-5bf4-4e9b-a71d-245c675893c5">. </x><source id="6000a2b6-c9cd-4427-914c-2e57930657f0">Am J Transplant</source><x id="b2a17db7-e066-43ec-a037-875b56e8b1d5"> </x><year id="08ee548a-2c3b-41e8-bc77-3448830acf09">2020</year><x id="84a9da2c-588a-4979-9d65-f07b9e04de95">.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R12" id="R12" data-id="R12" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R12" data-validated="true"><label id="66240442-a643-4bfa-8031-743837038f3f">12</label><element-citation publication-type="journal" id="7ab39176-2d8b-41c4-a19e-acdc2df58a8b"><person-group person-group-type="author" id="0c098136-825d-4035-b1ba-e4f7eaf8f008"><name id="7b44384d-a273-4b10-b56a-3681596bcef6"><surname id="a2f12cf6-52e4-4513-a99c-e0750bb79c89">Aslam</surname> <given-names id="f3834e55-8660-4405-8316-21019db3bf64">S</given-names></name><x id="fbdbdcd7-1967-4b3e-9a25-3e3309b4913a">, </x><name id="9a32a6c9-99ff-4853-b74e-8f6acebf72d8"><surname id="d23bc6fc-9ccb-48b0-bbf7-d038dec359f0">Mehra</surname> <given-names id="e6059be7-1a01-442b-8f84-b8da757b8c46">MR</given-names></name></person-group><x id="462f2311-5ddd-470e-acef-8d0dd9df2956">. </x><article-title id="6c741f3b-7a2e-4677-87b2-cf24c0078566">COVID-19: yet another coronavirus challenge</article-title><x id="3349bd82-b419-4d80-955e-613fe4f688fa">. </x><source id="e774a0c6-5dc3-4574-9bff-1b30c88f107a">J Heart Lung Transplant</source><x id="280f9963-18ec-46d8-b890-a5b0e19d2a7d"> </x><year id="a5a3f82b-edc3-4b71-9f74-7b464ec5bb19">2020</year><x id="79f41bec-754c-47d9-8895-2f74c5a968d0">.</x></element-citation></ref><ref data-class="jrnlRefText" id="R13" data-id="R13" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R13" data-validated="true"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name id="700f0798-8954-488c-b28c-dada90546fc4"><surname id="6f48b84e-f3f0-4586-b889-c178162fa178">Guillen</surname> <given-names id="b85b79a2-4dfe-45e7-b510-012363515283">E</given-names></name><x>, </x><name id="a90117be-2cf5-4816-9068-515a06715632"><surname id="aaef1572-b07d-47fa-b2d4-7155b51b616e">Pineiro</surname> <given-names id="f02f638d-d8ea-4a28-9dcc-c2c298a5e6ab">GJ</given-names></name><x>, </x><name id="e817b599-da1d-4912-98da-1fef9d538395"><surname id="3978bee3-8e01-4b28-b3d0-fd4e349233ec">Revuelta</surname> <given-names id="fd166342-630b-49be-b587-db20b06e7feb">I</given-names></name><x>, </x><etal data-class="RefEtal" id="89a340f7-82ba-4093-99a1-9e2d3635b54c">et al</etal></person-group><x>. </x><article-title id="bd5e1452-c441-4273-8e85-4541e26c1e7a">Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation?</article-title><x> </x><source id="23ee4371-253a-415f-a0d8-83d0cfb53726">Am J Transplant</source><x> </x><year id="ed6745b4-9bf0-4a63-a49f-419e7decf7c5">2020</year><x>;</x><volume id="05a37922-06ee-48f9-9c76-14d339759b2c">00</volume><x>:</x><fpage id="36f05e45-056e-4fad-badf-485c7827bbfe">1</fpage><x>&#x2013;</x><lpage id="6ad69a6d-acb3-40a4-ba49-1973b102035d">4</lpage><x>.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R14" id="R14" data-id="R14" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R14" data-validated="true"><label id="b2848d9d-61f6-488c-8b05-244cf81a9396">14</label><element-citation publication-type="journal" id="ef0e673a-9112-4524-b8dc-6007c1219dd3"><person-group person-group-type="author" id="c0536248-6a29-43f9-a011-7fb0b18087d1"><name id="9b585bde-9f94-45d2-950b-0d37d6cc578d"><surname id="3eba7f07-28cb-4931-a61d-105028e6f27d">Fern&#xe1;ndez-Ruiz</surname> <given-names id="4c715a09-8b31-4d93-bf44-96da2ef26708">M</given-names></name><x id="d3c0e738-dd0d-4b52-bbb9-5c8c40858f20">, </x><name id="cb829eb2-0336-4041-a119-c2268843f003"><surname id="00693dc2-643a-4123-9dff-0437e705f471">Andr&#xe9;s</surname> <given-names id="aa2f281d-86b0-47b3-8f9b-b0ef4c85e8b1">A</given-names></name><x id="fe802b0b-f46e-48dc-80ac-6eb935a693ab">, </x><name id="76845f9a-06b0-47f4-b6cb-ad0dfd872b28"><surname id="634e3045-93a3-4ec1-9afe-bb5fde2a184a">Loinaz</surname> <given-names id="10482097-76c0-454c-a663-1a891176e29f">C</given-names></name><x id="6de8f4f7-b3f9-422f-95fa-0e2f57831f6d">, </x><etal data-class="RefEtal" id="08810723-ae61-4ddf-bded-8af98b899587">et al</etal></person-group><x id="f825b907-60ad-443b-982b-20df05faf5e0">. </x><article-title id="b693ffff-a2c3-49b0-81ee-8299aa919610">COVID-19 in solid organ transplant recipients: a single-center case series from Spain</article-title><x id="e16cdcbd-adfd-4bb1-9367-679495f0f93e">. </x><source id="a3a058ef-effb-4fee-bfb4-55bed0b895cf">Am J Transplant</source><x id="2c708b4b-dea3-4ba3-ac4f-08faf1033dfe"> </x><year id="8f3a2dc6-faf6-4d2c-8857-0b0e0526a99f">2020</year><x id="ce09ccd3-0bc4-4b90-893d-6c8ff24b0fce">.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R15" id="R15" data-id="R15" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R15" data-doi="10.1002/rmv.722" data-validated="true"><label id="77809465-ee3f-4818-89d3-d2376d79f500">15</label><element-citation publication-type="journal" id="8b6ff979-e723-4c1f-aeb2-ab81b95a8c75"><person-group person-group-type="author" id="22afdd6f-6441-4bb9-9cdb-ce9187ec9c01"><name id="6a1d8761-35e7-4ffa-8939-fdf21a0d5301"><surname id="41e14ed8-227c-420b-a89c-a784a8874527">Keating</surname> <given-names id="b513a790-42e9-4150-b5f5-e3882db32d36">JA</given-names></name><x id="626de445-b69f-43c9-b89d-e465a48d0167">, </x><name id="9ae47fb6-1907-408f-a9f5-652015a20d56"><surname id="f371fdfa-61d0-4353-9118-5a49c59b083c">Striker</surname> <given-names id="25c52845-5306-405d-95f7-b1de4de4a70d">R</given-names></name></person-group><x id="cf35186a-0add-4464-bd4e-20ac2dd37cb3">. </x><article-title id="cbc30d33-479a-49ad-bb1a-0178eb7cb8e6">Phosphorylation events during viral infections provide potential therapeutic targets</article-title><x id="c50db117-3c1a-4343-905e-b43a6e863ff9">. </x><source id="32480a57-f850-42e8-867d-38fbf118e3ac">Rev Med Virol</source><x id="9ed4a116-311b-4995-b8b7-4852b4bca772"> </x><year id="7601596b-d7e7-42a0-9354-580eb8b1ccc7"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729041" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R91" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="ecee7649-4922-4b22-ac93-900d377d005c">2011</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729041" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R91" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="64575a5a-3b57-49a6-a4e2-1ffcad782a67">2012</named-content></year><x id="fab853af-f3ab-45c8-9b13-181db431990d">;</x><volume id="075ecadd-6f1a-4301-9272-3b1ff9428aa3">22</volume><x id="619f8679-fa44-4b64-8ecc-3d3c2bc43a35">:</x><fpage id="c7bf55f8-6437-4bc6-b105-2cef522ed009">166</fpage><x id="69b5b305-cfcb-41b0-a46e-f96cfedd90b7">&#x2013;</x><lpage id="d364536c-775a-48b8-93af-df95182a221a">81</lpage><x id="4a34b5b1-a5f5-4200-a2fe-f3f040d0c462">.</x><pub-id pub-id-type="doi" id="74f4bd47-351a-4082-ab56-d5d977ffb5f0">10.1002/rmv.722</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R16" id="R16" data-id="R16" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R16" data-doi="10.1007/s40265-017-0830-1" data-validated="true"><label id="1fb5b88e-a129-4182-a291-b23648ad085a">16</label><element-citation publication-type="journal" id="d4d38776-87b9-428d-9950-517a824964a2"><person-group person-group-type="author" id="ad68d3a7-fbd4-4e48-9d8c-9bfe3c4380e6"><name id="23b4f505-8a83-4da9-a5ed-4021b21a4bdc"><surname id="4ed599da-e60d-4d73-b01c-e8684a34d72f">Dyall</surname> <given-names id="3d2fbcdb-a0f4-440d-a532-584828494503">J</given-names></name><x id="47f6096f-2bb2-43f2-a836-08657895fad6">, </x><name id="b6d2b666-fdee-440e-b0a7-86048a11066f"><surname id="d7bd4817-932b-40d8-81af-d1d27db5bfdc">Gross</surname> <given-names id="92e0d809-9280-4e39-98c8-568d2a471d3c">R</given-names></name><x id="ad57cfc2-3037-472b-99d0-7679b6b40aae">, </x><name id="7ccd5006-1b07-40a1-b239-0fe2adcb1f00"><surname id="ded17cc2-92c5-4670-bf9f-82f8302af143">Kindrachuk</surname> <given-names id="8c9621ce-420c-459b-aeae-9fd801d1864c">J</given-names></name><x id="65ab84a3-a533-42ca-959b-51d5b9851c51">, </x><etal data-class="RefEtal" id="9a2dbb10-730d-49d9-b0fa-8f697ebebcb4">et al</etal></person-group><x id="66a49344-e3db-48b8-8e48-d1481a48568b">. </x><article-title id="64ede583-7a0b-4668-9330-5b4a2b31f58a">Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies</article-title><x id="4b620398-a2b8-4e6b-8286-ef940a654d89">. </x><source id="8a49c180-2d20-4886-aab3-652cdccc9b22">Drugs</source><x id="8db2efe4-43f1-4a71-bb34-57bd0ba116a6"> </x><year id="6997ed09-803c-4710-9625-4689941c354f">2017</year><x id="b8f00a81-0004-4fe7-a2bc-d2c195ce2523">;</x><volume id="291e2e6a-d222-4a61-a8c1-121ae9eabda5">77</volume><x id="4ad9247e-7185-4fe4-9a20-7b46a294908c">:</x><fpage id="aaa3d26e-e99c-4075-8698-9b9717724203">1935</fpage><x id="e405c639-2b47-45f9-a9a1-c5b1f3a773d6">&#x2013;</x><lpage id="b2f3a278-be76-4cca-97cd-fea72a06c4d3">66</lpage><x id="dae8d6fa-6c11-4c2f-9d99-26efb6d23302">.</x><pub-id pub-id-type="doi" id="ed636b67-7c27-4137-a87c-fdadf783a58a">10.1007/s40265-017-0830-1</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R17" id="R17" data-id="R17" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R17" data-doi="10.1097/CCM.0b013e3182a2727d" data-validated="true"><label id="a58e309d-12cf-457c-a51a-5d1fca2d6965">17</label><element-citation publication-type="journal" id="a8d503de-c8f7-4362-b2dc-51945a1baf6e"><person-group person-group-type="author" id="2981c2f3-ff9d-4ce4-b471-5783fbedd511"><name id="69860544-5803-4d4e-b856-1d1cfcc352c6"><surname id="72afaf38-40a5-463a-8036-3aece18e3d41">Wang</surname> <given-names id="caa208bb-900f-4d59-b638-f9069619e8e3"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729042" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="54afe2cb-5f67-4b25-bcf4-f563947cae61">CH</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729042" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="1bef800a-b1d6-4a9e-963b-cecb269b4b0f">C-H</named-content></given-names></name><x id="c6c1db62-2001-4f97-8f66-3ce35740b3b4">, </x><name id="f80371d6-e7ec-4351-b261-a855b8372649"><surname id="0a4c6825-872b-4459-9936-dfdd68c57fef">Chung</surname> <given-names id="dba22004-c179-49e7-b1b0-9574bd078a0b"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729043" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="2ed82f87-0b7a-4425-a3d9-c8030e863fdf">FT</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729043" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="7f520de9-57c1-4890-9d6b-309a150e8539">F-T</named-content></given-names></name><x id="f4413661-7cea-4ee1-8fee-932e5d5bee12">, </x><name id="d099817c-f97f-4e41-896d-02bdc53e58d6"><surname id="23baa134-1b6a-4004-a225-1999f44d07e8">Lin</surname> <given-names id="08b843a4-ea6e-40bf-a30a-90760d81fda0"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729044" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="3aa2bb60-3d55-4e9c-bbe9-09f56f0f43b7">SM</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729044" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="ef1c8815-97ce-489b-8e04-a3e479391f21">S-M</named-content></given-names></name><x id="fa1425c3-fd62-474a-8032-4d7f574e6739">, </x><etal data-class="RefEtal" id="f1b1b385-c92e-4974-9940-cf1a7bc23073">et al</etal></person-group><x id="ecdcc539-4500-419e-9527-eecca5e42263">. </x><article-title id="c70f3e6e-d115-43cf-923d-141a5ce71c56">Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729045" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="8b77e06d-36c3-449d-a3c7-3c06b9d75772">failure</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729045" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="b8f62fa7-5381-4f37-9268-8690cbadbf85">Failure*</named-content></article-title><x id="20495444-3f26-4432-b38c-afb7ed5ddef5">. </x><source id="531d7989-2428-455e-8a95-6896b7549262">Crit<named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729046" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="74940376-3a63-4785-b261-ff0c1143b4c5">.</named-content> Care Med</source><x id="65c02b8a-4528-4a82-b8c8-7f9743e5b7b0"> </x><year id="76629217-02e6-4d7f-9ad1-ae50553214d1">2014</year><x id="f7a302e6-81a1-4901-8698-b583ee4ce245">;</x><volume id="39db815d-28df-4e26-89fe-af39b30cb73c">42</volume><x id="27ff8bfa-3b5a-4fd8-8071-f1ae6f4a49da">:</x><fpage id="43333651-ffb7-4b82-ba1b-f2062e373eb1">313</fpage><x id="f242c6df-4224-43fe-ab5d-5656f84feab9">&#x2013;</x><lpage id="292a38cf-90c7-4e0d-b004-61fe4dd6ca3f">21</lpage><x id="2ecc6861-e40a-44cc-bbaf-5b61fdc6fc8f">.</x><pub-id pub-id-type="doi" id="e143c980-c74c-402d-a970-5b36af50b965">10.1097/CCM.0b013e3182a2727d</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R18" id="R18" data-id="R18" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R18" data-doi="10.1097/CCM.0000000000000489" data-validated="true"><label id="59c9c48c-46b8-4283-aa86-613ec12c9289">18</label><element-citation publication-type="journal" id="fa44ad92-594f-4ec9-ba19-aee2c73856e0"><person-group person-group-type="author" id="10811f60-58a0-4a75-9ea9-d765600bd89c"><name id="8e1286c8-42fb-4815-b139-f5e8458fafb2"><surname id="26eb756a-45e4-4304-8c0f-fc9ed305c949">Chuang</surname> <given-names id="3c9f17ce-96ff-49da-9cd8-5e46d5d22f6c"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729047" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="0c3859a2-4ad9-49c0-ab74-fa4e23a9b7a8">YC</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729047" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="7b721551-9724-459b-825c-5137e342f4f2">Y-C</named-content></given-names></name><x id="e7aa431c-d631-49cc-a9f8-ba4332a2e363">, </x><name id="35c1af96-588a-41d3-ae88-b0f65b08f84d"><surname id="2243e7c9-f6f0-4c38-9523-00eb7d272cf4">Ruan</surname> <given-names id="caea8409-a8bb-4f7f-8b40-a7f1f310a98a"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729048" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="706cce11-b8ad-4af3-9d2d-bc7e75784fb9">SY</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729048" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="b53f415c-7cc7-41ee-9090-19c77d02d884">S-Y</named-content></given-names></name><x id="ef90a68d-3e4a-4d0a-a83a-e3bcd7d39581">, </x><name id="a275fc22-50d6-456e-8a62-ecb4db772a8a"><surname id="eb097090-eff1-4dfc-b608-2e3f960915e7">Huang</surname> <given-names id="f1b95bff-7651-4b62-b7d9-3dc44e0f050e"><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729049" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="20820421-c236-4a36-9c7a-d16bc929d27c">CT</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729049" content-type="ins cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2020/12/11 18:32 pm" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="754e9e0d-b11a-42cf-ab8e-fc8e84c875f6">C-T</named-content></given-names></name></person-group><x id="a759aa9e-e591-4ac7-a320-97a23c7c3398">. </x><article-title id="a8ef4cba-ed8c-4f99-afa7-a9a312d0ad12">Compelling results of adjuvant therapy with sirolimus for severe H1N1 pneumonia</article-title><x id="e03202d2-8a89-49ea-aa60-88ce6e2649ce">. </x><source id="8c8cdb5d-20f7-47a3-a4eb-32d7c861d281">Crit Care Med</source><x id="4eaa9f6a-7849-4706-98b8-3cb8b9c1d511"> </x><year id="b597f381-8ea6-4498-a570-0e9829aca4ee">2014</year><x id="b3cfa987-3fd5-4a20-8e4b-6434d0a7cff9">;</x><volume id="327d9659-f090-41ab-b1a6-128a380ad23f">42</volume><x id="6eff12bb-0344-4d9a-9445-3ed0c125edbd">:</x><fpage id="de604d8b-172f-48cb-8a4b-88c040a2acee">e687</fpage><x id="93f31a3c-8f4e-45a8-acaa-eca6a7a6c193">&#x2013;</x><lpage id="dc4f3d3b-6abf-4688-af08-43f24f44d15b">8</lpage><x id="7781f773-661c-4d98-993e-50150b0eb8c9">.</x><pub-id pub-id-type="doi" id="4c3b2e8d-7a56-4772-af37-32c60bd51d17">10.1097/CCM.0000000000000489</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R19" id="R19" data-id="R19" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R19" data-doi="10.1097/CCM.0b013e3182a63779" data-validated="true"><label id="938f509e-b6fd-4c58-afc7-9edd64102424">19</label><element-citation publication-type="journal" id="46ee540a-3f1d-4944-a92c-b976312b6e8f"><person-group person-group-type="author" id="6e2d05b4-f392-418b-b77d-2babddd9d6fb"><name id="74fdf18a-a67f-457b-9f50-10d4fc16c5c7"><surname id="e2afe942-28ee-4106-9a5c-e0aa4289f48d">Ison</surname> <given-names id="4b1c9b88-110f-40e4-96d7-3848414631b6">MG</given-names></name></person-group><x id="39ca4e2e-3357-423a-8593-a4764d817f86">. </x><article-title id="a8a99dec-a3c0-4301-a77d-57c07fd4a4a1">Adjuvant immunosuppression in the management of severe influenza<named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1607691729050" content-type="del cts-1" specific-use="1607691729000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2020/12/11 18:32 pm" data-userid="cross-ref" data-username="cross-ref" data-time="1607691729000" id="a6de093b-9c30-4138-8095-5ec0f0b0ceec">: Friend or foe?</named-content></article-title><x id="ea1f8aee-f525-412f-bac7-b9f5c8e53a1d">. </x><source id="06c8a7d9-dd55-4745-b61e-815b4e38c19f">Crit Care Med</source><x id="183132e1-7ca4-4918-a836-17f28598fc93"> </x><year id="23c3c018-d3cf-498d-8eb7-13e0fa376749">2014</year><x id="8f157039-324c-4094-9d48-f487b33aa53f">;</x><volume id="edb0fc7c-0b7c-4421-8684-406593602d7f">42</volume><x id="a45b0981-e3bf-47a3-a014-45e0810c2473">:</x><fpage id="a9e74e9f-200e-4f3c-b14a-969d2b08b205">457</fpage><x id="cfb65b89-ced9-4427-b48b-b8dec9946bb2">&#x2013;</x><lpage id="d70ef02a-8ff2-4cc3-9db1-ce84420b2468">9</lpage><x id="0b90723f-e58a-430b-ab39-dcd2d3ef9bc1">.</x><pub-id pub-id-type="doi" id="34c8f9bc-0ba9-43f3-9837-6f4d19223526">10.1097/CCM.0b013e3182a63779</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R20" id="R20" data-id="R20" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R20" data-doi="10.1111/j.1462-5822.2011.01590.x" data-validated="true"><label id="813c0ca4-82fb-48fe-9d35-16a8324b7a17">20</label><element-citation publication-type="journal" id="1ac937cc-d431-42d9-9866-9d9da0186dfe"><person-group person-group-type="author" id="2790e642-0eef-414e-abda-75d81d49724b"><name id="ca343bd5-00d5-4e22-90c3-b57b20231beb"><surname id="5d382d39-5086-4f50-beb9-822ad9df90b0">Martins</surname> <given-names id="ed9de56b-7b23-4691-92e9-bc4ce1c86cdc">RM</given-names></name><x id="fd723b79-8551-499e-b4d9-37831c2cca4e">, </x><name id="429018ad-2c0c-43db-87f4-e4a1c4bbcd2b"><surname id="dfe3be9d-4ea9-4289-a56c-6a9be92c92b6">Alves</surname> <given-names id="1b6c031e-1d20-470c-b7d2-1042bd98cc1b">RM</given-names></name><x id="5342b747-e3dc-4ef0-a46d-826dd748ceb4">, </x><name id="a7be45ac-93f1-49b0-aaf5-da21fa102013"><surname id="a3b7aad6-410e-4828-a2be-c4085931393d">Macedo</surname> <given-names id="9f163e35-9b85-46e5-ad41-6b9deae45d64">S</given-names></name><x id="3c4a6b93-37f0-4e3d-a86e-97e89a3a9ad8">, </x><etal data-class="RefEtal" id="fba25ef6-5585-4bdd-bf3c-2890425e1479">et al</etal></person-group><x id="b0cccc7b-f363-4acb-b8ad-b1e766b2e889">. </x><article-title id="a30910b2-fe0d-4ce3-9b1d-52a4bee2cf57">Starvation and rapamycin differentially regulate host cell lysosome exocytosis and invasion by Trypanosoma cruzi metacyclic forms</article-title><x id="f6abc159-c6a7-423a-8598-90d94f1087a8">. </x><source id="9af05ade-1750-492b-b314-afa3e5e60182">Cell Microbiol</source><x id="3fb44b3d-5738-4cb1-b5c4-8e817211bb14"> </x><year id="81396eed-695f-4a8f-878e-2253e2d3667d">2011</year><x id="d305f064-39f9-41d4-a1c4-8270d3d89f8d">;</x><volume id="3714e007-8e31-46ab-abdd-8a8c47b7a616">13</volume><x id="52212ce2-df5f-4a9b-b4b2-9d4c19c0470d">:</x><fpage id="3c1eed6b-aaaf-4cc9-9686-4badb7f54d27">943</fpage><x id="7fabd6e4-4a4c-43f4-8519-439f6c3dea4b">&#x2013;</x><lpage id="4b9379f7-24a4-4533-80e3-57c6e1a63d2c">54</lpage><x id="5968488d-6a4a-4162-8518-b2930b210c8a">.</x><pub-id pub-id-type="doi" id="32945a90-705b-43d7-8cd9-e3c75f46d1f1">10.1111/j.1462-5822.2011.01590.x</pub-id></element-citation></ref></ref-list></back><workflow ftp-file-name="bcr-2020-238413" data-job-id="f20b1b5f-53f2-4149-bf7d-d4d29084b9f1"><priority requested-date="2020-12-11 12:00:40">on</priority><current-stage>Copyediting</current-stage><paw-stage><previous>Clean up</previous><current>Copy edit</current></paw-stage><word-count/><word-count-without-ref>2441</word-count-without-ref><stage><name>addJob</name><customer-stage-name>Add Job</customer-stage-name><start-date-time/><end-date-time/><start-date>2020-12-11</start-date><end-date>2020-12-11 07:30:10</end-date><duration>0</duration><end-word-count-without-ref>57</end-word-count-without-ref><end-word-count>57</end-word-count><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on/><reason/></assigned><time-log><log><start/><end/><duration/><status/></log></time-log></stage><stage><iteration>1</iteration><start-word-count>57</start-word-count><start-word-count-without-ref>57</start-word-count-without-ref><name>File download</name><customer-stage-name>Clean up</customer-stage-name><start-date>2020-12-11 07:30:10</start-date><end-date>2020-12-11 07:30:16</end-date><duration>0</duration><end-word-count-without-ref>57</end-word-count-without-ref><end-word-count>57</end-word-count><sla-start-date>2020-12-11 07:30:10</sla-start-date><sla-end-date>2020-12-15 07:30:10</sla-end-date><planned-start-date>2020-12-11 07:30:10</planned-start-date><planned-end-date>2020-12-15 07:30:10</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>2020-12-11 07:30:10</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><iteration>1</iteration><start-word-count>57</start-word-count><start-word-count-without-ref>57</start-word-count-without-ref><name>Convert Files</name><customer-stage-name>Clean up</customer-stage-name><start-date>2020-12-11 07:30:16</start-date><end-date>2020-12-11 07:30:24</end-date><duration>0</duration><end-word-count-without-ref>443</end-word-count-without-ref><end-word-count>443</end-word-count><sla-start-date>2020-12-11 07:30:10</sla-start-date><sla-end-date>2020-12-15 07:30:10</sla-end-date><planned-start-date>2020-12-11 07:30:16</planned-start-date><planned-end-date>2020-12-15 07:30:16</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>2020-12-11 07:30:16</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><iteration>1</iteration><start-word-count>443</start-word-count><start-word-count-without-ref>443</start-word-count-without-ref><name>Pre-editing</name><customer-stage-name>Clean up</customer-stage-name><start-date>2020-12-11 07:30:24</start-date><end-date>2020-12-11 13:09:48</end-date><duration>8</duration><end-word-count-without-ref>2441</end-word-count-without-ref><end-word-count>3036</end-word-count><sla-start-date>2020-12-11 07:30:10</sla-start-date><sla-end-date>2020-12-15 07:30:10</sla-end-date><planned-start-date>2020-12-11 07:30:24</planned-start-date><planned-end-date>2020-12-15 07:30:24</planned-end-date><status>completed</status><comments/><assigned><to>Priyanka Balan, priyanka.balan@exeterpm.com</to><by>System, Exeter</by><on>2020-12-11 12:58:59</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Priyanka (PREEDITOR)" role="preeditor" time="1607692092100" path="http://kriya2.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/bcr-2020-238413.pdf?method=server"/></proof></object><job-logs><log><username>Priyanka Balan</username><useremail>priyanka.balan@exeterpm.com</useremail><start-date>2020-12-11</start-date><start-time>12:58:59</start-time><end-date>2020-12-11</end-date><end-time>13:02:39</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Priyanka Balan</username><useremail>priyanka.balan@exeterpm.com</useremail><start-date>2020-12-11</start-date><start-time>13:02:44</start-time><end-date>2020-12-11</end-date><end-time>13:08:21</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Priyanka</username><useremail>priyanka.balan@exeterpm.com</useremail><start-date>2020-12-11</start-date><start-time>13:09:17</start-time><end-date>2020-12-11</end-date><end-time>13:09:17</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><iteration>1</iteration><start-word-count>3036</start-word-count><start-word-count-without-ref>2441</start-word-count-without-ref><name>Waiting for CE</name><customer-stage-name>Copy edit</customer-stage-name><start-date>2020-12-11 13:09:48</start-date><end-date>2020-12-16 20:46:21</end-date><duration>0</duration><end-word-count-without-ref>2441</end-word-count-without-ref><end-word-count>3036</end-word-count><sla-start-date>2020-12-11 13:09:48</sla-start-date><sla-end-date>2020-12-14 13:09:48</sla-end-date><planned-start-date>2020-12-11 13:09:48</planned-start-date><planned-end-date>2020-12-14 13:09:48</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>2020-12-11 13:09:48</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><iteration>1</iteration><start-word-count>3036</start-word-count><start-word-count-without-ref>2441</start-word-count-without-ref><name>Copyediting</name><customer-stage-name/><start-date>2020-12-16 20:46:21</start-date><end-date>2020-12-17 20:46:21</end-date><sla-start-date>2020-12-16 20:46:21</sla-start-date><sla-end-date>2020-12-17 20:46:21</sla-end-date><planned-start-date>2020-12-16 20:46:21</planned-start-date><planned-end-date>2020-12-17 20:46:21</planned-end-date><status>in-progress</status><comments/><assigned><to/><by>CE manager, cetest.m@exeterpm.com</by><on>2021-03-30 05:45:31</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1611539128483" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1611539170879" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612162990113" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612168757952" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612170515514" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612182346259" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612182762471" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612184128090" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612184774319" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612244240571" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612246397544" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612433094432" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1612507022772" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1614312463865" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/><pdf user="Copyeditor (COPYEDITOR)" role="copyeditor" time="1614314609579" path="http://testing.kriyadocs.com/resources/bmj/bcr/bcr-2020-238413/proofing/testing.kriyadocs.com/bcr-2020-238413.pdf?method=server"/></proof></object><job-logs><log><username>Copyeditor 3</username><useremail>cetest3@exeterpm.com</useremail><start-date>2021-01-10</start-date><start-time>11:57:51</start-time><end-date>2021-01-10</end-date><end-time>12:06:49</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest3@exeterpm.com</useremail><start-date>2021-01-10</start-date><start-time>12:07:16</start-time><end-date>2021-01-10</end-date><end-time>12:12:49</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest3@exeterpm.com</useremail><start-date>2021-01-10</start-date><start-time>12:13:12</start-time><end-date>2021-01-10</end-date><end-time>12:16:14</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest3@exeterpm.com</useremail><start-date>2021-01-10</start-date><start-time>13:44:26</start-time><end-date>2021-01-10</end-date><end-time>13:49:24</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest3@exeterpm.com</useremail><start-date>2021-01-10</start-date><start-time>14:43:49</start-time><end-date>2021-01-10</end-date><end-time>14:43:49</end-time><status type="system">open</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest3@exeterpm.com</useremail><start-date>2021-01-10</start-date><start-time>14:43:49</start-time><end-date>2021-01-10</end-date><end-time>14:49:39</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest3@exeterpm.com</useremail><start-date>2021-01-10</start-date><start-time>15:18:08</start-time><end-date>2021-01-10</end-date><end-time>15:18:08</end-time><status type="system">open</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest3@exeterpm.com</useremail><start-date>2021-01-10</start-date><start-time>15:18:09</start-time><end-date>2021-01-10</end-date><end-time>15:18:09</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-01-25</start-date><start-time>01:43:31</start-time><end-date>2021-01-25</end-date><end-time>01:53:41</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-01-28</start-date><start-time>06:15:00</start-time><end-date>2021-01-28</end-date><end-time>06:15:00</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-01-28</start-date><start-time>06:20:28</start-time><end-date>2021-01-28</end-date><end-time>06:20:28</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-01-28</start-date><start-time>06:28:07</start-time><end-date>2021-01-28</end-date><end-time>06:28:07</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-01-28</start-date><start-time>09:22:55</start-time><end-date>2021-01-28</end-date><end-time>09:22:55</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>06:58:08</start-time><end-date>2021-02-01</end-date><end-time>07:03:50</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>07:08:28</start-time><end-date>2021-02-01</end-date><end-time>07:19:14</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>07:19:23</start-time><end-date>2021-02-01</end-date><end-time>07:28:11</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>08:37:18</start-time><end-date>2021-02-01</end-date><end-time>08:53:30</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>08:58:08</start-time><end-date>2021-02-01</end-date><end-time>08:58:08</end-time><status type="system">open</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>08:58:08</start-time><end-date>2021-02-01</end-date><end-time>09:00:09</end-time><status type="system">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>09:05:22</start-time><end-date>2021-02-01</end-date><end-time>09:15:21</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>09:16:22</start-time><end-date>2021-02-01</end-date><end-time>09:17:07</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>09:17:18</start-time><end-date>2021-02-01</end-date><end-time>09:21:24</end-time><status type="system">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>09:27:01</start-time><end-date>2021-02-01</end-date><end-time>09:27:29</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>10:11:33</start-time><end-date>2021-02-01</end-date><end-time>10:11:33</end-time><status type="system">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>10:40:34</start-time><end-date>2021-02-01</end-date><end-time>10:40:34</end-time><status type="system">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>11:47:43</start-time><end-date>2021-02-01</end-date><end-time>12:02:32</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>12:22:48</start-time><end-date>2021-02-01</end-date><end-time>12:26:59</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>12:30:37</start-time><end-date>2021-02-01</end-date><end-time>12:41:01</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>12:46:11</start-time><end-date>2021-02-01</end-date><end-time>12:46:11</end-time><status type="system">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>12:54:26</start-time><end-date>2021-02-01</end-date><end-time>12:54:26</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>12:58:05</start-time><end-date>2021-02-01</end-date><end-time>13:00:11</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>13:00:31</start-time><end-date>2021-02-01</end-date><end-time>13:02:27</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-01</start-date><start-time>13:05:07</start-time><end-date>2021-02-01</end-date><end-time>13:21:18</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-02</start-date><start-time>05:03:12</start-time><end-date>2021-02-02</end-date><end-time>05:05:18</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-02</start-date><start-time>05:07:27</start-time><end-date>2021-02-02</end-date><end-time>05:07:37</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-02</start-date><start-time>05:26:43</start-time><end-date>2021-02-02</end-date><end-time>05:26:49</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-02</start-date><start-time>05:36:01</start-time><end-date>2021-02-02</end-date><end-time>05:40:13</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-02</start-date><start-time>05:43:57</start-time><end-date>2021-02-02</end-date><end-time>05:44:06</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-02</start-date><start-time>06:12:23</start-time><end-date>2021-02-02</end-date><end-time>06:24:33</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-03</start-date><start-time>09:11:17</start-time><end-date>2021-02-03</end-date><end-time>09:16:43</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-03</start-date><start-time>09:25:46</start-time><end-date>2021-02-03</end-date><end-time>09:42:31</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-03</start-date><start-time>11:44:37</start-time><end-date>2021-02-03</end-date><end-time>11:49:23</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-03</start-date><start-time>11:59:24</start-time><end-date>2021-02-03</end-date><end-time>12:01:25</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-03</start-date><start-time>12:31:01</start-time><end-date>2021-02-03</end-date><end-time>12:36:03</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-03</start-date><start-time>12:41:20</start-time><end-date>2021-02-03</end-date><end-time>12:41:20</end-time><status type="system">open</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-03</start-date><start-time>12:41:21</start-time><end-date>2021-02-03</end-date><end-time>12:55:47</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-03</start-date><start-time>13:47:07</start-time><end-date>2021-02-03</end-date><end-time>13:47:11</end-time><status type="system">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-04</start-date><start-time>10:03:35</start-time><end-date>2021-02-04</end-date><end-time>10:09:52</end-time><status type="system">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-05</start-date><start-time>06:36:04</start-time><end-date>2021-02-05</end-date><end-time>06:40:11</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>04:06:49</start-time><end-date>2021-02-26</end-date><end-time>04:08:57</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>04:42:20</start-time><end-date>2021-02-26</end-date><end-time>04:46:27</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>05:05:48</start-time><end-date>2021-02-26</end-date><end-time>05:05:48</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>05:18:24</start-time><end-date>2021-02-26</end-date><end-time>05:18:24</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>05:27:50</start-time><end-date>2021-02-26</end-date><end-time>05:27:50</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>05:35:03</start-time><end-date>2021-02-26</end-date><end-time>05:35:03</end-time><status type="user">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>05:38:06</start-time><end-date>2021-02-26</end-date><end-time>05:43:37</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>05:45:29</start-time><end-date>2021-02-26</end-date><end-time>05:54:08</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>05:54:09</start-time><end-date>2021-02-26</end-date><end-time>05:58:55</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>05:59:04</start-time><end-date>2021-02-26</end-date><end-time>05:59:56</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>06:01:18</start-time><end-date>2021-02-26</end-date><end-time>06:03:38</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>06:07:12</start-time><end-date>2021-02-26</end-date><end-time>06:08:02</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>06:09:25</start-time><end-date>2021-02-26</end-date><end-time>06:19:58</end-time><status type="system">in-active</status></log><log data-doi="bcr-2020-238413" data-project="bcr" data-customer="bmj"><username>Copyeditor</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-02-26</start-date><start-time>06:24:56</start-time><end-date>2021-02-26</end-date><end-time>06:25:02</end-time><status type="system">logged-off</status></log><log><username>Copyeditor 2</username><useremail>cetest2@exeterpm.com</useremail><start-date>2021-03-16</start-date><start-time>09:29:18</start-time><end-date>2021-03-16</end-date><end-time>09:29:18</end-time><status type="system">logged-off</status></log></job-logs></stage></workflow><production-notes><note type="workflow"><id>123</id><fullname>Workflow</fullname><created>2020-12-11 07:30:08</created><content>Job created on 2020-12-11 07:30:08</content></note><note id="a01f50da-608d-4882-baba-af062588f489" type="workflow"><id>a01f50da-608d-4882-baba-af062588f489</id><fullname>Workflow</fullname><created>2020-12-11 07:30:10</created><content>Article signed-off from addJob to File download</content></note><note id="a54941d7-6f75-46e2-8d40-01cf5144b96e" type="workflow"><id>a54941d7-6f75-46e2-8d40-01cf5144b96e</id><fullname>Workflow</fullname><created>2020-12-11 07:30:16</created><content>Article signed-off from File download to Convert Files</content></note><note id="6c7f5334-4608-46f4-8922-854cc5337c07" type="workflow"><id>6c7f5334-4608-46f4-8922-854cc5337c07</id><fullname>Workflow</fullname><created>2020-12-11 07:30:17</created><content><div class="jsonresp"><div class="note-head">Payment and license info has been updated</div><div class="jsondata"><pre>{<br/><span class="key">"license":</span><span class="string">"covid-19-tdm"</span>,<br/><span class="key">"copyrightStatement":</span><span class="string">"covid-19-tdm"</span>,<br/><span class="key">"paymentMethod":</span><span class="string">"noapc"</span>,<br/><span class="key">"paymentStatus":</span><span class="string">"no"</span>,<br/><span class="key">"currentStage":</span><span class="string">"Convert Files"</span>,<br/><span class="key">"priority":</span><span class="string">"on"</span>,<br/><span class="key">"holdType":</span><span class="string">"NoHold"</span>,<br/><span class="key">"holdStatus":</span><span class="string">"false"</span>,<br/><span class="key">"matchStage":</span><span class="string">"Convert Files"</span>}</pre></div></div></content></note><note id="635c41b9-76d5-4dd7-8560-b23b31ac9e2d" type="email"><id>635c41b9-76d5-4dd7-8560-b23b31ac9e2d</id><fullname>Workflow</fullname><created>2020-12-11 07:30:23</created><content><email-content><mail-id>0100017650b53d03-7496a162-d04f-4f25-8f9c-28b895e1bff6-000000</mail-id><mail-subject>Job Notification: Article 10.1136/bcr-2020-238413 loaded</mail-subject><from>donotreply@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><p>Dear typesetter</p><p>The article '<span class="article-id">10.1136/bcr-2020-238413</span>' is now ready for editing.</p><p>Thank you,</p><p style="font-size:10.0pt;">kriy&#x101;@BMJ</p></mail-body></email-content></content></note><note id="cd2367d6-56c2-47ed-8b06-922e5f76658b" type="workflow"><id>cd2367d6-56c2-47ed-8b06-922e5f76658b</id><fullname>Workflow</fullname><created>2020-12-11 07:30:24</created><content>Article signed-off from Convert Files to Pre-editing</content></note><note id="96ff53e7-5e2a-4aef-adb9-f71d7c441c90" type="workflow"><id>96ff53e7-5e2a-4aef-adb9-f71d7c441c90</id><fullname>kriy&#x101; (automation)</fullname><created>2020-12-11 08:45:02</created><content><div class="jsonresp"><div class="note-head">Payment and license info has been updated</div><div class="jsondata"><pre>{<br/><span class="key">"license":</span><span class="string">"CC-BY-NC"</span>,<br/><span class="key">"copyrightStatement":</span><span class="string">"CC-BY-NC"</span>,<br/><span class="key">"paymentMethod":</span><span class="string">"noapc"</span>,<br/><span class="key">"paymentStatus":</span><span class="string">"no"</span>,<br/><span class="key">"currentStage":</span><span class="string">"Pre-editing"</span>,<br/><span class="key">"priority":</span><span class="string">"on"</span>,<br/><span class="key">"holdType":</span><span class="string">"NoHold"</span>,<br/><span class="key">"holdStatus":</span><span class="string">"false"</span>,<br/><span class="key">"matchStage":</span><span class="string">"Pre-editing"</span>}</pre></div></div></content></note><note id="b107ed64-b2f0-4b75-9548-b90d1aa954c6"><id>b107ed64-b2f0-4b75-9548-b90d1aa954c6</id><fullname>Automation</fullname><created>2020-12-11 08:45:02</created><content><div messageid="17650ee769722cfc" class="mail-subject">Subject: <span class="pre">bcr-2020-238413 to be made open access</span></div><div class="content">License has been modified (<span class="pre">CC-BY-NC</span>).</div></content></note><note id="78702a7f-b741-4950-bd6e-a43730552e7c" type="workflow"><id>78702a7f-b741-4950-bd6e-a43730552e7c</id><fullname>Radhika Padmasekar, radhika.p@exeterpremedia.com</fullname><created>2020-12-11 09:56:28</created><content>Assigned to : Priyanka Balan, priyanka.balan@exeterpm.com</content></note><note id="8f93e3fa-a59a-405e-b6f2-de64eeb125be" type="workflow"><id>8f93e3fa-a59a-405e-b6f2-de64eeb125be</id><fullname>kriy&#x101; (automation)</fullname><created>2020-12-11 12:00:38</created><content><div class="jsonresp"><div class="note-head">Payment and license info has been updated</div><div class="jsondata"><pre>{<br/><span class="key">"license":</span><span class="string">"nonOA"</span>,<br/><span class="key">"copyrightStatement":</span><span class="string">"nonOA"</span>,<br/><span class="key">"paymentMethod":</span><span class="string">"noapc"</span>,<br/><span class="key">"paymentStatus":</span><span class="string">"no"</span>,<br/><span class="key">"currentStage":</span><span class="string">"Pre-editing"</span>,<br/><span class="key">"priority":</span><span class="string">"on"</span>,<br/><span class="key">"holdType":</span><span class="string">"NoHold"</span>,<br/><span class="key">"holdStatus":</span><span class="string">"false"</span>,<br/><span class="key">"matchStage":</span><span class="string">"Pre-editing"</span>}</pre></div></div></content></note><note id="85137e0a-e5cf-478f-b3b1-401e9e1f1eb3"><id>85137e0a-e5cf-478f-b3b1-401e9e1f1eb3</id><fullname>Automation</fullname><created>2020-12-11 12:00:39</created><content>Free tag updated for this COVID related article</content></note><note id="8f3f4560-ba45-4928-bec9-b04fd5774a7d"><id>8f3f4560-ba45-4928-bec9-b04fd5774a7d</id><fullname>Automation</fullname><created>2020-12-11 12:00:39</created><content><div messageid="17651a0fcea9b5ac" class="mail-subject">Subject: <span class="pre">bcr-2020-238413 no longer open access</span></div><div class="content">License has been modified (<span class="pre">nonOA</span>) and released from <span class="pre">Hold</span></div></content></note><note id="2403c2d4-9b89-467d-9c3d-eff74d3a4cc8" type="workflow"><id>2403c2d4-9b89-467d-9c3d-eff74d3a4cc8</id><fullname>kriy&#x101; (automation)</fullname><created>2020-12-11 12:00:39</created><content><div class="jsonresp"><div class="note-head">Payment and license info has been updated</div><div class="jsondata"><pre>{<br/><span class="key">"license":</span><span class="string">"nonOA"</span>,<br/><span class="key">"copyrightStatement":</span><span class="string">"nonOA"</span>,<br/><span class="key">"paymentMethod":</span><span class="string">"noapc"</span>,<br/><span class="key">"paymentStatus":</span><span class="string">"no"</span>,<br/><span class="key">"currentStage":</span><span class="string">"Pre-editing"</span>,<br/><span class="key">"priority":</span><span class="string">"on"</span>,<br/><span class="key">"holdType":</span><span class="string">"NoHold"</span>,<br/><span class="key">"holdStatus":</span><span class="string">"false"</span>,<br/><span class="key">"matchStage":</span><span class="string">"Pre-editing"</span>}</pre></div></div></content></note><note id="1165dc5f-1352-4b09-8cfd-421d8f205a2e"><id>1165dc5f-1352-4b09-8cfd-421d8f205a2e</id><fullname>Automation</fullname><created>2020-12-11 12:00:40</created><content>Free tag updated for this COVID related article</content></note><note id="79c6af08-a971-4bf0-a3e5-78c97f14aec5"><id>79c6af08-a971-4bf0-a3e5-78c97f14aec5</id><fullname>Automation</fullname><created>2020-12-11 12:00:40</created><content><div messageid="17651a102016f2d5" class="mail-subject">Subject: <span class="pre">Update to metadata bcr-2020-238413</span></div><div class="content">PaymentMethod has been changed to "<b>No APC</b>"; License has been modified ("<b>nonOA</b>").</div></content></note><note id="0a07c53c-102f-438b-baf0-cc8d3ebd3eb6" type="workflow"><id>0a07c53c-102f-438b-baf0-cc8d3ebd3eb6</id><fullname>kriy&#x101; (automation)</fullname><created>2020-12-11 12:00:40</created><content><div class="jsonresp"><div class="note-head">Payment and license info has been updated</div><div class="jsondata"><pre>{<br/><span class="key">"license":</span><span class="string">"nonOA"</span>,<br/><span class="key">"copyrightStatement":</span><span class="string">"nonOA"</span>,<br/><span class="key">"paymentMethod":</span><span class="string">"noapc"</span>,<br/><span class="key">"paymentStatus":</span><span class="string">"no"</span>,<br/><span class="key">"currentStage":</span><span class="string">"Pre-editing"</span>,<br/><span class="key">"priority":</span><span class="string">"on"</span>,<br/><span class="key">"holdType":</span><span class="string">"NoHold"</span>,<br/><span class="key">"holdStatus":</span><span class="string">"false"</span>,<br/><span class="key">"matchStage":</span><span class="string">"Pre-editing"</span>}</pre></div></div></content></note><note id="96f1eb4e-fe06-4960-b7f8-00cfc4c09244"><id>96f1eb4e-fe06-4960-b7f8-00cfc4c09244</id><fullname>Automation</fullname><created>2020-12-11 12:00:40</created><content>Free tag updated for this COVID related article</content></note><note id="1f9e66a5-3421-4448-83f7-eedfbbb35db7"><id>1f9e66a5-3421-4448-83f7-eedfbbb35db7</id><fullname>Automation</fullname><created>2020-12-11 12:00:40</created><content><div messageid="17651a107a3f1749" class="mail-subject">Subject: <span class="pre">Update to metadata bcr-2020-238413</span></div><div class="content">PaymentMethod has been changed to "<b>No APC</b>"; License has been modified ("<b>nonOA</b>").</div></content></note><note id="85e87d4c-835d-4249-b736-d957aca98b46" type="workflow"><id>85e87d4c-835d-4249-b736-d957aca98b46</id><fullname>Priyanka Balan</fullname><created>2020-12-11 13:09:48</created><content>Article signed-off from Pre-editing to Waiting for CE</content></note><note id="b3bd2188-97dd-40de-928e-6899d889ee89" type="email"><id>b3bd2188-97dd-40de-928e-6899d889ee89</id><fullname>Priyanka Balan</fullname><created>2020-12-11 13:09:49</created><content><email-content><mail-id>0100017651ebff9e-5570fc83-e66f-45df-8bed-a27ec21c6305-000000</mail-id><mail-subject>Ready for Copyediting - 10.1136/bcr-2020-238413</mail-subject><from>donotreply@exeterpremedia.com</from><to>production.bmjcases@bmj.com</to><cc>bmj@exeterpremedia.com</cc><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><p>Dear Publisher</p><p>This article is ready for copyediting. Please assign the copy editor in paw.</p><p>Thank you</p><p style="font-size:10.0pt;">kriy&#x101;@BMJ</p></mail-body></email-content></content></note><note id="be46824c-5a90-428b-8594-1e4fc080c21e" type="paw"><id>be46824c-5a90-428b-8594-1e4fc080c21e</id><fullname>Priyanka Balan</fullname><created>2020-12-11 13:09:52</created><content><div class="jsonresp"><div class="note-head">PAW SUCCESS: Article moved from Clean up to Copy edit</div><div class="jsondata"><pre>{ <br/><span class="key">"pawstage":</span> <span class="string">"PAW stage and current stage is matching :Clean up"</span>, <br/><span class="key">"pawpost":</span> { <br/><span class="key">"Typesetter":</span> <span class="string">"5F52C243-5D08-44F3-AAC3-92517D348713"</span>, <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjcr"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bcr-2020-238413"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Clean up"</span>, <br/><span class="key">"NextArticleStage":</span> <span class="string">"Copy edit"</span> }, <br/><span class="key">"pawurl":</span> <span class="string">"http://typesetter.publishingatwork.com/api/typesetter/completearticlestageto"</span>, <br/><span class="key">"pawresponse":</span> [ { <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjcr"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bcr-2020-238413"</span>, <br/><span class="key">"ManuscriptPages":</span> <span class="number">3.3</span>, <br/><span class="key">"AuthorName":</span> <span class="string">"Dr John B Whitlam"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Copy edit"</span>, <br/><span class="key">"Started":</span> <span class="string">"2020-12-11T00:00:00"</span>, <br/><span class="key">"Due":</span> <span class="string">"2020-12-15T00:00:00"</span>, <br/><span class="key">"Ended":</span> <span class="null">null</span> } ] }</pre></div></div></content></note><note id="4a4dabe2-ff3a-452d-a8e5-292f8f821653" type="workflow"><id>4a4dabe2-ff3a-452d-a8e5-292f8f821653</id><fullname>Copyeditor 3, cetest3@exeterpm.com</fullname><created>2021-01-09 17:18:17</created><content>Assigned to : Copyeditor 3, cetest3@exeterpm.com</content></note><note id="24c83d66-2d03-488e-b270-c4d953f5b9f0" type="workflow"><id>24c83d66-2d03-488e-b270-c4d953f5b9f0</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-01-15 09:02:50</created><content>Unassigned : Copyeditor 3, cetest3@exeterpm.com</content></note><note id="f91b2ca5-6f06-4638-8873-69e386a74991" type="email"><id>f91b2ca5-6f06-4638-8873-69e386a74991</id><fullname>CE manager</fullname><created>2021-01-15 09:02:50</created><content><email-content><mail-id>010001770548740f-ba655f25-039f-42bf-b87d-16fe6eb01b59-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest3@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="0252042c-0c7c-4849-b447-2c6801cee3e6" type="workflow"><id>0252042c-0c7c-4849-b447-2c6801cee3e6</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-01-18 08:13:26</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="6640cc51-1556-4fad-9558-ac1cf1462380" type="email"><id>6640cc51-1556-4fad-9558-ac1cf1462380</id><fullname>CE manager</fullname><created>2021-01-18 08:13:27</created><content><email-content><mail-id>01000177148e5059-6320c19e-2c55-4c40-971d-aebdc0afaae4-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="12a85bbb-9f5c-4787-bd60-faaacdb025d8" type="workflow"><id>12a85bbb-9f5c-4787-bd60-faaacdb025d8</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 09:28:56</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="a4afc4d7-e7bf-4f51-9d8e-96afe6a480d9" type="email"><id>a4afc4d7-e7bf-4f51-9d8e-96afe6a480d9</id><fullname>CE manager</fullname><created>2021-02-01 09:28:56</created><content><email-content><mail-id>010001775cec76cf-3beb6a84-18e7-455e-8223-270f0a52af3d-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="144dc3f9-0934-4fc1-9a66-6af17d238531" type="workflow"><id>144dc3f9-0934-4fc1-9a66-6af17d238531</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 09:46:57</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="e3d406e8-190d-4927-b072-fbe0ea9d42cf" type="workflow"><id>e3d406e8-190d-4927-b072-fbe0ea9d42cf</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 10:33:45</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="856e5248-1b1e-4a02-81da-b4c387dc37a3" type="email"><id>856e5248-1b1e-4a02-81da-b4c387dc37a3</id><fullname>CE manager</fullname><created>2021-02-01 10:33:45</created><content><email-content><mail-id>010001775d27cdac-00194449-49c0-44cd-95f0-57369350c43d-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="94b7a29f-32e3-4e6e-b9eb-8876ab5333f3" type="workflow"><id>94b7a29f-32e3-4e6e-b9eb-8876ab5333f3</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 10:37:54</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="5c0e3c35-b2bb-4e95-8206-83ea5d704aea" type="workflow"><id>5c0e3c35-b2bb-4e95-8206-83ea5d704aea</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 10:44:33</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="3fce2203-371d-4549-837a-f566471c81e6" type="email"><id>3fce2203-371d-4549-837a-f566471c81e6</id><fullname>CE manager</fullname><created>2021-02-01 10:44:33</created><content><email-content><mail-id>010001775d31afab-0979ede1-a9f0-4fdc-acb8-bf44a535ce4e-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="76b1eb70-937e-4a56-a996-82716fc03ddb" type="workflow"><id>76b1eb70-937e-4a56-a996-82716fc03ddb</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 10:52:27</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="56f72f69-1b31-41f9-b1cc-bbc3a6f08949" type="workflow"><id>56f72f69-1b31-41f9-b1cc-bbc3a6f08949</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 11:22:44</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="bdd6189d-5b9f-47b0-9f06-d178f0858014" type="email"><id>bdd6189d-5b9f-47b0-9f06-d178f0858014</id><fullname>CE manager</fullname><created>2021-02-01 11:22:44</created><content><email-content><mail-id>010001775d54a4f2-7a311678-fe49-47dd-afb6-972d8fb5317f-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="06c79c45-9069-4c9c-a695-648123b6df0c" type="workflow"><id>06c79c45-9069-4c9c-a695-648123b6df0c</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 11:39:05</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="9ce28200-4f84-41f3-ba98-66efb088130b" type="workflow"><id>9ce28200-4f84-41f3-ba98-66efb088130b</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 11:47:05</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="101a7e8e-d3bf-4c63-8c10-4ef71ac2a80c" type="email"><id>101a7e8e-d3bf-4c63-8c10-4ef71ac2a80c</id><fullname>CE manager</fullname><created>2021-02-01 11:47:06</created><content><email-content><mail-id>010001775d6af34e-20ea5dc3-28d1-4900-ba91-3bf723aa7c0a-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="f281b88e-006b-4486-807a-9e260bbf16df" type="workflow"><id>f281b88e-006b-4486-807a-9e260bbf16df</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 11:47:42</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="77d65875-ba2c-47fa-bcb2-9f12feb7aef7" type="workflow"><id>77d65875-ba2c-47fa-bcb2-9f12feb7aef7</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:00:53</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="2c1fbc59-1986-431b-8359-33902076eaef" type="email"><id>2c1fbc59-1986-431b-8359-33902076eaef</id><fullname>CE manager</fullname><created>2021-02-01 12:00:53</created><content><email-content><mail-id>010001775d77925a-d430529c-f01e-4057-bf17-8afa6cd28b9e-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="cec76d01-c678-4532-bcaf-ce29eeabf237" type="workflow"><id>cec76d01-c678-4532-bcaf-ce29eeabf237</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 12:01:36</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="6d0bf4bb-44bb-43ff-b285-acd5f15d6411" type="workflow"><id>6d0bf4bb-44bb-43ff-b285-acd5f15d6411</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:03:17</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="38adf7b1-75a9-4a02-8cd0-cfa14b60e429" type="email"><id>38adf7b1-75a9-4a02-8cd0-cfa14b60e429</id><fullname>CE manager</fullname><created>2021-02-01 12:03:17</created><content><email-content><mail-id>010001775d79c57a-1e773ff9-2d60-40cc-811c-7ad2f443d373-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="ac8d2d23-45c7-40ec-81d9-9bdb48a522d6" type="workflow"><id>ac8d2d23-45c7-40ec-81d9-9bdb48a522d6</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 12:06:54</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="37efa82f-a283-438a-bf2a-897f2e2dd07e" type="workflow"><id>37efa82f-a283-438a-bf2a-897f2e2dd07e</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:09:09</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="95a867d2-5d83-4e9f-b8ec-7af3894c70f1" type="email"><id>95a867d2-5d83-4e9f-b8ec-7af3894c70f1</id><fullname>CE manager</fullname><created>2021-02-01 12:09:10</created><content><email-content><mail-id>010001775d7f261d-4803868a-a5f1-4d3c-9fcc-865bdbea1503-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="d13ac37d-20e3-4b2a-903a-47f94d497e3a" type="workflow"><id>d13ac37d-20e3-4b2a-903a-47f94d497e3a</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 12:09:38</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="71d25c79-6f2f-4ccf-b8e2-17ba9ee0132a" type="workflow"><id>71d25c79-6f2f-4ccf-b8e2-17ba9ee0132a</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:10:48</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="fea0d47f-5588-4046-b5a3-d15294addcf5" type="email"><id>fea0d47f-5588-4046-b5a3-d15294addcf5</id><fullname>CE manager</fullname><created>2021-02-01 12:10:48</created><content><email-content><mail-id>010001775d80a77c-a846de18-29be-4c18-a381-88a4080eee99-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="9a9d45b8-ec11-42ac-ad42-e3f5c685ba92" type="workflow"><id>9a9d45b8-ec11-42ac-ad42-e3f5c685ba92</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 12:11:15</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="420ec3a6-33d9-4801-83f3-5623057a4a4a" type="workflow"><id>420ec3a6-33d9-4801-83f3-5623057a4a4a</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:13:58</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="33d0fc0a-ce39-4c61-90b4-62d6ae9a1f90" type="email"><id>33d0fc0a-ce39-4c61-90b4-62d6ae9a1f90</id><fullname>CE manager</fullname><created>2021-02-01 12:13:59</created><content><email-content><mail-id>010001775d838f2a-68c99838-dc37-48e1-9173-fa3f4010c288-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="87789ab7-3416-40ee-988d-d65d722393a7" type="workflow"><id>87789ab7-3416-40ee-988d-d65d722393a7</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 12:14:26</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="80d0484e-16be-4bdb-ae1c-8ed1087c33eb" type="workflow"><id>80d0484e-16be-4bdb-ae1c-8ed1087c33eb</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:16:07</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="b89f631d-624a-4575-8e81-b16b82554b95" type="email"><id>b89f631d-624a-4575-8e81-b16b82554b95</id><fullname>CE manager</fullname><created>2021-02-01 12:16:07</created><content><email-content><mail-id>010001775d85868b-8294bcba-b413-4b9c-8727-68b6f1da6dc6-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="6819aa27-56e8-4833-a441-32a495f48d26" type="workflow"><id>6819aa27-56e8-4833-a441-32a495f48d26</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 12:16:39</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="9db348cc-f6f9-417b-ba8e-d093b012fb77" type="workflow"><id>9db348cc-f6f9-417b-ba8e-d093b012fb77</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:26:16</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="277076cd-4de2-44f8-aa13-c386c2019d32" type="email"><id>277076cd-4de2-44f8-aa13-c386c2019d32</id><fullname>CE manager</fullname><created>2021-02-01 12:26:16</created><content><email-content><mail-id>010001775d8ed04c-d6f4b676-0335-4960-9b26-dbe23652b5af-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="c76a41d2-fda9-467e-9fad-44573ca37a67" type="workflow"><id>c76a41d2-fda9-467e-9fad-44573ca37a67</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 12:30:30</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="68295fc0-bc0d-4124-b91f-dbafaa8a8938" type="workflow"><id>68295fc0-bc0d-4124-b91f-dbafaa8a8938</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:41:59</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="40d6a5f2-5945-4187-9940-a858482ea20c" type="email"><id>40d6a5f2-5945-4187-9940-a858482ea20c</id><fullname>CE manager</fullname><created>2021-02-01 12:41:59</created><content><email-content><mail-id>010001775d9d32df-9b1f7c7a-c4f9-476e-b35b-d7080d56c1f5-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="bb1e6f35-8d09-48b0-b2fe-31bca97508b0" type="workflow"><id>bb1e6f35-8d09-48b0-b2fe-31bca97508b0</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 12:42:41</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="c1708a4d-eb34-4f66-8ec3-ad1f79bff4f3" type="workflow"><id>c1708a4d-eb34-4f66-8ec3-ad1f79bff4f3</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:44:42</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="ff93500b-f502-4d9f-aa20-b4a91e8f60b8" type="email"><id>ff93500b-f502-4d9f-aa20-b4a91e8f60b8</id><fullname>CE manager</fullname><created>2021-02-01 12:44:43</created><content><email-content><mail-id>010001775d9fb1e5-c99304a9-6088-43a5-822f-348ec124ad3b-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="a0ceabcf-5aae-4c2b-9fe0-f39f9c401e26" type="workflow"><id>a0ceabcf-5aae-4c2b-9fe0-f39f9c401e26</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 12:46:05</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="efba9fe8-b6a0-47f2-a689-123d46178523" type="workflow"><id>efba9fe8-b6a0-47f2-a689-123d46178523</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:53:10</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="d534e3b1-1f1e-435b-8b29-59e42ad3efa9" type="email"><id>d534e3b1-1f1e-435b-8b29-59e42ad3efa9</id><fullname>CE manager</fullname><created>2021-02-01 12:53:10</created><content><email-content><mail-id>010001775da7716d-4e4d0373-924a-47b8-bc8c-2eb1fa52b9cc-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="ffb12145-fe4e-4fad-aa42-ce648ac9fefb" type="workflow"><id>ffb12145-fe4e-4fad-aa42-ce648ac9fefb</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 12:54:20</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="cb9915f9-7fa8-410e-9dd0-8f9080164f54" type="workflow"><id>cb9915f9-7fa8-410e-9dd0-8f9080164f54</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 12:59:50</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="b1378074-9e2a-4e58-b7b8-52a0efeb4bfa" type="email"><id>b1378074-9e2a-4e58-b7b8-52a0efeb4bfa</id><fullname>CE manager</fullname><created>2021-02-01 12:59:50</created><content><email-content><mail-id>010001775dad8b54-c9aba626-659f-4115-8a4b-39e81ce1be1d-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="74ad348b-1771-42f7-b1b8-b2052576d3aa" type="workflow"><id>74ad348b-1771-42f7-b1b8-b2052576d3aa</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 13:00:25</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="d77ab1f4-9397-4406-bbf9-b6e6a832f962" type="workflow"><id>d77ab1f4-9397-4406-bbf9-b6e6a832f962</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-01 13:04:36</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="65d931eb-a58d-44be-b57a-924c46e825b1" type="email"><id>65d931eb-a58d-44be-b57a-924c46e825b1</id><fullname>CE manager</fullname><created>2021-02-01 13:04:37</created><content><email-content><mail-id>010001775db1eb74-7aec579a-e25d-406c-b16b-985a84c95857-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="13f6e046-0bfc-4fd5-a8c8-2262dec6b09e" type="workflow"><id>13f6e046-0bfc-4fd5-a8c8-2262dec6b09e</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-01 13:05:02</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="506f0bb7-3753-4ed3-92ef-910183bbe545" type="workflow"><id>506f0bb7-3753-4ed3-92ef-910183bbe545</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-02 05:03:43</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="3d57597f-7d3a-4325-a96d-db1d52fbd53a" type="email"><id>3d57597f-7d3a-4325-a96d-db1d52fbd53a</id><fullname>CE manager</fullname><created>2021-02-02 05:03:43</created><content><email-content><mail-id>010001776120026a-9e0194aa-c00c-49f1-af3d-70ae898ad52e-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="c9fbe66b-8717-42b0-aa81-20ad40a4087a" type="workflow"><id>c9fbe66b-8717-42b0-aa81-20ad40a4087a</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-02 05:05:14</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="a9d8ce56-9bca-47f6-8ee0-cc9bce8b3fc6" type="workflow"><id>a9d8ce56-9bca-47f6-8ee0-cc9bce8b3fc6</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-02 05:07:51</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="8fdcb757-054b-40e0-8094-4e465e0e5b59" type="email"><id>8fdcb757-054b-40e0-8094-4e465e0e5b59</id><fullname>CE manager</fullname><created>2021-02-02 05:07:51</created><content><email-content><mail-id>010001776123c9b5-f768f590-24dc-4303-8ddf-dbe241392d90-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="eca7b61d-e4b8-4c7a-a6ca-87f8e7e95bb2" type="workflow"><id>eca7b61d-e4b8-4c7a-a6ca-87f8e7e95bb2</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-02 05:20:37</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="da7a51dd-8ccf-49c2-bea4-32926b55a1c6" type="workflow"><id>da7a51dd-8ccf-49c2-bea4-32926b55a1c6</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-02 05:27:05</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="b5abbab8-2afd-41fa-a65f-8a22929046e0" type="email"><id>b5abbab8-2afd-41fa-a65f-8a22929046e0</id><fullname>CE manager</fullname><created>2021-02-02 05:27:05</created><content><email-content><mail-id>010001776135670e-cc31e570-7d48-472a-98fe-8c9a40365778-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="fd50ea18-6767-456f-b55d-27a7a6ab2298" type="workflow"><id>fd50ea18-6767-456f-b55d-27a7a6ab2298</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-02 05:35:57</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="54664ee4-27e7-46e3-9c95-4b7243a05aea" type="workflow"><id>54664ee4-27e7-46e3-9c95-4b7243a05aea</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-02 05:52:04</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="03584391-0da1-4867-81d9-5392cc0d1df6" type="email"><id>03584391-0da1-4867-81d9-5392cc0d1df6</id><fullname>CE manager</fullname><created>2021-02-02 05:52:05</created><content><email-content><mail-id>01000177614c4801-59f3fd3d-4893-44b2-a707-adc6fd6499b3-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="63f6b1c6-581c-4b03-99e4-07a68c14514b" type="workflow"><id>63f6b1c6-581c-4b03-99e4-07a68c14514b</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-02 05:53:13</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="2446b4e6-d31a-41e4-916b-6c70491ecfcb" type="workflow"><id>2446b4e6-d31a-41e4-916b-6c70491ecfcb</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-02 05:58:58</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="96ad0250-3f01-4287-8bfe-fe77e9c7e157" type="email"><id>96ad0250-3f01-4287-8bfe-fe77e9c7e157</id><fullname>CE manager</fullname><created>2021-02-02 05:58:59</created><content><email-content><mail-id>0100017761529861-e239b6fb-7eb9-46f8-b406-0fd3299354f3-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="e7b64bf9-dc63-4045-a628-02d7366b7eba" type="workflow"><id>e7b64bf9-dc63-4045-a628-02d7366b7eba</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-02 05:59:29</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="0be20cb9-78c2-4877-9df8-b671098385bc" type="workflow"><id>0be20cb9-78c2-4877-9df8-b671098385bc</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-02 06:01:11</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="6e934fcb-35a3-4187-adaa-c6ab0a651e0d" type="email"><id>6e934fcb-35a3-4187-adaa-c6ab0a651e0d</id><fullname>CE manager</fullname><created>2021-02-02 06:01:12</created><content><email-content><mail-id>010001776154a129-b04f7d01-4662-4147-aaa5-8eec33952a1f-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="b00b6337-f838-4c16-ba60-c3a218b5bdb1" type="workflow"><id>b00b6337-f838-4c16-ba60-c3a218b5bdb1</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-02 06:01:43</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="16b38d2b-16ce-4ba8-8ca5-e50131e5ae10" type="workflow"><id>16b38d2b-16ce-4ba8-8ca5-e50131e5ae10</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-02 06:03:05</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="9b2cd952-49da-470c-ab3e-fafb30bfa50a" type="email"><id>9b2cd952-49da-470c-ab3e-fafb30bfa50a</id><fullname>CE manager</fullname><created>2021-02-02 06:03:06</created><content><email-content><mail-id>0100017761565dc5-6d154e49-2ed4-4d39-8ba5-53990d9d0a2f-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="7b6cae40-50d2-438f-ad95-7153df8c6296" type="workflow"><id>7b6cae40-50d2-438f-ad95-7153df8c6296</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-02 06:03:44</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="c62786e6-deff-4e5d-a61a-c3d349d70a25" type="workflow"><id>c62786e6-deff-4e5d-a61a-c3d349d70a25</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-02 06:08:23</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="654b1a35-6daa-4d10-b4dd-b7888e26aeec" type="email"><id>654b1a35-6daa-4d10-b4dd-b7888e26aeec</id><fullname>CE manager</fullname><created>2021-02-02 06:08:23</created><content><email-content><mail-id>01000177615b34f5-a64b33f3-8678-445b-a0cf-758771f4ba99-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="aabe5106-eb4c-4eb6-a0ca-fed9b0d34f87" type="workflow"><id>aabe5106-eb4c-4eb6-a0ca-fed9b0d34f87</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-02 06:09:31</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="17274630-9799-4bcb-837b-14b08f0ba983" type="workflow"><id>17274630-9799-4bcb-837b-14b08f0ba983</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-02 06:10:53</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="c84b36b8-623f-4d0f-a170-45f365b01983" type="email"><id>c84b36b8-623f-4d0f-a170-45f365b01983</id><fullname>CE manager</fullname><created>2021-02-02 06:10:53</created><content><email-content><mail-id>01000177615d803d-bffc97c8-6ff5-4349-8e7b-16983cbf67af-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="c5401a16-1a7c-488d-8350-82876ee63d2f" type="workflow"><id>c5401a16-1a7c-488d-8350-82876ee63d2f</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-02 06:12:17</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="7ed52bbe-571e-4490-869b-d79b41e3a2ef" type="workflow"><id>7ed52bbe-571e-4490-869b-d79b41e3a2ef</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-04 10:01:38</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="e9ffe8b0-066c-4078-87d7-4cf46a67dcdd" type="email"><id>e9ffe8b0-066c-4078-87d7-4cf46a67dcdd</id><fullname>CE manager</fullname><created>2021-02-04 10:01:38</created><content><email-content><mail-id>010001776c7d7b28-13acb09c-a81f-4631-acf3-fdb599d95998-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="c67794ea-4742-4aac-b5cc-83c58b501b60" type="workflow"><id>c67794ea-4742-4aac-b5cc-83c58b501b60</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-04 10:03:29</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="0c7a64aa-8787-4af4-8809-eaa4a3f68af0" type="workflow"><id>0c7a64aa-8787-4af4-8809-eaa4a3f68af0</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-05 06:26:41</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="8cd41179-c7db-4496-8495-61f113207087" type="email"><id>8cd41179-c7db-4496-8495-61f113207087</id><fullname>CE manager</fullname><created>2021-02-05 06:26:42</created><content><email-content><mail-id>0100017770df0c6a-8d623273-271c-4181-a255-98e42f94b4eb-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Unassigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest2@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Unassigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Unassigned</p></mail-body></email-content></content></note><note id="4ca13df4-4ced-4a4b-b013-099edf31d84c" type="workflow"><id>4ca13df4-4ced-4a4b-b013-099edf31d84c</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-05 06:35:58</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="b141b656-dc80-44df-87d3-d783c3f0339c" type="workflow"><id>b141b656-dc80-44df-87d3-d783c3f0339c</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-26 07:34:04</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="4abdfc19-f3fd-49ff-a92c-a8cd6327941d" type="email"><id>4abdfc19-f3fd-49ff-a92c-a8cd6327941d</id><fullname>CE manager</fullname><created>2021-02-26 07:34:05</created><content><email-content><mail-id>01000177dd4249e0-38880bba-e3ef-4d65-807b-ac764fc692ec-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="391402ef-dce4-43f8-b41f-946308709ad3" type="workflow"><id>391402ef-dce4-43f8-b41f-946308709ad3</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-26 07:34:37</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="6e4e37a8-93c5-4689-b0a9-73715eab1fd0" type="workflow"><id>6e4e37a8-93c5-4689-b0a9-73715eab1fd0</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-27 17:18:18</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="2db918c1-68c9-406b-af58-46a7e94dc61c" type="email"><id>2db918c1-68c9-406b-af58-46a7e94dc61c</id><fullname>CE manager</fullname><created>2021-02-27 17:18:18</created><content><email-content><mail-id>01000177e47f853c-e0a5ab7b-6ba7-4ba8-a46c-f05f4a20f09c-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="aaba6704-f027-448b-9ed7-251ec3ba6579" type="workflow"><id>aaba6704-f027-448b-9ed7-251ec3ba6579</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-27 17:18:44</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="99500ea7-aeb9-4cc8-ae4f-57856d802de5" type="workflow"><id>99500ea7-aeb9-4cc8-ae4f-57856d802de5</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-02-27 17:20:00</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="a8342f8f-e571-40ff-bee5-d1b794b27eea" type="email"><id>a8342f8f-e571-40ff-bee5-d1b794b27eea</id><fullname>CE manager</fullname><created>2021-02-27 17:20:00</created><content><email-content><mail-id>01000177e481139e-bf91a65f-0f5e-4415-8c89-ee53524e50e6-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="34ca5309-c5a8-417e-b491-30273a6900ac" type="workflow"><id>34ca5309-c5a8-417e-b491-30273a6900ac</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-02-27 17:20:49</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="28ed3e9c-acb9-4175-a719-0e8efd73bded" type="workflow"><id>28ed3e9c-acb9-4175-a719-0e8efd73bded</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-01 04:11:29</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="b4cf07ad-7a4f-4987-9e9e-4ccd7b0046d9" type="email"><id>b4cf07ad-7a4f-4987-9e9e-4ccd7b0046d9</id><fullname>CE manager</fullname><created>2021-03-01 04:11:29</created><content><email-content><mail-id>01000177ebfbe446-093e9049-326e-41d7-997e-b709ea44f416-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="1c43b8b5-4d4d-42ba-8b0f-c39b90a24aeb" type="workflow"><id>1c43b8b5-4d4d-42ba-8b0f-c39b90a24aeb</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-01 04:12:16</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="037e2ed5-0f59-47c5-8b86-b26f47741db2" type="workflow"><id>037e2ed5-0f59-47c5-8b86-b26f47741db2</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-01 04:16:36</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="49effd65-5565-45a0-95f0-11218b772956" type="email"><id>49effd65-5565-45a0-95f0-11218b772956</id><fullname>CE manager</fullname><created>2021-03-01 04:16:36</created><content><email-content><mail-id>01000177ec0092a9-f2ed882b-3108-432a-878e-c5c10632e21c-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="cd32f798-21b2-4b69-bc3c-77d2806877f7" type="workflow"><id>cd32f798-21b2-4b69-bc3c-77d2806877f7</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-01 04:17:00</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="54524136-ec3c-40d3-8f9c-e5d90e2cdcfb" type="workflow"><id>54524136-ec3c-40d3-8f9c-e5d90e2cdcfb</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-01 04:57:32</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="3dbef942-693b-41ce-adff-4469a83d68d0" type="email"><id>3dbef942-693b-41ce-adff-4469a83d68d0</id><fullname>CE manager</fullname><created>2021-03-01 04:57:33</created><content><email-content><mail-id>01000177ec260e3b-65f6d088-06b5-4d61-947d-a9abbd81b0b4-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="d7042406-45be-49fe-9b2a-4bc9f4d5eb24" type="workflow"><id>d7042406-45be-49fe-9b2a-4bc9f4d5eb24</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-01 04:58:07</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="d7dd5b70-12bc-4770-ac67-dda7b0ef7e8d" type="workflow"><id>d7dd5b70-12bc-4770-ac67-dda7b0ef7e8d</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-01 05:05:54</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="1e11a4b8-597b-4b1f-8703-8111896f407d" type="email"><id>1e11a4b8-597b-4b1f-8703-8111896f407d</id><fullname>CE manager</fullname><created>2021-03-01 05:05:55</created><content><email-content><mail-id>01000177ec2db751-4666d217-3125-450e-8520-83a287bb0219-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="1b731b5d-c804-4f86-9ea4-4666edda461c" type="workflow"><id>1b731b5d-c804-4f86-9ea4-4666edda461c</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-01 05:06:38</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="0b00700d-06c5-45dc-ab05-47bb9376d9c2" type="workflow"><id>0b00700d-06c5-45dc-ab05-47bb9376d9c2</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-01 08:46:08</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="d0ff8a17-bea3-48f2-8aab-cde00897427a" type="email"><id>d0ff8a17-bea3-48f2-8aab-cde00897427a</id><fullname>CE manager</fullname><created>2021-03-01 08:46:08</created><content><email-content><mail-id>01000177ecf75775-2624f81b-4e33-4838-9304-8eb0d938b606-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="57ad6fba-40a5-4f74-a508-ca012366fc88" type="workflow"><id>57ad6fba-40a5-4f74-a508-ca012366fc88</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-01 08:48:12</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="5af0eb0e-7887-4256-a8f0-78aaf6034ce5" type="workflow"><id>5af0eb0e-7887-4256-a8f0-78aaf6034ce5</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-01 09:30:17</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="3c3297d9-9397-4678-9dc3-9895c0473dc4" type="email"><id>3c3297d9-9397-4678-9dc3-9895c0473dc4</id><fullname>CE manager</fullname><created>2021-03-01 09:30:18</created><content><email-content><mail-id>01000177ed1fc559-265c96e8-b46d-419f-bfcc-9be76beca39b-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="f4887d51-b589-4e1a-84f8-9a14a98f6d6c" type="workflow"><id>f4887d51-b589-4e1a-84f8-9a14a98f6d6c</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-01 09:32:22</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="dbd2fb67-fb34-4f38-9fe3-56d5524d6fed" type="workflow"><id>dbd2fb67-fb34-4f38-9fe3-56d5524d6fed</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-01 09:36:37</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="a0850f81-d1c0-4e91-a370-aad97eed4b6b" type="email"><id>a0850f81-d1c0-4e91-a370-aad97eed4b6b</id><fullname>CE manager</fullname><created>2021-03-01 09:36:38</created><content><email-content><mail-id>01000177ed259052-72bd5f47-5eb5-447a-9416-a1f97d40ee4b-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="42187689-552d-431f-8878-e398931d03d6" type="workflow"><id>42187689-552d-431f-8878-e398931d03d6</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-01 09:39:04</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="68367db1-4018-4538-b961-c7d8369f0cf3" type="workflow"><id>68367db1-4018-4538-b961-c7d8369f0cf3</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-01 09:44:47</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="0884b3f5-5c02-480d-bc21-a643de4b994b" type="email"><id>0884b3f5-5c02-480d-bc21-a643de4b994b</id><fullname>CE manager</fullname><created>2021-03-01 09:44:47</created><content><email-content><mail-id>01000177ed2d0939-25f70899-9fd9-4cba-b36c-edba3c47160f-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="0e58ec9a-3038-44cd-9bd4-3f3c0c53e924" type="workflow"><id>0e58ec9a-3038-44cd-9bd4-3f3c0c53e924</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-01 09:45:43</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="cf1779c8-08d3-4fb8-bdd3-01616ac0f14b" type="workflow"><id>cf1779c8-08d3-4fb8-bdd3-01616ac0f14b</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-02 04:42:53</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="e740331e-9e52-4e37-ab35-afaf8b98b565" type="email"><id>e740331e-9e52-4e37-ab35-afaf8b98b565</id><fullname>CE manager</fullname><created>2021-03-02 04:42:53</created><content><email-content><mail-id>01000177f13efeb6-3c6839b4-7512-48a0-8e5d-299b7885771b-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="3a9f3247-ebfb-49ba-8655-70bb1423f151" type="workflow"><id>3a9f3247-ebfb-49ba-8655-70bb1423f151</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-02 05:34:24</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="7f5fb844-ca15-4d59-8705-0e59ca4e07be" type="workflow"><id>7f5fb844-ca15-4d59-8705-0e59ca4e07be</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-11 12:02:50</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="cec03f10-f0e6-4730-97fa-4849d0d133f8" type="email"><id>cec03f10-f0e6-4730-97fa-4849d0d133f8</id><fullname>CE manager</fullname><created>2021-03-11 12:02:53</created><content><email-content><mail-id>01000178212b0c3d-b4c50646-7c08-493e-b074-f68c23b380cb-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="b6d624c1-0bdc-42ec-b704-0db759903aea" type="workflow"><id>b6d624c1-0bdc-42ec-b704-0db759903aea</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-11 12:06:22</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="c4c2f68f-66e9-4587-b3d9-89b38920ad9e" type="workflow"><id>c4c2f68f-66e9-4587-b3d9-89b38920ad9e</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-11 12:14:26</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="7ed83158-f7e5-4b3d-b4d0-c275b20327f8" type="email"><id>7ed83158-f7e5-4b3d-b4d0-c275b20327f8</id><fullname>CE manager</fullname><created>2021-03-11 12:14:26</created><content><email-content><mail-id>010001782135a396-3eb3588e-34a3-482f-b3b1-cf105475b3ed-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="71b59ef1-bbcc-4eed-899c-3978753aa625" type="workflow"><id>71b59ef1-bbcc-4eed-899c-3978753aa625</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-11 12:14:44</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="59b34333-d836-4c7c-b7ce-fc1687581aba" type="workflow"><id>59b34333-d836-4c7c-b7ce-fc1687581aba</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-11 12:16:39</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="b6ba00ac-49c9-40e9-a159-22929f8b52b7" type="email"><id>b6ba00ac-49c9-40e9-a159-22929f8b52b7</id><fullname>CE manager</fullname><created>2021-03-11 12:16:39</created><content><email-content><mail-id>010001782137aab1-9646251b-e93b-4746-84b7-f4d1bdda598c-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="aba8f561-d6a3-4b2a-bec6-c1ca03db0d12" type="workflow"><id>aba8f561-d6a3-4b2a-bec6-c1ca03db0d12</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-11 12:17:00</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="b7c61359-f556-4fc4-884e-49a58a0feb3f" type="workflow"><id>b7c61359-f556-4fc4-884e-49a58a0feb3f</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-12 04:15:16</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="6a3bffb8-372a-45bc-9514-f400533189e6" type="email"><id>6a3bffb8-372a-45bc-9514-f400533189e6</id><fullname>CE manager</fullname><created>2021-03-12 04:15:16</created><content><email-content><mail-id>0100017824a54e14-54360c06-22b6-48f7-97de-0cc13e769614-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="5be8d3ca-db8b-497a-9c7c-68ab4356a569" type="workflow"><id>5be8d3ca-db8b-497a-9c7c-68ab4356a569</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-12 04:31:36</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="6a1bd87a-b3c5-414b-848d-eb70dcbc1d62" type="workflow"><id>6a1bd87a-b3c5-414b-848d-eb70dcbc1d62</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-15 04:49:42</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="03cf906b-1ff3-4925-bd06-b8f28d581519" type="email"><id>03cf906b-1ff3-4925-bd06-b8f28d581519</id><fullname>CE manager</fullname><created>2021-03-15 04:49:43</created><content><email-content><mail-id>010001783437ea36-92905cfc-b8d0-4ab6-89f3-8d929176eeb6-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="c57cf543-d257-4d3f-9ba1-87f81575541c" type="workflow"><id>c57cf543-d257-4d3f-9ba1-87f81575541c</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-15 05:58:48</created><content>Unassigned</content></note><note id="93b05715-f24a-41d1-9e08-6b7698c140c1" type="email"><id>93b05715-f24a-41d1-9e08-6b7698c140c1</id><fullname>CE manager</fullname><created>2021-03-15 05:58:49</created><content><email-content><mail-id>0100017834772d41-89a08dd9-6987-4411-b368-53f5e177be70-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="ff4c71f2-93b8-4c1c-9174-cb46ad70f85a" type="workflow"><id>ff4c71f2-93b8-4c1c-9174-cb46ad70f85a</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-15 07:15:11</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="e3f352c9-1c72-4177-a689-f3c61158b39e" type="workflow"><id>e3f352c9-1c72-4177-a689-f3c61158b39e</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-16 04:04:43</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="3543141e-0a48-4130-88c5-37b1a059025f" type="email"><id>3543141e-0a48-4130-88c5-37b1a059025f</id><fullname>CE manager</fullname><created>2021-03-16 04:04:45</created><content><email-content><mail-id>0100017839351b3c-1436a43c-9917-4d95-8f76-ed66eb070af5-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="73468d5b-1ff7-494a-8146-7b40a16a0c4a" type="workflow"><id>73468d5b-1ff7-494a-8146-7b40a16a0c4a</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-16 04:58:02</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="aa2a646a-2760-41a5-a0f9-eecaa36ce50c" type="workflow"><id>aa2a646a-2760-41a5-a0f9-eecaa36ce50c</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-16 05:25:46</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="029c1620-4ad2-4b55-9117-e0dbe7ba8469" type="email"><id>029c1620-4ad2-4b55-9117-e0dbe7ba8469</id><fullname>CE manager</fullname><created>2021-03-16 05:25:47</created><content><email-content><mail-id>01000178397f4ac5-bafd2630-d228-4706-8269-6d2aca4cacca-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="0d0392ee-26f4-4dbc-b2d3-0e96b25c3d66" type="workflow"><id>0d0392ee-26f4-4dbc-b2d3-0e96b25c3d66</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-16 05:34:26</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="afbb5d07-a3fc-45ab-bcb6-526b397f074b" type="workflow"><id>afbb5d07-a3fc-45ab-bcb6-526b397f074b</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-16 06:02:04</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="150a1701-73cd-4fe4-afd3-2ea340cba99a" type="email"><id>150a1701-73cd-4fe4-afd3-2ea340cba99a</id><fullname>CE manager</fullname><created>2021-03-16 06:02:04</created><content><email-content><mail-id>0100017839a085bf-07b7947c-2251-4d73-87db-4aa14d7841c0-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="f1b757ab-1723-41b2-b0bb-7456c558ca1c" type="workflow"><id>f1b757ab-1723-41b2-b0bb-7456c558ca1c</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-16 06:08:09</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="4adc18df-b229-495c-a917-08475e731d71" type="workflow"><id>4adc18df-b229-495c-a917-08475e731d71</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-16 07:12:26</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="0ee27bac-887d-40a6-8346-aae747f2a8f4" type="email"><id>0ee27bac-887d-40a6-8346-aae747f2a8f4</id><fullname>CE manager</fullname><created>2021-03-16 07:12:27</created><content><email-content><mail-id>0100017839e0f3f4-14cc0097-5867-44e1-a97b-75573e5eb44e-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="f1d10b53-e8ed-4abb-b362-ff81878e2ade" type="workflow"><id>f1d10b53-e8ed-4abb-b362-ff81878e2ade</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-16 07:14:25</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="c726fee0-aa02-4098-ba10-dfe1b0d74810" type="workflow"><id>c726fee0-aa02-4098-ba10-dfe1b0d74810</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-16 07:24:40</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="cce36774-b1b6-4fb6-bc6a-033a5e36b49c" type="email"><id>cce36774-b1b6-4fb6-bc6a-033a5e36b49c</id><fullname>CE manager</fullname><created>2021-03-16 07:24:40</created><content><email-content><mail-id>0100017839ec25a9-85310e21-cd1b-4201-8373-4cb3fa5d7822-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="e2f0c7c6-7c5e-4eba-b287-05a368d48f8b" type="workflow"><id>e2f0c7c6-7c5e-4eba-b287-05a368d48f8b</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-16 09:27:56</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="7daeece3-7ea4-4e40-b2c0-2102b04f7df3" type="workflow"><id>7daeece3-7ea4-4e40-b2c0-2102b04f7df3</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-16 10:04:47</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="bdf671cd-5425-4c69-ab97-65eafdaf8385" type="email"><id>bdf671cd-5425-4c69-ab97-65eafdaf8385</id><fullname>CE manager</fullname><created>2021-03-16 10:04:48</created><content><email-content><mail-id>010001783a7ebe71-b17f0e5c-a61c-4ec1-ac39-fd1274daacf4-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="5361893f-3028-4ae5-91f4-9b696c3f6160" type="workflow"><id>5361893f-3028-4ae5-91f4-9b696c3f6160</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-16 11:12:51</created><content>Unassigned</content></note><note id="f9d701b3-a6e9-4690-b9c0-a27d71061e38" type="email"><id>f9d701b3-a6e9-4690-b9c0-a27d71061e38</id><fullname>CE manager</fullname><created>2021-03-16 11:12:52</created><content><email-content><mail-id>010001783abd0deb-ad3bb1d8-931f-4d49-b96f-09732217fb27-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="ce1c3487-9d27-4228-be69-a65cbb3ad506" type="workflow"><id>ce1c3487-9d27-4228-be69-a65cbb3ad506</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 03:57:02</created><content>Unassigned</content></note><note id="72303300-701b-4a7d-a3cf-d73c7dfc9f67" type="email"><id>72303300-701b-4a7d-a3cf-d73c7dfc9f67</id><fullname>CE manager</fullname><created>2021-03-17 03:57:03</created><content><email-content><mail-id>010001783e546ae6-5c979eb0-89a4-4010-8d16-2f8fdc38d97c-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="9c4c09a3-cebb-4204-8fe3-bdcff0b457b6" type="workflow"><id>9c4c09a3-cebb-4204-8fe3-bdcff0b457b6</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-17 04:16:48</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="da863793-c85f-456c-a061-f98d67890cdf" type="workflow"><id>da863793-c85f-456c-a061-f98d67890cdf</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 11:02:54</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="bd9e62ec-07f9-4314-bea6-c2bbc7c6f56e" type="email"><id>bd9e62ec-07f9-4314-bea6-c2bbc7c6f56e</id><fullname>CE manager</fullname><created>2021-03-17 11:02:54</created><content><email-content><mail-id>010001783fda4d71-19f5b91a-7bc0-450a-b803-efcb4f7fc27f-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="62300c1a-7051-4ce1-b376-a62370012d5a" type="workflow"><id>62300c1a-7051-4ce1-b376-a62370012d5a</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 13:46:34</created><content>Assigned to : CE Beginner, cebeginner@exeterpremedia.com</content></note><note id="3de77670-dcac-4cf1-af95-89a437c1d08b" type="email"><id>3de77670-dcac-4cf1-af95-89a437c1d08b</id><fullname>CE manager</fullname><created>2021-03-17 13:46:36</created><content><email-content><mail-id>01000178407027d4-2d9c7c28-ce61-44ff-9f79-6bb707760218-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cebeginner@exeterpremedia.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="a4542991-357a-4491-9351-7268390f2e5a" type="workflow"><id>a4542991-357a-4491-9351-7268390f2e5a</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 13:55:47</created><content>Unassigned : CE Beginner, cebeginner@exeterpremedia.com</content></note><note id="c0edf38d-2511-42fa-bf3a-4f896350c516" type="email"><id>c0edf38d-2511-42fa-bf3a-4f896350c516</id><fullname>CE manager</fullname><created>2021-03-17 13:55:48</created><content><email-content><mail-id>0100017840789625-97b7cfbe-4b7b-4298-83c5-f87d5cd99120-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="c98b69f0-1c2b-4f15-8039-999660ff73d8" type="workflow"><id>c98b69f0-1c2b-4f15-8039-999660ff73d8</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 13:57:53</created><content>Unassigned</content></note><note id="1d689c2c-a9fc-4165-a90a-cfe12d770aa0" type="email"><id>1d689c2c-a9fc-4165-a90a-cfe12d770aa0</id><fullname>CE manager</fullname><created>2021-03-17 13:57:54</created><content><email-content><mail-id>01000178407a825b-61c05f1c-fea5-45c3-b9f0-f0ceeed8f6ba-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="da3e4428-a577-4eda-b780-3b33421a3c4c" type="workflow"><id>da3e4428-a577-4eda-b780-3b33421a3c4c</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 13:58:09</created><content>Unassigned</content></note><note id="0d67bb79-49dd-4a17-9d68-a6670e3c7482" type="email"><id>0d67bb79-49dd-4a17-9d68-a6670e3c7482</id><fullname>Workflow</fullname><created>2021-03-17 13:58:09</created><content><email-content><mail-id>01000178407abf1a-4a55b9d2-75b0-4c81-b8fc-b85a3387d6cd-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="87ad8861-296e-44fe-a1c4-e93964db295b" type="workflow"><id>87ad8861-296e-44fe-a1c4-e93964db295b</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 13:58:15</created><content>Assigned to : Copyeditor 3, cetest3@exeterpm.com</content></note><note id="58cc69ca-9f63-409f-846f-0fdcd93c84c1" type="email"><id>58cc69ca-9f63-409f-846f-0fdcd93c84c1</id><fullname>Workflow</fullname><created>2021-03-17 13:58:15</created><content><email-content><mail-id>01000178407ad6b7-dc1b8182-61de-4952-a8b6-350b7e1b8af4-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest3@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="932a26a8-8173-402f-8f9d-43e2a7815990" type="workflow"><id>932a26a8-8173-402f-8f9d-43e2a7815990</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 13:58:53</created><content>Unassigned : Copyeditor 3, cetest3@exeterpm.com</content></note><note id="902b48c8-d732-4847-9535-51550cab875c" type="email"><id>902b48c8-d732-4847-9535-51550cab875c</id><fullname>Workflow</fullname><created>2021-03-17 13:58:54</created><content><email-content><mail-id>01000178407b6df6-b4d0e6c0-fa67-4d8a-8ac7-07a4d87c1ddc-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="2ffbb206-1fd9-4cf9-b73d-767ad115a073" type="workflow"><id>2ffbb206-1fd9-4cf9-b73d-767ad115a073</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 13:59:04</created><content>Assigned to : Copyeditor 3, cetest3@exeterpm.com</content></note><note id="92cdf99c-0f54-4bbd-b2d9-a852698a8c9d" type="email"><id>92cdf99c-0f54-4bbd-b2d9-a852698a8c9d</id><fullname>Workflow</fullname><created>2021-03-17 13:59:04</created><content><email-content><mail-id>01000178407b9689-b0236a36-4890-4682-8d4b-bd5675b3c233-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest3@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="08422036-f0bd-4509-a8fe-16f3676d5d2e" type="workflow"><id>08422036-f0bd-4509-a8fe-16f3676d5d2e</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 13:59:14</created><content>Unassigned : Copyeditor 3, cetest3@exeterpm.com</content></note><note id="85e0c87e-d34d-4c1d-be03-82970b1a5661" type="email"><id>85e0c87e-d34d-4c1d-be03-82970b1a5661</id><fullname>Workflow</fullname><created>2021-03-17 13:59:14</created><content><email-content><mail-id>01000178407bbd25-7a186d43-f5ac-43ac-b5b1-c109a2e1c770-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="e90e1e91-cf0f-4dbf-8912-cc148433ba2b" type="workflow"><id>e90e1e91-cf0f-4dbf-8912-cc148433ba2b</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 13:59:39</created><content>Unassigned</content></note><note id="0db3f5e4-1792-46e8-bf55-9111a557d31c" type="email"><id>0db3f5e4-1792-46e8-bf55-9111a557d31c</id><fullname>Workflow</fullname><created>2021-03-17 13:59:40</created><content><email-content><mail-id>01000178407c219a-4a428e41-9f5c-4d8c-8cbb-dc591ea325fe-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="da1cb14f-0637-4ab0-80ac-1104325275fe" type="workflow"><id>da1cb14f-0637-4ab0-80ac-1104325275fe</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 14:02:48</created><content>Unassigned</content></note><note id="695892a7-bc9b-48dc-a859-ecfd97086812" type="email"><id>695892a7-bc9b-48dc-a859-ecfd97086812</id><fullname>CE manager</fullname><created>2021-03-17 14:02:48</created><content><email-content><mail-id>01000178407f024b-fb0fba7c-eec5-4e37-8c31-b0d8133ed00b-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="72f6623b-2d2f-4e57-8fe4-78f94b45a604" type="workflow"><id>72f6623b-2d2f-4e57-8fe4-78f94b45a604</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 14:05:42</created><content>Unassigned</content></note><note id="fe24ceab-d911-4a51-9ac7-cb9126327382" type="email"><id>fe24ceab-d911-4a51-9ac7-cb9126327382</id><fullname>CE manager</fullname><created>2021-03-17 14:05:42</created><content><email-content><mail-id>010001784081a9fe-11b01d53-d3ab-4478-8ad6-0bd4600cb37b-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="3173bf77-fa33-4f7c-aa2a-5630cb347085" type="workflow"><id>3173bf77-fa33-4f7c-aa2a-5630cb347085</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 14:07:59</created><content>Unassigned</content></note><note id="63bf4e4d-0d5d-4bbd-8291-8be9831a028b" type="email"><id>63bf4e4d-0d5d-4bbd-8291-8be9831a028b</id><fullname>CE manager</fullname><created>2021-03-17 14:07:59</created><content><email-content><mail-id>010001784083c04a-0e69b5f6-9205-4b38-9874-8bef1a20d2d3-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="b451662a-1f31-4dbd-bfdc-052fcebb07db" type="workflow"><id>b451662a-1f31-4dbd-bfdc-052fcebb07db</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 14:13:15</created><content>Unassigned</content></note><note id="3be03b9c-978f-4836-bfb2-26e89983e1a9" type="email"><id>3be03b9c-978f-4836-bfb2-26e89983e1a9</id><fullname>CE manager</fullname><created>2021-03-17 14:13:15</created><content><email-content><mail-id>01000178408891fb-11877686-8c04-4c5f-a3ae-de99164fae16-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="16832888-4813-497e-8898-83d8a3c9ede4" type="workflow"><id>16832888-4813-497e-8898-83d8a3c9ede4</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-17 14:13:26</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="d6b7f2cb-e200-4ea7-a918-b581a1bda3a5" type="workflow"><id>d6b7f2cb-e200-4ea7-a918-b581a1bda3a5</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-17 14:39:11</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="0a417a42-a865-4782-91f3-ca0f9b0a0615" type="email"><id>0a417a42-a865-4782-91f3-ca0f9b0a0615</id><fullname>CE manager</fullname><created>2021-03-17 14:39:12</created><content><email-content><mail-id>0100017840a05276-2c81d732-c894-4b27-9921-653f3b1be4c4-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="c50466ad-cd52-4b30-816e-b686631239e0" type="workflow"><id>c50466ad-cd52-4b30-816e-b686631239e0</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-17 14:39:23</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="b4ca664f-1c5f-4e8a-8173-2cb7b4cb57ac" type="workflow"><id>b4ca664f-1c5f-4e8a-8173-2cb7b4cb57ac</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-18 04:51:57</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="d12acf5a-d470-43a4-a52d-3cfd99d2afa6" type="email"><id>d12acf5a-d470-43a4-a52d-3cfd99d2afa6</id><fullname>CE manager</fullname><created>2021-03-18 04:51:57</created><content><email-content><mail-id>0100017843ad0be8-291aa0d8-2ef3-477e-9b1c-6fe006c5dd71-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="fd91bdb0-f736-4e73-8ee6-cf1cc839be41" type="workflow"><id>fd91bdb0-f736-4e73-8ee6-cf1cc839be41</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-18 04:52:08</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="16837407-c75f-41b8-88f0-acd849e026fe" type="workflow"><id>16837407-c75f-41b8-88f0-acd849e026fe</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-18 05:16:11</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="398d02d5-b886-4028-8789-4b1364b8910b" type="email"><id>398d02d5-b886-4028-8789-4b1364b8910b</id><fullname>CE manager</fullname><created>2021-03-18 05:16:11</created><content><email-content><mail-id>0100017843c33b48-4d10d0d1-8a9f-4989-a74c-61f50b9799e3-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="50199e22-856a-4bd4-bcae-e22bf10100fc" type="workflow"><id>50199e22-856a-4bd4-bcae-e22bf10100fc</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-18 05:16:21</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="c7477200-a941-4bd9-8248-f8be529a5f41" type="workflow"><id>c7477200-a941-4bd9-8248-f8be529a5f41</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-18 10:35:02</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="285be97f-1ee6-415d-a5a9-f6478a81a409" type="email"><id>285be97f-1ee6-415d-a5a9-f6478a81a409</id><fullname>CE manager</fullname><created>2021-03-18 10:35:03</created><content><email-content><mail-id>0100017844e72728-c4ec2651-4034-4d90-85ba-569fbee18f9b-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="639362b1-502d-4226-9ef3-376bbb41c7c8" type="workflow"><id>639362b1-502d-4226-9ef3-376bbb41c7c8</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-18 10:35:14</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="e74fc069-8f73-4c41-ab9e-ff8e87b1a949" type="workflow"><id>e74fc069-8f73-4c41-ab9e-ff8e87b1a949</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-19 05:42:19</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="33119f67-4f14-47f1-a7f0-d19a56851db8" type="email"><id>33119f67-4f14-47f1-a7f0-d19a56851db8</id><fullname>CE manager</fullname><created>2021-03-19 05:42:20</created><content><email-content><mail-id>0100017849018738-eae4f250-f26f-4459-a4d9-aee7f269f289-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="6dfd6f71-0ea4-4d87-9262-f2d404853faf" type="workflow"><id>6dfd6f71-0ea4-4d87-9262-f2d404853faf</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-19 05:42:31</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="dfcc60cb-4a7c-484b-8c10-41816fd17166" type="workflow"><id>dfcc60cb-4a7c-484b-8c10-41816fd17166</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-19 12:59:30</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="696b2811-c488-495e-8637-8b4f0154a17a" type="email"><id>696b2811-c488-495e-8637-8b4f0154a17a</id><fullname>CE manager</fullname><created>2021-03-19 12:59:31</created><content><email-content><mail-id>010001784a91c6bb-c4aee0fc-4517-4a78-94dc-8876a06ce102-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="45483d07-8a59-4c46-bf49-6a2c8e6cee4c" type="workflow"><id>45483d07-8a59-4c46-bf49-6a2c8e6cee4c</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-19 12:59:42</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="9c02f97f-1df7-448d-aa37-2a3900508659" type="workflow"><id>9c02f97f-1df7-448d-aa37-2a3900508659</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-22 05:12:48</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="181787ab-15fe-42a0-9c0b-0b851d6c75a7" type="email"><id>181787ab-15fe-42a0-9c0b-0b851d6c75a7</id><fullname>CE manager</fullname><created>2021-03-22 05:12:49</created><content><email-content><mail-id>01000178585996f2-64b5c572-2bf7-480b-a7cb-9d372d62cf54-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="e4026781-bb55-4e1b-a27e-980ccafd72c8" type="workflow"><id>e4026781-bb55-4e1b-a27e-980ccafd72c8</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-22 05:13:00</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="99177a9f-eea6-4eba-a4cd-48b731229043" type="workflow"><id>99177a9f-eea6-4eba-a4cd-48b731229043</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-23 04:16:34</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="7227fb8e-4dfe-4496-9ce0-784e417bca35" type="email"><id>7227fb8e-4dfe-4496-9ce0-784e417bca35</id><fullname>CE manager</fullname><created>2021-03-23 04:16:35</created><content><email-content><mail-id>010001785d4c7645-aee4c992-c024-4970-ba65-6957643eb4a0-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="0172fa0c-3ea4-40dd-86f9-92a8ab576d90" type="workflow"><id>0172fa0c-3ea4-40dd-86f9-92a8ab576d90</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-23 04:16:50</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="e8becba9-8e38-4a47-8e9e-c28c4b0548fc" type="workflow"><id>e8becba9-8e38-4a47-8e9e-c28c4b0548fc</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-24 04:24:58</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="936be59d-9e2d-4130-adac-01ceb4f49f7a" type="email"><id>936be59d-9e2d-4130-adac-01ceb4f49f7a</id><fullname>CE manager</fullname><created>2021-03-24 04:24:59</created><content><email-content><mail-id>01000178627a812d-6f2c7911-d5a5-4e09-872e-5fb885e64199-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="568d3c3c-f1f7-474d-999b-4841540d97e0" type="workflow"><id>568d3c3c-f1f7-474d-999b-4841540d97e0</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-24 04:25:19</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="66fddb43-ee21-417e-ab63-dc4c9c081dd8" type="workflow"><id>66fddb43-ee21-417e-ab63-dc4c9c081dd8</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-24 04:33:44</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="9a726de3-acfa-4caa-a860-f413a3fe203e" type="email"><id>9a726de3-acfa-4caa-a860-f413a3fe203e</id><fullname>CE manager</fullname><created>2021-03-24 04:33:45</created><content><email-content><mail-id>01000178628287d9-881d414b-debd-43eb-801a-844b15ee4733-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="c975d999-cd5a-4ddf-8e99-b425a76b21d6" type="workflow"><id>c975d999-cd5a-4ddf-8e99-b425a76b21d6</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-24 04:33:56</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="ec49dd9f-9fcb-43d1-85ca-2debf9512391" type="workflow"><id>ec49dd9f-9fcb-43d1-85ca-2debf9512391</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-25 12:01:26</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="c1a67259-145a-4329-9686-190d0149445d" type="email"><id>c1a67259-145a-4329-9686-190d0149445d</id><fullname>CE manager</fullname><created>2021-03-25 12:01:27</created><content><email-content><mail-id>010001786942c6e2-e385892a-09f5-4feb-ac28-40f645230182-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="81414cde-9f5c-4efc-98c0-ee524721ade1" type="workflow"><id>81414cde-9f5c-4efc-98c0-ee524721ade1</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-25 12:01:55</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="b82d6da4-7b82-4723-a447-4a33dd2b99ae" type="workflow"><id>b82d6da4-7b82-4723-a447-4a33dd2b99ae</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-29 05:39:54</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="a999fd68-7628-40f1-be08-8646c6b05be9" type="email"><id>a999fd68-7628-40f1-be08-8646c6b05be9</id><fullname>CE manager</fullname><created>2021-03-29 05:39:54</created><content><email-content><mail-id>010001787c7ee609-c7529ba7-5e45-4433-8848-aaf4e92aa663-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="fcf8add5-5ea4-4d22-9f72-52ed05915e03" type="workflow"><id>fcf8add5-5ea4-4d22-9f72-52ed05915e03</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-29 05:40:04</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="06041294-8a83-4c32-bc56-a3ae295b6bd5" type="workflow"><id>06041294-8a83-4c32-bc56-a3ae295b6bd5</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-29 10:48:10</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="e898301b-fa41-44b1-8885-8e9e756cc791" type="email"><id>e898301b-fa41-44b1-8885-8e9e756cc791</id><fullname>CE manager</fullname><created>2021-03-29 10:48:10</created><content><email-content><mail-id>010001787d9920f6-e48fcf62-d0fd-4187-9829-90fae3f02129-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="bcccbb90-9e71-458a-8138-c58ca551ec4f" type="workflow"><id>bcccbb90-9e71-458a-8138-c58ca551ec4f</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-29 10:59:25</created><content>Unassigned</content></note><note id="af4a003f-1275-409b-8b43-734ac32f42ff" type="email"><id>af4a003f-1275-409b-8b43-734ac32f42ff</id><fullname>CE manager</fullname><created>2021-03-29 10:59:25</created><content><email-content><mail-id>010001787da36d53-8f401ce5-054a-4712-a7c9-00e4fbbe29f0-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="54089858-c8fa-4373-8e57-8c8b503ad5bf" type="workflow"><id>54089858-c8fa-4373-8e57-8c8b503ad5bf</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-29 11:08:21</created><content>Unassigned</content></note><note id="ceb118ad-791d-4080-9443-154fa16adca7" type="email"><id>ceb118ad-791d-4080-9443-154fa16adca7</id><fullname>CE manager</fullname><created>2021-03-29 11:08:21</created><content><email-content><mail-id>010001787dab9aca-ab02dcf0-a007-4338-a771-fb5c2d8ec725-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="2fdd33ce-efb5-4c71-b079-f90dba6f59dc" type="workflow"><id>2fdd33ce-efb5-4c71-b079-f90dba6f59dc</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-29 11:08:31</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="ead695c2-7dc7-47e6-9bef-b83a97e5c87b" type="workflow"><id>ead695c2-7dc7-47e6-9bef-b83a97e5c87b</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-30 05:42:25</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="543ba6c6-0476-468e-ba70-d2ee81538746" type="email"><id>543ba6c6-0476-468e-ba70-d2ee81538746</id><fullname>CE manager</fullname><created>2021-03-30 05:42:25</created><content><email-content><mail-id>0100017881a79029-b89b55e8-af6a-410e-8f55-0f05e70fc842-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note><note id="a2d9a838-1f30-461d-a942-0b40eef9a7ae" type="workflow"><id>a2d9a838-1f30-461d-a942-0b40eef9a7ae</id><fullname>Copyeditor 2, cetest2@exeterpm.com</fullname><created>2021-03-30 05:42:37</created><content>Assigned to : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="20d9f84a-48aa-4b61-b3f6-90ba95add8e4" type="workflow"><id>20d9f84a-48aa-4b61-b3f6-90ba95add8e4</id><fullname>CE manager, cetest.m@exeterpm.com</fullname><created>2021-03-30 05:45:31</created><content>Unassigned : Copyeditor 2, cetest2@exeterpm.com</content></note><note id="5cc38171-81c8-47a9-8326-daad81b04ca3" type="email"><id>5cc38171-81c8-47a9-8326-daad81b04ca3</id><fullname>CE manager</fullname><created>2021-03-30 05:45:32</created><content><email-content><mail-id>0100017881aa697b-c0fe367b-a815-4ea1-9b3b-6d758345d4ec-000000</mail-id><mail-subject>FOR TESTING PURPOSE: bcr-2020-238413 - Article has been Assigned to Copyeditor</mail-subject><from>donotreply@exeterpremedia.com</from><to>crest@exeterpremedia.com</to><mail-body><div style="background:#8080803b;padding:10px;display:inline-block;">This is an automatic email. If you need to reply please contact </div><div style="background:#8080803b;padding:10px;display:block;margin-top: 10px;">*************************************************<p>THIS MESSAGE WILL APPEAR ONLY IN TEST</p><p>Values used in Live - </p><p>To: cetest.m@exeterpm.com</p><p>cc: </p><p>bcc: </p><p>Email Subject: bcr-2020-238413 - Article has been Assigned to Copyeditor</p>*************************************************</div><p><b>bcr-2020-238413</b> has been Assigned</p></mail-body></email-content></content></note></production-notes></article>
